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ABSTRACT 
Background: Pharmaceutical care has become the philosophy of pharmacy 
practice worldwide. Accordingly, pharmaceutical services started to shift from 
product-oriented to patient-focused services. There are no reported studies on the 
means for implementation of this important aspect in Sudan. 
Study Design: Community and hospital based cross-sectional descriptive surveys. 
Setting: Community pharmacies and Teaching hospitals in Khartoum state. 
Objectives: To investigate the current situation of community pharmacy practice 
in Sudan and compare that with the practice in selected developing and developed 
countries. To recognize suitable models of patient-focused practice that can be 
applied in Sudan. 
Methods: Three self-administered, pre-tested, structured questionnaires were 
distributed to, randomly selected, 128 community pharmacists, 122 medical 
practitioners and 256 community pharmacy customers. The questionnaires 
assessed Knowledge, attitude and practice of pharmacists, doctors’ and customers’ 
views concerning pharmaceutical care. Data about pharmacy practice in other 
countries was obtained electronically. Descriptive statistical analysis was used for 
direct questions. 5-point Likert-type scale was used to measure attitude responses 
(Scores =  3 are considered positive). Possible association between socio-
demographic characteristics and attitude responses was measured by Student’s t-
test and One-Way ANOVA. Statistical significance was considered if P<0.05.  
Results: Pharmacists’ survey: The response rate was 50%. Community pharmacy 
practice is mainly product-focused (Mean Positive Score ± SD = 4.47 ± 1.02, 
Frequency (%) = 87.5%) with no or little clinical activities. However, there is 
positive attitude among pharmacists towards the implementation of pharmaceutical 
care activities (4.39 ± 0.73, 89%) such as chronic disease management (4.54 ± 
0.74, 95.3%), health promotion (4.56 ± 0.76, 90.6%) and screening services. Many 
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barriers for implementation of patient care were highlighted including public and 
health care professionals’ perception on pharmacists’ clinical role (4.25 ± 0.84, 
82.8%), structure of the health care system (3.92 ± 1.09, 73.5%), lack of time (3.98 
± 1.02, 78.1%) and clinical skills (4.27 ± 0.73, 87.5%).  
Doctors’ survey: Response rate was 65%. Medical officers maintained more 
contact with community pharmacists than consultants (P = 0.025) through direct 
visits (90%). Doctors showed positive response to the extended role of the 
pharmacists (14 out of 19 scores > 3). Their attitudes towards pharmaceutical care 
implementation were very encouraging (all scores > 3). 
Customers’ survey: Response rate was 50%. Customers visit community 
pharmacies mainly for prescription dispensing (84.4%) and over the counter 
medications (70.9%). Forty percent use the same pharmacy all the time. Customers 
were quite satisfied with the current services of community pharmacists and view 
them as readily accessible and willing to give advices. Customers do not seek 
pharmacists’ advice regarding health promotion (all responses < 35%). However, 
most customers (82.6%) agreed to the introduction of patient care services in 
community pharmacies such as medication review (83.4%), screening (72%) and 
patient counseling (64%). 
Conclusion: Exploration of community pharmacy practice in Sudan revealed that 
the practice is mainly traditional dispensing with no clinical roles compared to 
developed countries. The surveyed community pharmacists, doctors and customers 
favor the application of pharmaceutical care in Sudan. Consequently, “Health 
Promotion and Disease Prevention”, “Medication Review for Chronic Diseases” 
and “Treatment of Minor Diseases” models were suggested as means to start 
patient care in community pharmacies. This requires revision of pharmacy  
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curriculum, pharmacy practice policies and high level of collaboration between all 
concerned professional bodies. 
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CHAPTER ONE 
SECTION  I : 
                    ϭ͘ϭINTRODUCTION 
 
ϭ͘ϭ͘ϭ Evolution of pharmacy profession 
Pharmacy profession through its evolution and progress had 
passed into different stages, which marked its history with various 
developmental periods. For a long time in the history, pharmacy as a 
practice remained embedded within Medical profession. The separation 
of pharmacy from medicine to be a unique profession specialized in 
compounding and dispensing medications, took place in different areas 
or countries at different rates depending on the culture and the 
conditions surrounding the emergence of the practice ͘,ĂŵĂƌŶĞŚ;ϭϵϲϮͿ
noted that 'The emergence of professional pharmacy in medieval Islam 
period as a separate entity from medicine has followed almost the same 
pattern that modeled other branches of health field during this period. 
But difficulty arose from the fact that there was no clear governmental 
legislation to prohibit the pharmacist from diagnosing and giving medical 
treatment to his customers or to restrict the physician from 
compounding and dispensing drugs to his patients. The charlatan and 
uncultured practitioners, from both professions, not only in rural areas 
but also in cities, prevented pharmacy from attaining professional status. 
Nevertheless, in larger hospitals and centers close to governmental 
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supervision retail pharmacists as well as those in hospitals and 
government services enjoyed recognition and prestige. In the Abbasside 
period in Bagdad and during the reign of Al-DƵƩĂƐŝŵ;ϴϯϯ-ϴϰϱͿŝƚǁĂƐ
reported that educated and morally respectable pharmacists (Sayadilah) 
were granted license to operate their own drug stores near army camps, 
while uncultured drug sellers and quacks were forbidden that privilege. 
Privately owned 'public' pharmacy shops existed in Iraq in the last 
quarter of the eighth century. Educated, responsible pharmacists are 
reported almost forty years later, but charlatans, spice and perfume 
sellers and drug dealers continued to form a majority. Nevertheless, the 
separation of pharmacy from medicine in Islam, when it was made, was 
not the result of legislative action enforced by the central government. 
Rather it was the outcome of a need for specialization in view of 
expanding trade and knowledge of drugs and the skill required for 
compounding the various pharmaceutical preparations. In Europe by the 
nineteenth century due to their scientific contributions and the solid 
upper-middle-class credentials, pharmacists attained well established 
social position similar to that of physicians. In Britain the position of the 
pharmaceutical profession within the hierarchy of healing did not 
become established firmly until the mid-ϭϵƚŚĐĞŶƚƵƌǇ͘dŚĞŽƌŝŐŝŶĂůĐůĂƐƐ
of pharmacy practitioners, the apothecaries, had evolved during the 
ϭϲϬϬƐĂŶĚϭϳϬϬƐŝŶƚŽĂƐĞĐŽŶĚŐƌŽƵƉŽĨŵĞĚŝĐĂůƉƌĂĐƟƟŽŶĞƌƐƐĞƌǀŝĐŝŶŐ
those who could not afford the high fees demanded by the small cadre 
of university-educated physicians. As apothecaries became more and 
more like general practitioners of medicine, "chemist" and "druggists", 
i.e. those who manufactured and sold drugs and medicines for the 
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apothecaries, rose up to take over the open pharmaceutical niche 
;,ŝŐďǇ͕ϭϵϵϱͿ͘/Ŷϭϴϰϭ͕ĂŶĚƚŚƌŽƵŐŚĐŽŵƉůĞǆĚĞǀĞůŽƉŵĞŶƚƐ͕ƚŚŝƐŐƌŽƵƉ
of "chemists and druggists" established the Pharmaceutical association 
ŽĨ'ƌĞĂƚƌŝƚĂŝŶ;ƌĞůŝŶ͕ϭϵϲϳͿ͘/ŶŵĞƌŝĐĂĚƵƌŝŶŐƚŚĞĞĂƌůǇϭϴƚŚĐĞŶƚƵƌǇ
the boundaries between medicine and pharmacy is not clear, with most 
physicians having some sort of shop practice, and most apothecary 
shops were run either by an attending physician or his apprentice, or by 
an apothecary hired by the owner-physician. Many factors supported 
the growth of pharmaceutical profession in America either commercial 
e.g. appearance of mass-manufacturers which began producing drug 
ƉƌĞƉĂƌĂƟŽŶƐŝŶƚŚĞůĂƚĞϭϴϱϬƐ͕ǁŝƚŚůĞƐƐƐŬŝůĞĚƉĞƌƐŽŶƐĞŶƚĞƌŝŶŐƚŚĞ
rank of pharmacy, or development within the health-care sector, as 
physicians supported the growth of the pharmacy profession, releasing 
them from compounding medicines and stocking a shop, or due to their 
need of the expertise of the best druggists and apothecaries. The 
American PharmaceuƟĐĂůƐƐŽĐŝĂƟŽŶǁĂƐĨŽƵŶĚĞĚŝŶϭϴϱϮ;,ŝŐďǇ͕
ϭϵϵϱͿ͕ĚĞŶŽƟŶŐĂŶĞǁĞƌĂŽĨƉŚĂƌŵĂĐǇƉƌŽĨĞƐƐŝŽŶŝŶŵĞƌŝĐĂ͘
WŚĂƌŵĂĐŝƐƚƐĞŶƚĞƌĞĚƚŚĞϮϬth century as apothecaries (traditional name 
which remained linked with pharmacy and describes the practice of 
compounding and dispensing medicines in the apothecary shop). In this 
period (pre-industrial period) the main features of the practice are 
procurement, compounding of patented preparations, choosing pure 
unadulterated raw materials, and dispensing those medicines, they 
prepare, over-the counter. At this period and through their role in the 
apothecary (and later chemist or druggist shop or store), they have 
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tangible role in the society, because they are closer to patients and are 
prestiged as having the secrets of medicines compounding.  
The emergence of industrialization in the field of pharmaceuticals 
and medicines, have influenced many changes in pharmacy profession 
and its role in the society. The spread of pharmaceutical manufacturers 
and readymade medicines had taken over many activities which are 
traditionally done by the pharmacist. Pharmacists no longer prepare or 
compound drugs as the main activity, and this starts to decrease or 
disappear gradually, instead pharmacists enters in a period mostly 
described by "pour and count" period, in which they are only dispensing 
prescriptions for readymade medicines and to some extent advice on 
their dosage and use. The spread and development in research and 
manufacture of medicines leads to enrichment of the market or the 
community with a wide varieties of pharmacologic groups of drugs with 
different uses, mechanisms of actions, and dosage forms. The 
community still find itself in need of the expertise of the pharmacist due 
to the need of more information on drugs and their uses, and moreover 
their complications. 
 
ϭ͘ϭ͘ϮůŝŶŝĐĂůWŚĂƌŵĂĐǇ 
Pharmacy profession acknowledge the compelling need for 
redefining and reorientation of the pharmacist role to cope with the fast 
changes in the field of pharmacotherapy, and although pharmacists are 
keeping on giving advice and counseling to the community, still the role 
of the pharmacist is considered as "product oriented" and mainly 
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concentrate on distribution and prescription filling. The slight clinical 
activities done in counseling or advising patients is done passively and 
without a concise systematic well-defined procedures, and with a lack in 
clinical-proactive approaches towards patients. 
The overall forces of the complexity in the field of 
pharmacotherapy, the need for the pharmacist as an expert adviser on 
drugs and the profession ambition to utilize the scientific knowledge 
they own, drives pharmacy profession towards redesigning itself for 
carrying a new clinical role in which the patient is the centered target. 
This leads, in the hospital setting to the development of the "clinical 
ƉŚĂƌŵĂĐǇΗŝŶƚŚĞŵŝĚϭϵϲϬƐ͕ŝŶh^͘ůŝŶŝĐĂůƉŚĂƌŵĂĐǇƵƟůŝǌĞĚƚŚĞ
pharmacist knowledge in pharmacology, Biopharmaceutics, 
pharmacokinetic and lead to the development of the current activities: 
Therapeutic drug monitoring, pharmacokinetic dosing, total parenteral 
nutrition….etc. 
ϭ͘ϭ͘ϯWŚĂƌŵĂĐĞƵƟĐĂůĂƌĞ 
WŚĂƌŵĂĐĞƵƟĐĂůĐĂƌĞĂƉƉĞĂƌĞĚĂƐĂƉŚŝůŽƐŽƉŚǇŽĨƉƌĂĐƟĐĞŝŶϭϵϵϬ͘
Pharmaceutical care was first defined by DŝŬĞĂůĞƚĂů;ϭϵϳϱͿ  as the care 
that a given patient receives which assures rational and safe drug usage. 
,ĞƉůĞƌ;ϭϵϵϬͿĂůƐŽĚĞƐĐƌŝďĞĚƉŚĂƌŵĂĐĞƵƟĐĂůĐĂƌĞĂƐΗĂĐŽǀĞŶĂŶƚĂů
relationship between a patient and a pharmacist in which the 
pharmacist perform drug-use-control functions (with appropriate 
knowledge and skill) governed by awareness of and commitment to the 
ƉĂƟĞŶƚƐŝŶƚĞƌĞƐƚ͘,ĞƉůĞƌĂŶĚ^ƚƌĂŶĚ;ϭϵϵϬͿĨƵƌƚŚĞƌĚĞĮŶĞĚƚŚĞƚĞƌŵ
"pharmaceutical care" as "The responsible provision of drug therapy for 
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the purpose of achieving definite outcomes that improve a patient's 
quality of life". These outcomes are: 
1. Cure of a disease  
2. Elimination or reduction of a patient's symptomatology,  
3. Arresting or slowing of a disease process, or  
4. Preventing a disease or symptomatology. 
The definition of pharmaceutical care later was also refined as "a 
patient-centered practice in which the practitioner assumes 
responsibility for a patient's drug-related needs and is held accountable 
ĨŽƌƚŚŝƐĐŽŵŵŝƚŵĞŶƚΗ;ŝƉŽůĞĞƚĂů͕͘ϮϬϬϰͿ͘ 
Translated into everyday practice, pharmaceutical care is what an 
individual pharmacist does when he or she (a) evaluates a patient drug-
related needs, (b) determines whether the patient has one or more 
actual or potential drug related-problems, and then (c) works with the 
patient and other professionals to design, implement, and monitor a 
pharmacotherapeutic plan that will resolve (or prevent) the drug related 
problem. A pharmacist delivers pharmaceutical care only when all these 
three responsibilities have been successfully executed for each and 
every pĂƟĞŶƚ;^ƚƌĂŶĚĞƚĂů͕͘ϭϵϵϮͿ͘ 
The pharmacist as pharmaceutical care practitioner has the 
responsibility that all patient's related needs are satisfactorily met. 
These patient's drug related needs should be discovered during 
pharmaceutical care encounter and based upon the patient medical 
conditions. The need of the "pharmaceutical care" comes from the 
increase in the drug-related morbidity and mortality. The cost of drug 
related morbidity in the United States has been estimated to be as high 
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ĂƐΨϳďŝůŝŽŶĂŶŶƵĂůǇ;^ŽƵƚŚǁŝĐŬ͕ϭϵϴϴͿ͘ƌƵŐ-related morbidity is the 
phenomenon of therapeutic malfunction or miscarriage – the failure of a 
therapeutic agent to produce the intended therapeutic outcome. The 
concept includes both treatment failure (e.g. failure to cure or control a 
disease and production of a new medical problem (e.g. adverse or toxic 
drug effect). Drug related morbidity is the clinical or biosocial 
manifestation of unresolved drug-related problems and may be 
recognized by the patient, a care taker, or a clinician. If not recognized 
and resolved, drug-related morbidity, (manifested as either treatment 
failure or a new medical problem) can lead to drug related mortality, the 
ultimate therapeutic miscarriage. Drug-related morbidity is often 
preceded by a drug-ƌĞůĂƚĞĚƉƌŽďůĞŵ͘ŝƉŽůĞĞƚĂů;ϮϬϬϰͿĐĂƚĞŐŽƌŝǌĞƐƚŚĞ
major drug related problems as follows:  
1- The patient has a medical condition that requires drug therapy (a 
drug indication) but the patient is not receiving a drug for that 
indication. 
2- The patient has a medical condition for which the wrong drug is 
being taken.  
3- The patient has a medical condition for which too little of the 
correct drug is being taken. 
4- The patient has a medical condition for which too much of the 
correct drug is being taken.  
5- The patient has a medical condition resulting from an adverse 
reaction.  
6- The patient has a medical condition resulting from a drug-drug, 
drug-food, and drug-disease interaction. 
7- The patient has a medical condition that is the result of not 
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receiving the prescribed drug. 
8- The patient has a medical condition that is the result of taking a 
drug for which there is no valid indication. 
The initiation practice model of pharmaceutical care comes from 
the innovators, and from community pharmacy setting. Strand and 
colleagues in Peter' institute in Minnesota college of pharmacy started 
an important project to test whether the pharmaceutical care concept 
could work. This is denoted by the name "Minnesota project". The 
project showed that as far as outcomes were concerned, pharmaceutical 
care seemed to be having a positive effect. Drug therapy problems were 
ŝĚĞŶƟĮĞĚĂŶĚƌĞƐŽůǀĞĚ;^ŝŵƉƐŽŶ͕ϭϵϵϳͿ͘ 
Many projects which utilized pharmaceutical care in community 
pharmacies used various models especially the disease-based 
pharmaceutical care model to target patients with chronic diseases. 
/ŶϭϵϵϳĂůŽŶŐ-term community based project for diabetes care in 
community pharmacies was started in Asheville city by Asheville city, 
North Carolina. The objectives of the study were to use the short-term 
ŽƵƚĐŽŵĞƐĂŌĞƌƚŚĞĮƌƐƚϳƚŽϵŵŽŶƚŚƐŽĨƉŚĂƌŵĂĐĞƵƟĐĂůĐĂƌĞ͕ƚŽ
evaluate the effects of the pharmaceutical care services interventions on 
these short-term outcomes when controlling for other factors, and to 
assess the persistence of outcomes aŌĞƌϱǇĞĂƌƐ͘dŚĞƵŶŝƋƵĞĐŽŵƉŽŶĞŶƚ
of the program were pharmaceutical care services provided by 
community pharmacist who reimbursed for their cognitive services, the 
availability of diabetes education center (DEC) that employed certified 
diabetes educators, and patient participation incentives, including a 
home glucose monitor and waiver of co-payment for all diabetes drugs 
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and supplies. The overall results after five years (starting from the first 
ĞŶƌŽůŵĞŶƚĂƚŵĂƌĐŚϭϵϵϳĂŶĚĞŶĚŝŶŐĂƚĞĐĞŵďĞƌϮϬϬϭͿƐŚŽǁƐ that 
diabetic patients receiving pharmaceutical care services in community 
pharmacies maintained clinically meaningful improvement in their 
,ďϭĐ;ŐůǇĐŽƐǇůĂƚĞĚŚĞŵŽŐůŽďŝŶͿĐŽŶĐĞŶƚƌĂƟŽŶƐŽǀĞƌƟŵĞ͕ĂŶĚƚŚŝƌĚ
party payers expressed an overall decline in mean total direct medical 
costs during each year of follow up. Along with this line a Sudanese 
study investigated diabetic care in community pharmacy in Khartoum 
ƐƚĂƚĞ;ůƚĂǇĞďĂŶĚDŽŚĂŵĞĚ͕ϮϬϬϵͿ͘ 
This model for diabetic patients is also extended in Asheville to 
asthmatic patients, through Medication Therapy Management program 
(MTMͿ;ƵŶƟŶŐĂŶĚƌĂŶŽƌ͕ϮϬϬϲͿ͘ 
International pharmacy professional organizations started to 
embrace the philosophy of pharmaceutical care and participated in the 
dissemination of the idea between countries through education and 
ƚŚƌŽƵŐŚĚĞǀŝƐŝŶŐŐƵŝĚĞůŝŶĞƐĂŶĚƐƚĂŶĚĂƌĚƐĨŽƌŝŵƉůĞŵĞŶƚĂƟŽŶ͘/ŶϭϵϵϮ͕
the International Pharmacist Federation (FIP) developed standards for 
pharmacy service under the heading 'Good pharmacy practice in 
CommunitǇĂŶĚ,ŽƐƉŝƚĂůƐĞƫŶŐƐΖ;tŽƌůĚŚĞĂůƚŚŽƌŐĂŶŝǌĂƟŽŶ͕ϭϵϵϲͿ͕
which was revised further by the World Health Organization, and 
expanded to reflect the WHO policies regarding the role of the 
pharmacist in assuring the quality of pharmaceutical products 
throughout the distribution chain, and published as a joined work 
ďĞƚǁĞĞŶ&/WĂŶĚƚŚĞt,KŝŶϭϵϵϲ͘dŚĞƉƵƌƉŽƐĞŽĨƚŚŝƐĚŽĐƵŵĞŶƚŝƐƚŽ
promote excellence of practice and to encourage national 
pharmaceutical organizations to focus in the developing role of the 
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pharmacist, it was thus presented in form of minimum requirements or 
guidelines which can be implemented according to the situation of 
pharmacy practice in each country, and it can be implemented stepwise. 
The GPP, as stated, is considered as a way of implementing 
pharmaceutical care. 
Being aware of the need of developing countries for improvement 
in pharmacy practice and due to different problems facing the practice 
in such countries due to lack of trained pharmacy practitioners, non 
availability or weakness of national professional organizations to set 
standards, limited resources etc. the FIP, issued guidelines for 
ŝŵƉůĞŵĞŶƚĂƟŽŶŽĨ'WWŝŶĚĞǀĞůŽƉŝŶŐĐŽƵŶƚƌŝĞƐŝŶϭϵϵϳ;/ŶƚĞƌŶĂƟŽŶĂů
WŚĂƌŵĂĐĞƵƟĐĂů&ĞĚĞƌĂƟŽŶ͕ϭϵϵϳͿ͘dŚĞƐĞŐƵŝĚĞůŝŶĞƐĂůƐŽƚĂŬĞŝŶƚŽ
consideration the stepwise application and encourage the devising of 
national standards. 
Other pharmacy societies and associations as the American 
Society of Health System Pharmacists produced statement supporting 
pharmaceutical care (American Society of Health-System Pharmacists, 
ϭϵϵϲĂͿ͘ 
ϭ͘ϭ͘ϰdŽƚĂůWŚĂƌŵĂĐǇĂƌĞ 
KƚŚĞƌĂƵƚŚŽƌƐ;,ŽůĂŶĚĂŶĚEŝŵŵŽ͕ϭϵϵϵͿĐŽŶĐĞƉƚƵĂůŝǌĞĚƚŚĂƚ
"pharmaceutical care" will not be the only acceptable practice model 
that pharmacy profession can adopt. Instead they provided other 
general model for practice, building upon the current pharmacists' 
activities, including pharmaceutical care as one of different models that 
pharmacy profession can practice. 
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Holland and Nimmo described a different model for total 
pharmacy practice known as "Total Pharmacy Care, TPC". This model 
presented pharmacy practice as an amalgam of five distinct practice 
models: drug information, self care, clinical pharmacy, pharmaceutical 
care and dispensing". The model stressed that "for pharmacists to meet 
a population's needs they should provide pharmaceutical services in all 
the five practice models". 
 
ϭ͘ϭ͘ϱ Prescribing Models 
Pharmacists in USA, UK and other developed countries started to 
contribute in a tangible manner in 'prescribing'. Pharmacists by 
undergoing prescribing role entered in a traditional field of 'Medicine'. 
Although there is much debate about pharmacists taking the role of the 
'prescribers', some kind of models, done with approval of both 
professions, found a certain degree of success in the countries which 
gave such authority to pharmacists e.g. USA and UK. 
In UK prescribing authority is given to pharmacists and other 
ŚĞĂůƚŚƉƌŽĨĞƐƐŝŽŶĂůƐƐŝŶĐĞϮϬϬϯ͕ĂŶĚůĂƚĞƌŽŶŝŶϮϬϬϱĐŚĂŶŐĞƐŝŶE,^
regulations had enabled three other professions, namely 
chiropodists/podiatrists, physiotherapist and radiographers to be able to 
train as supplementary prescribers. In UK department of health 
described the aims behind extending prescribing responsibilities to non-
medical profession as to: 
- improve patient care without compromising patient safety; 
- make it easier for patients to get the medicines they need; 
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- increase patient choice in accessing medicines; 
- make better use of the skills of health professionals; 
- contribute to the introduction of more flexible team working 
across the NHS (Department of Health, 2005). 
ŵŵĞƌƚŽŶĞƚĂů͘;ϮϬϬϱͿƌĞǀŝĞǁĞĚƚŚĞŝŶƚĞƌŶĂƟŽŶĂůĚĞǀĞůŽƉŵĞŶƚ
in the pharmacists prescribing rights. They identified eight models for 
the practice of prescribing from USA, UK, Canada and New Zealand. 
These models are:  
ϭ͘ϭ͘ϱ͘ϭ/ŶĚĞƉĞŶĚĞŶƚƉƌĞƐĐƌŝďŝŶŐ 
ϭ͘ϭ͘ϱ͘ϮƉƌĞƐĐƌŝďŝŶŐďǇƉƌŽƚŽĐŽů 
ϭ͘ϭ͘ϱ͘ϯWĂƟĞŶƚ'ƌŽƵƉŝƌĞĐƟŽŶƐ͕ 
ϭ͘ϭ͘ϱ͘ϰƉƌĞƐĐƌŝďŝŶŐďǇĨŽƌŵƵůĂƌǇ 
ϭ͘ϭ͘ϱ͘ϱƉƌĞƐĐƌŝďŝŶŐďǇƉĂƟĞŶƚƌĞĨĞƌƌĂů͕ 
ϭ͘ϭ͘ϱ͘ϲƌĞƉĞĂƚƉƌĞƐĐƌŝďŝŶŐ͕ 
ϭ͘ϭ͘ϱ͘ϳ-Supplementary prescribing: which is a voluntary partnership 
between the independent prescriber (usually physician or dentist) and a 
supplementary prescriber (usually pharmacist or nurse), to implement 
an agreed patient-specific clinical management plan with the patient's 
agreement; and  
ϭ͘ϭ͘ϱ͘ϴ-Collaborative prescribing models: which requires a cooperative 
practice between a pharmacist and a physician or practice group, with 
legal authority to prescribe medications? In this situation the physician 
diagnoses and makes initial treatment decisions for the patient and the 
pharmacists selects, initiates, monitors, modifies and continue or 
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discontinues pharmacotherapy as appropriate to achieve the agreed 
patient outcomes.  
The pharmacists were be able to prescribe independently in 
ŶŐůĂŶĚĨƌŽŵDĂǇ͕ϮϬϬϲ͘Ɖharmacist to practice as independent 
prescriber must be a registered pharmacist whose name is held on 
the membership register of the Royal Pharmaceutical Society of 
Great Britain (RPSGB), with an annotation signifying that the 
pharmacist has successfully completed an education and training 
program accredited by the RPSGB and is qualified as an independent 
ƉƌĞƐĐƌŝďĞƌ;ĞƉĂƌƚŵĞŶƚŽĨŚĞĂůƚŚ͕ϮϬϬϲĂͿ͘ 
The experience of the independent prescribing, which is 
considered as a recent issue in UK, is awaiting assessment and 
verification, after its wide implementation. In such situations, 
Supplementary prescribing may well still be the appropriate 
mechanism for prescribing, for instance where a pharmacist is newly 
qualified as a prescriber or where a team approach to prescribing is 
clearly appropriate, or where a patient's Clinical Management Plan 
includes Controlled Drugs. 
ϭ͘ϭ͘ϲ^ĞůĨĂƌĞĂŶĚ^ĞůĨ-medication 
The process of health care and how people can seek healthcare 
from health professionals had vastly changed. The traditional process 
in which care is being only given through health institutions had 
changed into a situation in which patients are given the incentives to 
sometimes self control their medical conditions. This picture has 
many advantages whether for health systems and for the patients. 
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For health systems it has the economic value of better use of 
resources and saving time of physicians and health staff for major 
medical conditions and for patients it solves the problem of the 
difficulty sometimes in accessibility to health institutions, satisfy the 
self need for relief from symptoms, and save the patient time and 
expense. All these and other different motivations leads to 
emergence of international movement towards "self care". The WHO 
and many other organizĂƟŽŶƐĂŶĚŚĞĂůƚŚĂƵƚŚŽƌŝƟĞƐ;t,Kϭϵϵϴ͕
/ŶƚĞƌŶĂƟŽŶĂůWŚĂƌŵĂĐĞƵƟĐĂů&ĞĚĞƌĂƟŽŶ͕ϭϵϵϲͿĞŵƉŚĂƐŝǌĞĚƚŚĞ
importance of self care. The WHO ;ϭϵϵϴͿŝĚĞŶƟĮĞƐƚŚĞƌŽůĞŽĨƚŚĞ
pharmacist in self-care and self-medication as a communicator of 
information for patient and physician, as quality drug supplier, as a 
trainer through continuous professional development such as 
continuous education and a trainer for other non-pharmacist staff 
and supervisor for other technical pharmacy staff, as a collaborator 
with other health professionals, national associations, pharmacy 
industry, government, patients and general public, as health 
promoter through participation in health screening, health promotion 
campaigns to improve awareness of health issues and in prevention. 
Self care is defined as "All health care activities carried out by 
individuals for themselves and their families including the 
maintenance of health, prevention of disease, self diagnosis and self-
treatment". Self limiting conditions could be treated by the individual 
as well as providers other than the physician, namely a pharmacist. 
Pharmacists can contribute in self care starting from dispensing drugs 
without prescription "responding to symptoms" to involvement in 
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management of chronic conditions. Self care had been postulated as 
one of the five models of pharmacists practice suggested by Nimmo 
ĂŶĚ,ŽůĂŶĚ;ϭϵϵϵͿ͘ 
In UK self care had been one of the heath policy agendas. One 
of the important white papers augmenting this concept is 'our health, 
our care, our say: a new direction for community services' 
;ĞƉĂƌƚŵĞŶƚŽĨŚĞĂůƚŚ͕ϮϬϬϲͿ͕ǁŚŝĐŚƉƌŽǀŝĚĞƐŝŐŶŝĮĐĂŶƚŽƉƉŽƌƚƵŶŝƟĞƐ
for pharmacists to expand their role and maximize their potential. 
ϭ͘ϭ͘ϳMinor Ailment OR Responding to symptoms 
One of the most traditional roles of community pharmacists is the 
advice given when dispensing non-prescription drugs (over the counter 
medicines, OTC). These medicines may be medicines for common or 
minor ailments as cough syrups, herbal products and neutricals. 
Pharmacists are expected to have good knowledge in the use and effects 
of such medicines. Most commonly people seek treatment for minor 
diseases from the community pharmacist and others from the general 
medical practitioner. For general practitioners treating minor ailment 
increases the work load. Community pharmacy remains the best choice 
for many patients with minor conditions due to its easy accessibility. 
Explaining symptoms and receiving treatment in pharmacy for common 
ailments is described by "responding to symptoms". 
There is no agreed definition of what constitutes a minor illness, 
although the following criteria can be used as a framework. The 
condition should be: 
- -Of limiting duration 
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- -Self-limiting 
- -Something which is perceived as non-threatening. 
Minor illness for which non-prescription medicines are available 
includes: acne, allergy, cough and colds, diarrhea, earache, eczema, 
head lice, pain, heart burn, indigestion, fungal infections, irritable bowel 
ƐǇŶĚƌŽŵĞ͕ĨĞǀĞƌ͕ŚĞĂĚĂĐŚĞ͘ Ğ͘ƚĐ;,ĂƌŵĂŶĂŶĚDĂƐŽŶ͕ϮϬϬϮ).The 
pharmacist in this cases has the limit of referral to the doctor when 
symptoms prevail or when suspecting a threatening condition. 
/Ŷh<ƚŚĞĐŽŵŵƵŶŝƚǇƉŚĂƌŵĂĐŝƐƚĐŽŶƚƌĂĐƚƵĂůĨƌĂŵĞǁŽƌŬŽĨϮϬϬϱ
considered ' Minor Ailment Service' one of the enhanced services to be 
provided by the community pharmacist (Pharmaceutical Service 
EĞŐŽƟĂƟŶŐŽŵŵŝƩĞĞ͕ϮϬϬϰͿ͘/Ŷh^͕&ůŽƌŝĚĂƐƚĂƚĞůĞŐŝƐůĂƟŽŶƐ͕ŐĂǀĞ
approval for Pharmacist Self-ĂƌĞŽŶƐƵůƚĂŶƚ>ĂǁƐŝŶĐĞϭϵϴϱ͘dŚŝƐůĂǁ
allows pharmacists to independently prescribe specific categories of 
ŵĞĚŝĐĂƟŽŶƐ;,ŽǁĂƌĚĂŶĚDĐŽƌŵŝĐŬ͕ϭϵϵϵͿ͘ 
ϭ͘ϭ͘ϴ Public Health 
Pharmacists started to be key members of public health activities 
and a part of implementing its policies. The most widely used and over-
arching definition of public health was coined by Sir Donald Acheson in 
ϭϵϴϴĂƐ͗ΗƚŚĞƐĐŝĞŶĐĞĂŶĚĂƌƚŽĨƉƌĞǀĞŶƟŶŐĚŝƐĞĂƐĞ͕ƉƌŽůŽŶŐŝŶŐůŝĨĞĂŶĚ
promoting, protecting and improving health through the organized 
ĞīŽƌƚƐŽĨƐŽĐŝĞƚǇΗ;ĐŚĞƐŽŶ͕ϭϵϴϴͿ͘ 
The definition encompasses a very wide range of activities and 
emphasizes the importance of strategic approach to public health as well 
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as collaboration between different groups and individuals to achieve 
these aims. 
Pharmaceutical public health, with appropriate amendment to 
Acheson' definition, can be defined as: "The application of 
pharmaceutical knowledge, skills and resources to the science and art of 
preventing disease, prolonging life, promoting, protecting and improving 
ŚĞĂůƚŚĨŽƌĂůƚŚƌŽƵŐŚŽƌŐĂŶŝǌĞĚĞīŽƌƚƐŽĨƐŽĐŝĞƚǇΗ;tĂůŬĞƌ͕ϮϬϬϬͿ͘ 
Community pharmacy with its location within community has a 
good position for involvement in public health and particularly in health 
promotion. People visit the community pharmacy when they are healthy 
and when they are sick. This gives a chance for wide dissemination of 
health information between population regarding prevention, 
management and control of disease. 
ϭ͘ϭ͘ϵ,ĞĂůƚŚWƌŽŵŽƟŽŶ 
Health promotion aims is to enable people to have more control 
ŽǀĞƌĂƐƉĞĐƚƐŽĨƚŚĞŝƌůŝǀĞƐǁŚŝĐŚĂīĞĐƚƚŚĞŝƌŚĞĂůƚŚ;t,K͕ϭϵϴϰͿ͘ The 
world health organization's succinct definition of health promotion 
encompasses two main features: improving health and being more in 
control of it;"health promotion is the process of enabling people to 
increase control over, and to improve, their health". The concept 
includes many variable activities ranging from education, prevention to 
management and health protection. Promotion of good health, 
avoidance of ill health and the achievement of health objectives are one 
of the four main elements of the 'Good pharmacy practice GPP'. These 
activities can be described as "providing facility for confidential 
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conversation and counseling, provision of general advice on health 
matters, involvement in health campaigns, and quality assurance of 
equipment and adviĐĞŐŝǀĞŶŝŶĚŝĂŐŶŽƐƟĐƚĞƐƟŶŐΗ;t,K͕ϭϵϵϲͿ͘ 
Examples of health promotion activities provided in community 
pharmacies include: 
- Healthy life style  
- Sexual health  
- Substance abuse 
Evidence for contribution of community pharmacists in health 
promotion activities comes from many international research work or 
governmental policies. Evidence from Canada comes from the Canadian 
study (SCRIP); the study of Cardiovascular Risk Intervention by 
ƉŚĂƌŵĂĐŝƐƚƐ;dƐƵǇƵŬŝĞƚĂů͕͘ϮϬϬϮͿŝƐĂŝŵĞĚƚŽĚĞƚĞƌŵŝŶĞƚŚĞĞīĞĐƚŽĨ
community pharmacist intervention on the process of cholesterol risk 
management in patients at high risk for cardiovascular events. The study 
ŝƐƌĂŶĚŽŵŝǌĞĚĐŽŶƚƌŽůĞĚƚƌŝĂůĐŽŶĚƵĐƚĞĚŝŶϱϰĐŽŵŵƵŶŝƚǇƉŚĂƌŵĂĐŝĞƐ
;ϭϵϵϴ-ϮϬϬϬͿŝŶĐůƵĚĞĚƉĂƟĞŶƚƐĂƚŚŝŐŚƌŝƐŬĨŽƌĐardiovascular events (with 
atherosclerotic disease or diabetes mellitus with another risk factor). 
The conclusion is that community based intervention program improved 
the process of cholesterol management in high-risk patients, and 
demonstrates the value of community pharmacists working in 
collaboration with patients and physicians. 
Community pharmacists in USA participate in immunization and 
ďǇĚŽŝŶŐƐŽĞǆƉĂŶĚƚŚĞŝƌƌŽůĞƐĂƐŚĞĂůƚŚĐĂƌĞƉƌŽǀŝĚĞƌƐ;ĞƌƟŶ͕ϮϬϬϱͿ͘ 
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ϭ͘ϭ͘ϭϬ/ŶƚĞƌŶĞƚWŚĂƌŵĂĐǇ 
Internet pharmacies, also known as cyperpharmacy, online 
pharmacy-pharmacy, and virtual pharmacy/drug stores, continue to 
increase in number as consumers seek more competitive prices and 
ŐƌĞĂƚĞƌĐŽŶǀĞŶŝĞŶĐĞ;ƌĂǁĨŽƌĚ͕ϮϬϬϯͿ͘dŚĞƚǇƉŝĐĂůƉƌŽĚƵĐƚŵŝǆŝŶĐůƵĚĞƐ
prescription drugs, nonprescription drugs and herbal products, health 
and beauty aids, drug information, consumer health information, and 
ŽƚŚĞƌƐ;>ŝŶŐůĞ͕ϮϬϬϭͿ͘ƐƟŵĂƚĞƐŽĨƚŚĞŶƵŵďĞƌŽĨ/ŶƚĞƌŶĞƚƉŚĂƌŵĂĐǇ
ƐŝƚĞƐ΂ŝŶh^΃ƌĂŶŐĞďĞƚǁĞĞŶϱϬϬĂŶĚϲϬϬ͕ĂŶĚĐŽŶƐŝƐƚŽĨĨŽƵƌŵĂũŽr 
types: 
1- Traditional chain pharmacies, with a Web presence. 
2- Independent community pharmacies, with a Web presence 
3- Stand-alone, exclusively pharmacy sites; and 
4- "Rogue" pharmacy sites (Lingle, 2001). 
Internet sites offer advantages such as twenty-four-hour 
availability, anonymity, online access to personalized medication 
records, delivery services, and direct price comparisons. Concerns, 
usually regarding these sites come from the worry regarding safety and 
quality of the products and the security and the availability of potentially 
dangerous or controlled drugs which can be readily available through 
ƌŽŐƵĞƐŝƚĞƐ;^ǌĞŝŶďĂĐŚĂŶĚ>ŝƉŽǁƐŬŝ͕ϮϬϬϱͿ͘dŚĞǁŽƌƌǇĂůƐŽĞǆƚĞŶĚĞĚ
towards the loss of the face to face contact with pharmacists and the 
decreased level of counseling. The National Association Boards of 
Pharmacy (NABP) in the USA has developed a program to certify the 
quality of online pharmacies; the Verified Internet Pharmacy Practice 
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Sites (VIPPS) Program (National Association Boards of Pharmacy, NABP 
ϮϬϬϱͿ͘ 
ϭ͘ϭ͘ϭϭdĞůĞƉŚĂƌŵĂĐǇ 
The role of technology in pharmacy practice extended further to 
solve shortage of pharmacists in remote areas, and provide advice and 
counseling to patients from distance. Telepharmacy is one of the new 
advents which are used in USA. Telepharmacy as an enabling technology 
represents a unique and innovative way to deliver quality pharmacy 
services to rural areas. In the US, two principal models are in 
Washington and North Dakota, although other states such as Texas, 
Nebraska and Alaska also have telepharmacy models in place. The 
suggested model to be investigated in Australia is Home Medication
Reviews (HMRs) to be done via Telepharmacy (Kimber and Peterson, 
ϮϬϬϲͿ͘ 
North Dakota pharmacy board set certain rules which governs 
Telepharmacy practŝĐĞ;EŽƌƚŚĂŬŽƚĂWŚĂƌŵĂĐǇŽĂƌĚ͕ϮϬϬϯͿ͖ƚŚĞƌƵůĞƐ
defines Telepharmacy as "a central pharmacy with one or more remote 
sites in which all sites are connected via computer link, video link and 
audio link"; the "remote site" is defined as a pharmacy staffed by a 
registered pharmacy technician with access to its main pharmacy and 
registered pharmacist by computer link, and audio link while open". The 
rules stressed that dispensing is considered done at the central 
pharmacy under the responsibility and supervision of the pharmacist in 
the central pharmacy. A pharmacist at the central pharmacy must 
approve each prescription before it leaves the remote site. Counseling 
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must be done by a pharmacist via video link. Inspection must be done by 
a pharmacist to the remote site monthly. And the inspection report must 
be maintained until the board of pharmacy inspection. All steps should 
be recorded, The pharmacy technician must demonstrate knowledge 
and experience in preparation of prescriptions for dispensing and 
working with patients and the technician must be registered with the 
state board of pharmacy and have at least one year of work experience 
ĂƐĂEŽƌƚŚĂŬŽƚĂƉŚĂƌŵĂĐǇƚĞĐŚŶŝĐŝĂŶ͘ƐŽĨ:ĂŶƵĂƌǇϮϬϬϲ͕ĮŌǇ-seven 
pharmacies are involved in the North Dakota Telepharmacy sites and 
thirty-six remote telepharmacy sites. Of the fifty-seven pharmacies forty 
four are community pharmacies (thirteen are hospital pharmacies) 
;EŽƌƚŚĂŬŽƚĂ^ƚĂƚĞhŶŝǀĞƌƐŝƚǇ͕ϮϬϬϳͿ͘ 
 
ϭ͘ϭ͘ϭϮWŚĂƌŵĂĐǇƉƌĂĐƟĐĞŝŶ^ƵĚĂŶ 
In Sudan pharmacy practice, especially in community pharmacies, 
is still lagging behind, and much work for development is required. 
Patient-oriented practice is still lacking in community pharmacies, and 
more efforts are needed for refining the available traditional distribution 
and dispensing activities. More social mandate for community 
pharmacists is expected, especially with the international trends towards 
extended roles for pharmacists. Many drug therapy problems addressed 
by pharmaceutical care are available in Sudan, which usually passed 
unseen or unnoticed but affect a wide range of the population. 
Therefore, there is a necessity for starting investigation of the concepts 
of patient-centered practice (as pharmaceutical care, chronic disease 
Please purchase PDFcamp Printer on http://www.verypdf.com/ to remove this watermark.
  
ϮϮ 
management and minor ailments management) and other roles (as 
public health, health promotion and self care) and their applicability in 
Sudan. Since the vast area in which the pharmacist is in daily contact 
with patients, is the community pharmacy, involving the community 
pharmacists, who remained isolated from the heath care professionals 
and sometimes considered as not a part of the health care system, in the 
health care activities through models of team work is the aim of this 
study. Investigation of the current situation of practice, applicability of 
patient oriented practice in such facilities, and improvement in 
dispensing systems are among the objectives of this study. 
AIMS AND OBJECTIVES OF THIS STUDY 
AIM 
To investigate current community pharmacy practice in Sudan by 
surveying  all the stakeholders involved(pharmacists ,doctors and 
customers),and their views regarding implementation of  patient-oriented 
practice and other extended roles in community pharmacies. 
To devise new models of practice through reviewing recent development 
in the practice in examples of  both developed and developing countries . 
 
OBJECTIVES 
A-To investigate the current situation of community pharmacy practice in 
Sudan by: 
- Evaluation of current community pharmacists' professional activities . 
- surveying: 
 -awareness and attitudes of pharmacists towards application of 
pharmaceutical care in community pharmacies. 
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-the expected barriers for application of pharmaceutical care and how 
these can be overcome. 
-the views of the  pharmacists regarding application of disease 
management in pharmacies 
-the present health promotion activities in pharmacies ,and the attitude of 
community pharmacists towards more systemized health promotion 
activities 
-current responding to symptoms activities and whether proper policies 
and guidelines were followed 
B- To investigate: 
 -relationship between community pharmacists and doctors (general 
practitioners& specialists). 
-perceptions of doctors about extended roles of community pharmacists, 
including, pharmaceutical care 
C-To investigate community pharmacy customers by: 
  -evaluation of their relation with community pharmacists, and their 
awareness of the roles of the pharmacists as health professionals. 
-elucidation of their views about new services to be provided in 
community pharmacies ( e.g. blood screening, consultation and 
pharmaceutical care). 
 
D-To develop suitable models of patient-oriented practice in community 
pharmacy, considering the results of the study, and the new trends 
attained in examples of developed countries(USA,UK,Australia), and 
developing countries(Gulf counties). 
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SECTION II  
  ϭ͘Ϯ>/dZdhZZs/t 
ϭ͘Ϯ͘ϭ Community pharmacy practice in the developing countries: 
ϭ͘Ϯ͘ϭ͘ϭ Community Pharmacy practice in UNITED STATES OF AMERICA 
ϭ͘Ϯ͘ϭ͘ϭ͘ϭ/EdZKhd/KE 
The United States of America (USA) is located in North America 
bordering the North Atlantic Ocean and the North Pacific Ocean, 
ďĞƚǁĞĞŶĂŶĂĚĂĂŶĚDĞǆŝĐŽ͘ǆƚĞŶĚŝŶŐŝŶĂƚŽƚĂůĂƌĞĂŽĨϵ͕ ϴϮϲ͕ ϲϯϬƐƋ
km and ƉŽƉƵůĂƟŽŶŽĨϯϬϭ͕ ϭϯϵ͕ ϵϰϳ;:ƵůǇ ϮϬϬϳĞƐƚ͘Ϳ͕ŝƚŝƐĐŽŶƐŝĚĞƌĞĚ as 
the World s third- largest country by size (after Russia and Canada) and 
by population (after China and India). The government is Constitution-
based federal republic consisting of ϱϬƐƚĂƚĞƐĂŶĚŽŶĞĚŝƐƚƌŝĐƚ
(Washington DC). The ethnic groups of the population is mainly white 
;ϴϭ͘ϳйͿ͕ǁŝƚŚďůĂĐŬϭϮ͘ϵй͕ƐŝĂŶϰ͘Ϯй͕ŵĞƌŝŶĚŝĂŶĂŶĚůĂƐŬĂŶĂƟǀĞƐ
ϭй͕ŶĂƟǀĞ,ĂǁĂŝĂŶĂŶĚŽƚŚĞƌƉĂĐŝĮĐŝƐůĂŶĚĞƌƐϬ͘Ϯй;ϮϬϬϯĞƐƚ͘Ϳ͘ 
Important health indicators: Total infant mortality rate is 
ϲ͘ϯϳĚĞĂƚŚƐͬϭ͕ϬϬϬůŝǀĞďŝƌƚŚƐ͘>ŝĨĞĞǆƉĞĐƚĂŶĐǇĂƚďŝƌƚŚŝƐϳϴǇĞĂƌƐ͘(The 
world fact ďŽŽŬ͕ϮϬϬϳͿ͘ 
 
ϭ͘Ϯ͘ϭ͘ϭ͘Ϯh͘ ^,ĞĂůƚŚĐĂƌĞƐǇƐƚĞŵ 
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Health care is provided through both public and private sectors. 
Health service is mostly covered through insurance with exception of 
other populations who are not under any insurance plans. 
ƉƉƌŽǆŝŵĂƚĞůǇϱϱƉĞƌĐĞŶƚŽĨƚŚĞƚŽƚĂůŚĞĂůƚŚĐĂƌĞĞǆƉĞŶĚŝƚƵƌĞŝƐƐƉĞŶƚďǇ
private sector. Examples of private sector health insurance plans include: 
Blue Cross/Blue Shield insurance plans, Commercial health insurance 
companies, Health Maintenance organizations (HMO) and Preferred 
provider organization (PPO) plans, and employer-self insurance 
ƉƌŽŐƌĂŵƐ͘WƵďůŝĐƐĞĐƚŽƌƐƉĞŶĚŝŶŐĐƵƌƌĞŶƚůǇĐŽŵƉƌŝƐĞƐĂďŽƵƚϰϰƉĞƌĐĞŶƚ͘
It can be noticed that Managed care companies (MCOs) played great 
role in the private sector offering services, through insurance, for a vast 
number of population. 
The federal government –provided care institutions comprises of: 
Military Medical care, Indian Health Service, Community Health Centers 
(CHCs), and Medicaid anĚDĞĚŝĐĂƌĞ;^ĐŽƩ͕ϮϬϬϱͿ͘ 
ϭ͘Ϯ͘ϭ͘ϭ͘ϯW,ZDzEd,h͘^͘,>d,Z^z^dD 
Pharmacy practice is regulated through State Pharmacy Boards. 
Each state derives its regulations based on the federal rules and 
regulations. The organization, which combines all the state pharmacy 
boards, is the: National Association of Boards of Pharmacy (NABP) 
;EĂƟŽŶĂůƐƐŽĐŝĂƟŽŶŽĨŽĂƌĚƐŽĨWŚĂƌŵĂĐǇ͕ϮϬϬϳͿ͘WŚĂƌŵĂĐŝƐƚƐĂƌĞ
given license to practice pharmacy after completing an internship 
training period and after passing both the North American Pharmacists 
licensure Examination (NAPLEX) and law examinations which is called 
Multistate Pharmacy Jurisprudence Examination (MJPE). Pharmacist 
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license is renewed every two years. A pharmacy should also be 
registered with the state board and licensed to practice pharmacy; this 
license should also be renewed biennially. The pharmacist should submit 
evidence of continuing education upon each license renewal (State of 
ĞůĂǁĂƌĞ͕ϮϬϬϳͿ͘ 
ϭ͘Ϯ͘ϭ͘ϭ͘ϰŽŶƟŶƵŝŶŐĞĚƵĐĂƟŽŶƌĞƋƵŝƌĞŵĞŶƚƐ 
Each pharmaĐŝƐƚƐŚŽƵůĚĂĐƋƵŝƌĞϯϬŚŽƵƌƐĐŽŶƟŶƵŝŶŐĞĚƵĐĂƟŽŶƉĞƌ
biennial licensure. Evidence of continuing education shall be submitted 
to the pharmacy board of the state on an appropriate format 
;DŝƐƐŝƐƐŝƉƉŝŽĂƌĚŽĨWŚĂƌŵĂĐǇ͕ϮϬϬϳͿ͘ 
ϭ͘Ϯ͘ϭ͘ϭ͘ϱ/ŶƚĞƌŶĞƚƉŚĂƌŵĂĐŝĞƐ 
A pharmacy operating within or outside the state shall not sell; 
dispense any prescription only drug to any consumer in the state 
through an Internet site or by electronic mail unless it is in compliance 
with federal and state law. 
Requirements for Internet Sites: 
Internet Sites should display in a clear and conspicuous manner 
the address and the telephone number of the principal place of business 
for each pharmacy practicing through the site, and the pharmacy permit 
number assigned by the state board; or certification of the site by the 
national association of boards of pharmacy as a Verified Internet 
WŚĂƌŵĂĐǇWƌĂĐƟĐĞ^ŝƚĞ;ƌŬĂŶƐĂƐŽĂƌĚŽĨWŚĂƌŵĂĐǇ͕ϮϬϬϳͿ͘ 
ϭ͘Ϯ͘ϭ͘ϭ͘ϲdĞůĞƉŚĂƌŵĂĐǇZƵůĞƐ 
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Telepharmacy practice emerges, as a necessity in rural areas 
where many pharmacies start to close. In North Dakota there is a proper 
system for regulating such practice. Telepharmacy practice is a practice 
in which a central pharmacy with one or more remote sites in which all 
sites are connected via computer link, video link, and audio link. The 
remote site is a pharmacy staffed by a registered pharmacy technician 
with access to its central or main pharmacy and registered pharmacists 
by computer link, video link, and audiolink while open. The remote site 
should comply with the state rules governing requirements for a permit 
to operate a pharmacy. A pharmacist at the central pharmacy must 
approve each prescription before it leaves the remote site. Dispensing is 
considered to be done at the central pharmacy, and the pharmacist 
should compare via video link the stock bottle, drug dispensed, strength, 
and the entire label must be checked for accuracy on video link. Both 
pharmacist's and the technician’s initials must appear on the fill screen, 
patient profile, and label. Counseling must be done by a pharmacist via 
video link and audio link. The pharmacist must counsel the patient or the 
patient's agent on all new prescriptions and refills (North Dakota Board 
ŽĨWŚĂƌŵĂĐǇ͕ϮϬϬϳͿ͘ 
ϭ͘Ϯ͘ϭ͘ϭ͘ϳ&ŝůŝŶŐĂŶĚŝƐƉĞŶƐŝŶŐWƌĞƐĐƌŝƉƟŽŶƐ 
The general categories of drugs dispensed in USA pharmacies 
belong to: prescription-only-drugs which include controlled substances 
and over the counter or non-prescription drugs. A separate prescription 
department should be maintained in each pharmacy, which only opens 
upon the pharmacist presence, and it should be separate from any other 
merchandise products. A legend drug or device prescription means a 
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written verbal or electronically transmitted order issued by a 
practitioner for a drug or device to be dispensed for a patient by a 
ƉŚĂƌŵĂĐŝƐƚ;DŝƐƐŝƐƐŝƉƉŝŽĂƌĚŽĨWŚĂƌŵĂĐǇ͕ϮϬϬϳͿ͘ 
 
ϭ͘Ϯ͘ϭ͘ϭ͘ϴWƌĞƐĐƌŝƉƟŽŶĚƌƵŐŽƌĚĞƌƌĞĐŽƌĚƐ 
Generally prescriptions after being dispensed should be kept in 
the pharmacy for a period of two to three years according to different 
states reŐƵůĂƟŽŶƐ͘/ŶůĂƐŬĂƐƚĂƚĞ;ůĂƐŬĂŽĂƌĚŽĨWŚĂƌŵĂĐǇ͕ϮϬϬϳͿ
prescriptions should be kept for a period of two years from the date of 
filling or the date of the last dispensed refill. 
ϭ͘Ϯ͘ϭ͘ϭ͘ϵůĞĐƚƌŽŶŝĐdƌĂŶƐŵŝƐƐŝŽŶŽĨWƌĞƐĐƌŝƉƟŽŶƐ 
Electronic transmission of original prescriptions by an authorized 
practitioner to a licensed pharmacy is acceptable for a legend 
prescription drug or controlled drugs or refills. The pharmacist should 
exercise professional judgment regarding accuracy, validity, and 
authenticity of the prescription. Confidentiality is required regarding all 
the pharmacy patient's information and all electronic equipments for 
receipt of prescription orders should be maintained so as to ensure 
ĂŐĂŝŶƐƚƵŶĂƵƚŚŽƌŝǌĞĚĂĐĐĞƐƐ;^ƚĂƚĞŽĨĞůĂǁĂƌĞ͕ϮϬϬϳͿ͘ 
ϭ͘Ϯ͘ϭ͘ϭ͘ϭϬ^ƵďƐƟƚƵƟŽŶŽĨĚƌƵŐƐďǇƚŚĞƉŚĂƌŵĂĐŝƐƚ 
Pharmacist is allowed in dispensing a prescription for a drug 
product prescribed by its brand name to select any equivalent drug 
product if: 
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A- the purchaser specifically requests or consents to the substitution 
of a drug equivalent; 
B- the substituted drug product equivalent is of the same generic 
type and is designated the therapeutic equivalence evaluation in 
the approved drug products with therapeutic equivalence 
evaluation prepared by the Center for Drug Evaluation and 
Research of the Federal Food and Drug Administration (FDA). 
C- the substituted drug product is permitted to move in the 
interstate commerce 
D- the prescribing practitioner has not indicated that an equivalent 
drug product is not to be substituted 
E- the substitution is not otherwise prohibited by law (Utah Board of 
WŚĂƌŵĂĐǇ͕ϮϬϬϳͿ͘ 
 
ϭ͘Ϯ͘ϭ͘ϭ͘ϭϭWĂƟĞŶƚŽƵŶƐĞůŝŶŐĂŶĚWĂƟĞŶƚZĞĐŽƌĚƐ 
/ŶϭϵϵϬĂ&ĞĚĞƌĂůůĂǁŬŶŽǁŶĂƐƚŚĞKŵŶŝďƵƐƵĚŐĞƚ
Reconciliation Act (OBRA-ϵϬͿǁĂƐĞƐƚĂďůŝƐŚĞĚǁŚŝĐŚƌĞƋƵŝƌĞƐĂƚŚƌĞƐŚŽůĚ
legal standard for patient counseling. A condition of participation in the 
state-managed Medicaid program, which the federal government 
partially funds, OBRA-ϵϬƌĞƋƵŝƌĞƐƐƚĂƚĞƐƚŽƉƌŽŵƵůŐĂƚĞĞǆƉĂŶĚĞĚ
pharmacy practice standards. States have chosen to implement these 
standards in a variety of ways. Pharmacists may not actually be 
compelled to comply with the standards for all patients in every state, 
but the standards generally define a minimal legal expectation of 
pharmacists. The patient counseling of OBRA-ϵϬƌĞƋƵŝƌĞƐƚŚĂƚĂ
pharmacist make an offer to discuss medications with each patient. The 
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patient or the patient’ agent may waive the right to be counseled. If the 
offer is accepted, the pharmacist must discuss with the patient those 
matters that the pharmacist judges to be significant. The law provides a 
list of subjects that should be considered for inclusion in the discussion. 
OBRA-ϵϬƐƚĂŶĚĂƌĚƐĂůƐŽƌĞƋƵŝƌĞƚŚĂƚƉŚĂƌŵĂĐŝƐƚƐƐĐƌĞĞŶĞǀĞƌǇ
prescription prior to dispensing to detect and resolve any potential 
problems with drug therapy. This activity is sometimes referred to as 
prospective drug use review (ProDUR). Pharmacists do not have any 
discretion to decide when ProDUR is done; it must be done with every 
prescription. There is no provision for patients to waive or decline 
ProDUR. OBRA-ϵϬĂůƐŽƌĞƋƵŝƌĞƌĞĐŽƌĚŝŶŐŽĨƉĂƟĞŶƚŝŶĨŽƌŵĂƟŽŶ͘
Pharmacists must make what they consider a reasonable effort to 
acquire health-related information about the patient. Patients may, of 
course, decline to provide the information ;ĂǀŝĚ͕ϮϬϬϱͿ. 
ϭ͘Ϯ͘ϭ͘ϭ͘ϭϮŽŶƚƌŽůĞĚ^ƵďƐƚĂŶĐĞƐZĞŐƵůĂƟŽŶ 
A controlled substance means: a drug, substance, or immediate 
precursor included in schedules classified from I to V. The classification is 
based upon the criteria of potential for abuse, accepted medical use in 
the United States, and potential for addiction, Narcotics are considered 
ŝŶ^ĐŚĞĚƵůĞ/;EŽƌƚŚĂƌŽůŝŶĂŽĂƌĚŽĨWŚĂƌŵĂĐǇ͕ϮϬϬϳͿ͘ 
ϭ͘Ϯ͘ϭ͘ϭ͘ϭϮ͘ϭŝƐƉĞŶƐŝŶŐŽĨĐŽŶƚƌŽůĞĚƐƵďƐƚĂŶĐĞƐ 
A controlled substance in Schedule II to V, which is a prescription 
drug, should not be dispensed without a valid prescription or a valid 
order. A controlled substance in Schedule V, which is not a prescription 
drugs, may be dispensed pursuant to a valid prescription or it may be 
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dispensed without a prescription provided that certain specific rules 
ǁĞƌĞĨŽůŽǁĞĚ;DŝƐƐŝƐƐŝƉƉŝŽĂƌĚŽĨWŚĂƌŵĂĐǇ͕ϮϬϬϳͿ͘ 
 ϭ͘Ϯ͘ϭ͘ϭ͘ϭϮ͘ϮŝƐƉĞŶƐŝŶŐŽĨ^ĐŚĞĚƵůĞ/ĐŽŶƚƌŽůĞĚƐƵďƐƚĂŶĐĞƐ;EĂƌĐŽƟĐƐͿ 
A prescription for this schedule may not be refilled, and should 
not be dispensed for a patient with greater frequency than the 
approximate interval of time that the dosage regimen ordered by the 
prescriber would indicate unless circumstances are documented which 
would justify a shorter interval of time. Prescriptions of drugs in this 
schedule shall not be filled after six months from date of issuance 
;DŝƐƐŝƐƐŝƉƉŝŽĂƌĚŽĨWŚĂƌŵĂĐǇ͕ϮϬϬϳͿ͘ 
ϭ͘Ϯ͘ϭ͘ϭ͘ϭϮ͘ϯŝƐƉĞŶƐŝŶŐŽĨ^ĐŚĞĚƵůĞ//;ĂŵƉŚĞƚĂŵŝŶĞƐ͕ďĂƌďŝƚ͘Ϳ͕
Schedule IV (diazepams) and Schedule V (low quantities mixtures of 
narcotics) 
A prescription for drugs in these schedules may not be filled or 
refilled after six months from the date of issuance of the prescription or 
be refilled more than five times. 
Recording refills and partial filling: Partial filling or refilling is 
permitted provided the pharmacist sets forth the quantity dispensed, 
the date and his/her initials or identifying code as the dispensing 
pharmacist on the prescription or on some other uniformly maintained 
record system.  
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ϭ͘Ϯ͘ϭ͘ϭ͘ϭϮ͘ϰZĞĐŽƌĚŬĞĞƉŝŶŐŽŶĐŽŶƚƌŽůĞĚƐƵďƐƚĂŶĐĞƐ 
Every facility permitted by the pharmacy board shall keep 
complete and accurate records of the acquisition and disposition of all 
controlled substances. All such records shall be maintained for a period 
of two years. A hard copy of original prescriptions, whether records are 
maintained manually or in data processing system, shall be maintained 
and filled in one of the following ways: 
A- Three separate files may be maintained; a file for Schedule II 
prescriptions dispensed; a file for Schedule III, IV and V 
prescriptions dispensed; and a file for all other prescriptions 
dispensed. 
B- Two files may be maintained; a file for all Schedule II dispensed 
and another file for all other prescriptions dispensed including 
other Schedules and in this case files for the controlled schedules 
should be marked or stamped with the letter "c” in red ink. 
ϭ͘Ϯ͘ϭ͘ϭ͘ϭϮ͘ϱŝƐƉŽƐĂůŽĨĐŽŶƚƌŽůĞĚƐƵďƐƚĂŶĐĞƐ 
Disposal is required for any expired, excess or unwanted 
controlled substances by contacting and utilizing the services of a 
reverse distributor as defined by the Federal Enforcement 
Administration. All records of the disposal shall be maintained for a 
ƉĞƌŝŽĚŽĨƚǁŽǇĞĂƌƐ;DŝƐƐŝƐƐŝƉƉŝŽĂƌĚŽĨWŚĂƌŵĂĐǇ͕ϮϬϬϳͿ͘ 
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ϭ͘Ϯ͘ϭ͘ϭ͘ϭϯ- PATIENT-CENTERED COMMUNITY PHARMACY PRACTICE IN 
USA 
The shift in practice from mainly medication distribution, with a 
touch of "health care responder" activities, to proactive health-care 
provider is reflected in the tone and content of the Code of Ethics for the 
American pharmacists ͘ǆĐĞƌƉƚƐŽĨŽĚĞŽĨƚŚŝĐƐĨƌŽŵϭϵϱϮƚŽ ϭϵϵϯ
show the evolution in the philosophy of practice. 
/ŶƚŚĞϭϵϱϮ-ϭϵϲϵƉĞƌŝŽĚ͗ the primary obligation of pharmacy is 
the service it can render to the public in safeguarding the preparation, 
compounding and dispensing drugs and the storage and handling of 
drugs and medical devices. The pharmacist does not discuss the 
therapeutic effects or composition of a prescription with a patient. 
When such questions were asked, he suggested that the qualified 
practitioner is the proper person with whom such matters should be 
discussed.  
/Ŷϭϵϲϵ-ϭϵϵϯ͗A pharmacist should hold the health and safety of 
patients to be of first consideration and should render to each patient 
the full measure of professional ability as an essential health 
practitioner. 
/Ŷϭϵϵϯ;ĂŶĚŽŶǁĂƌĚƐͿ͗ The pharmacist should respect the 
covenantal relationship between the patient and the pharmacist, and 
should promote the good of every patient in a caring, compassionate 
and confidential manner. The pharmacist should respect the autonomy 
and dignity of each patient, and communicates with patients in terms 
ƚŚĂƚĂƌĞƵŶĚĞƌƐƚĂŶĚĂďůĞ;<ŶŽǁůƚŽŶ͕ϭϵϵϱͿ͘ 
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The shift in the philosophy of pharmacy practice to patient-
centered practice is paralled by developments in pharmacy education, 
training, and practice. During the ϮϬƚŚĐĞŶƚƵƌǇ͕ƉŚĂƌŵĂĐǇƚƌĂŝŶŝŶŐŝŶƚŚĞ
United States consisted of a four- to five -year baccalaureate program 
and a research -oriented pharmacy graduate training, primarily with 
master of science or doctor of philosophy degree paths. In ϭϵϱϬ͕ a six -
year advanced clinical degree, the Doctor of pharmacy (Pharm D), was 
recommended to prepare some pharmacy practitioners for greater 
responsibilities in advanced clinical practice; this education and training 
program would best prepare and position pharmacists for greater 
responsibilities for patient care. With the continuous shift towards more 
clinical roles for pharmacy, some pharmacy schools in the US changed 
their curricula or added an additional pathway for graduate pharmacists 
ǁŝƚŚƚŚĞWŚĂƌŵĚĞŐƌĞĞ͘/Ŷϭϵϵϳ͕ƚŚĞŵĞƌŝĐĂŶŽƵŶĐŝůŽŶ
Pharmaceutical Education (ACPE), the accreditation board for schools of 
pharmacy, formally adopted new accreditation standards and guidelines 
for a new Pharm D curriculum as the sole professional training program 
for the profesƐŝŽŶ͘dŚĞƐĞƐƚĂŶĚĂƌĚƐďĞĐĂŵĞĞīĞĐƟǀĞŝŶϮϬϬϬ͘dŚŝƐ
process has led to a steady increase in the number of pharmacy schools 
offering the Pharm D as the sole first professional degree (Zeind and 
DĐůŽƐŬĞǇ͕ϮϬϬϲͿ͘ ƐŽĨƚŚĞĨĂůŽĨϮϬϭϭ͕ŽŶĞŚƵŶĚƌĞĚĂŶĚŶŝŶĞteen 
;ϭϭϵͿĐŽůĞŐĞƐĂŶĚƐĐŚŽŽůƐǁŝůŽīĞƌWŚĂƌŵ͕ĂƐƚŚĞĮƌƐƚƉƌŽĨĞƐƐŝŽŶĂů
degree ;W͕ϮϬϭϬͿ͘ 
Community pharmacy is practiced in independent pharmacies, 
chain pharmacies, supermarket pharmacies and mass merchandisers. 
Community pharmacies either works independently or through 
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contracting with managed care companies or some governmental 
insurance systems such as the Medicare which provides health care for 
the elderly, and Medicaid which provides care for the indigent or the 
poor. Ambulatory care services are provided by physicians in private 
practice or managed care settings. Each individual choose a physician or 
managed care program to meet his or her own family’ health care needs. 
This informal set of services is paid for directly by the consumer or 
through a private health insurance plan. The coordination of this system 
is dependent on the customer or a primary care physician (e.g. family 
practice physician). When medications are prescribed, the individual 
decides which community pharmacy will be used. Dependent upon 
insurance coverage, these ambulatory services may or may not be 
covered. Increasingly, prescription drug coverage is being included in 
insurance plans. Typically, the individual pays out-of- pocket for most of 
these services until a certain deductible is met and then the health 
ŝŶƐƵƌĂŶĐĞƉůĂŶƚĂŬĞƐŽǀĞƌƚŚĞŵĂũŽƌŝƚǇŽĨĨƵƌƚŚĞƌƉĂǇŵĞŶƚƐ;^ĐŽƩ͕ϮϬϬϱͿ͘ 
Patient-centered practices provided by community pharmacies fall 
within the following: 
ϭ- Cognitive services  
Ϯ- Health promotion services 
ϯ- Pharmaceutical care 
ϰ- Disease management 
ϱ- Medication review 
ϲ- Prescribing authority.  
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ϭ͘Ϯ͘ϭ͘ϭ͘ϭϯ͘ϭŽŐŶŝƟǀĞƐĞƌǀŝĐĞƐ͗This mainly the non dispensing activities 
which depend on the pharmacist knowledge and the most important 
activity of this services is the information provided to the customers 
regarding medicines and include patient counseling, prospective drug 
review. The OBRA-ϵϬĂĐƚĐŽŵƉƌŝƐĞƐƐŽŵĞŽĨƚŚĞƐĞĐŽŵƉŽŶĞŶƚƐ͘ 
ϭ͘Ϯ͘ϭ͘ϭ͘ϭϯ͘Ϯ,ĞĂůƚŚƉƌŽŵŽƟŽŶĂĐƟǀŝƟĞƐ͗ These include smoking 
cessation, health screening, immunization, wellness screening ….. etc. 
 
 ϭ͘Ϯ͘ϭ͘ϭ͘ϭϯ͘ϯWŚĂƌŵĂĐĞƵƟĐĂůĐĂƌĞ: Pharmaceutical care in United States 
is stimulated by universities, the American Pharmaceutical Association 
(AphA), individual pharmacists or pharmacist's companies. The latter 
provide independent assistance to colleges or parties, as a kind of 
intermediate between the patient and the patient's own doctor and 
pharmacist. The pharmaceutical care associates is an example of such 
services and can be found in the Internet. The professional body of 
pharmacists, the American Pharmaceutical Association, created the 
American Center for pharmaceutical care (ACPC). They constructed a 
curriculum consisting of a series of learning modules providing 
comprehensive hands-on instructions in practice reengineering. They 
also created AphA Foundation, which strongly co-operates with the 
pharmacy industry and helps the profession to re-engineer itself for the 
future by advocating the proliferation of pharmaceutical care integration 
and research into the practice setting ;sĂŶDŝů͕ϭϵϵϵͿ͘ 
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ϭ͘Ϯ͘ϭ͘ϭ͘ϭϯ͘ϰŝƐĞĂƐĞŵĂŶĂŐĞŵĞŶƚ͗ Disease management is one of the 
key tools that managed care organizations (MCOs) have used in 
attempting to control costs and assure quality.  
Many projects in the United States utilize the pharmacist in 
providing disease management programs. The concept of disease 
management is sometimes mixed with disease-based pharmaceutical 
care.  Blenkinsopp and  Celino ;ϮϬϬϲͿinvestigated the integration of the 
community pharmacy contribution in Long-term conditions. Research in 
ƚŚĞh^ĨŽƵŶĚƚŚĂƚϯ͘ϮйŽĨĐŽŵŵƵŶŝƚǇƉŚĂƌŵĂĐŝĞƐ;ϲ͘ϳйŽĨŝŶĚĞƉĞŶĚĞŶƚ
ĂŶĚϭ͘ϴйŽĨŵƵůƟƉůĞƐͿŝŶƚŚĞƐƚĂƚĞŽĨĂůŝĨŽƌŶŝĂǁĞƌĞƉƌŽǀŝĚŝŶŐĚŝƐĞĂƐĞ
ƐƚĂƚĞŵĂŶĂŐĞŵĞŶƚƉƌŽŐƌĂŵƐĂŶĚƚŚĂƚĂĨƵƌƚŚĞƌϮϬйǁĞƌĞŝŶƚĞƌĞƐƚĞĚŝŶ
ĚŽŝŶŐƐŽ;Ϯϭ͘ϯйŽĨŝŶĚĞƉĞŶĚĞŶƚƐĂŶĚϭϴ͘ϵйŽĨŵƵůƟƉůĞƐͿ;>ĂǁĞƚĂů͕
ϮϬϬϱͿ͘dŚĞŵŽƐƚĐŽŵŵŽŶůǇƉƌŽǀŝĚĞĚƉƌŽŐƌĂŵƐǁĞƌĞĨŽƌĚŝĂďĞƚĞƐ͕
asthma and hyperlipidemia. 
ϭ͘Ϯ͘ϭ͘ϭ͘ϭϯ͘ϰ͘ϭdŚĞƐŚĞǀŝůĞWƌŽũĞĐƚ͗ 
Major studies of community pharmacists’ service provision, first in 
diabetes, and more recently in asthma, have resulted in services 
remunerated by local employers in Asheville. The services cover 
diabetes, hypertension, hyperlipidemia and asthma. The project has 
ďĞĞŶĞƐƚĂďůŝƐŚĞĚĨŽƌŽǀĞƌϭϬǇĞĂƌƐĂŶĚŚĂƐƌĞƉŽƌƚĞĚƌĞĚƵĐƟŽŶŝŶ
hospital admission and emergency room visits in diabetes and asthma 
;ƵŶƟŶŐ͕ϮϬϬϱͿ͘ 
ϭ͘Ϯ͘ϭ͘ϭ͘ϭϯ͘ϰ͘ϮDŝƐƐŝƐƐŝƉƉŝƐƚĂƚĞ^DƉƌŽŐƌĂŵƐ 
Mississippi was the first state to initiate payment for 
ƉŚĂƌŵĂĐĞƵƟĐĂůĐĂƌĞƐĞƌǀŝĐĞƐĨŽƌDĞĚŝĐĂŝĚƉĂƟĞŶƚƐŝŶϭϵϵϴ͘ΗŝƐĞĂƐĞ
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state certified pharmacists" could claim reimbursement for services for 
patients with diabetes, asthma, hyperlipidemia and anticoagulation. 
WŚĂƌŵĂĐŝƐƚƐĂƌĞƉĂŝĚϮϬΨh^ĚŽůĂƌƐĨŽƌĂϭϱ-ϯϬŵŝŶƵƚĞĐŽŶƐƵůƚĂƟŽŶǁŝƚŚ
ƉĂƟĞŶƚ͕ǁŝƚŚƵƉƚŽϭϮǀŝƐŝƚƐƉĞƌǇĞĂƌĨƵŶĚĞĚĨŽƌ diabetes, asthma, 
ŚǇƉĞƌůŝƉŝĚĞŵŝĂ͕ĂŶĚĂŶƟĐŽĂŐƵůĂƟŽŶ;ůĞŶŬŝŶƐŽƉƉĂŶĚĞůŝŶŽ͕ϮϬϬϲͿ͘ 
ϭ͘Ϯ͘ϭ͘ϭ͘ϭϯ͘ϱDĞĚŝĐĂƟŽŶƌĞǀŝĞǁƚǇƉĞƐĞƌǀŝĐĞƐ 
ϭ͘Ϯ͘ϭ͘ϭ͘ϭϯ͘ϱ͘ϭWŚĂƌŵĂĐĞƵƟĐĂůĂƐĞDĂŶĂŐĞŵĞŶƚ͗/ŽǁĂDĞĚŝĐĂŝĚ 
A Pharmaceutical Case Management program is remunerated by 
Iowa DĞĚŝĐĂŝĚĂŶĚǁĂƐŝŶƚƌŽĚƵĐĞĚŝŶϮϬϬϬ͘WŚĂƌŵĂĐŝƐƚƐǁŚŽƉƌŽǀŝĚĞ
this service must do so with a collaborating doctor, and both are paid. 
PCM is targeted at patients’ high-risk adverse effects from medicines 
and to be eligible a patient needs to be taken at least four medicines and 
ƚŽŚĂǀĞŽŶĞŽƌŵŽƌĞŽĨϭϮĞůŝŐŝďůĞĐŚƌŽŶŝĐĐŽŶĚŝƟŽŶƐ͘dŚĞŝŶŝƟĂů
assessment (undertaken by the pharmacist) includes medication history, 
evaluation of the indication for each medicine and progress towards 
treatment goals, assessment of the need for any medication changes. 
The pharmacist makes written recommendations to the patient's doctor 
and those that are accepted or modified are then considered for 
inclusion in an action plan. Pharmacists and doctors are equally eligible 
to provide services and are paid at the same rate (Iowa Pharmacy 
ƐƐŽĐŝĂƟŽŶ͕ϮϬϬϳͿ͘ 
ϭ͘Ϯ͘ϭ͘ϭ͘ϭϯ͘ϱ͘ϮDĞĚŝĐĂƟŽŶdŚĞƌĂƉǇDĂŶĂŐĞŵĞŶƚWƌŽŐƌĂŵƐ;DdDƐͿ 
Medication Therapy Management programs is a model of 
pharmaceutical care for community pharmacies approved under the 
MĞĚŝĐĂƌĞDŽĚĞƌŶŝǌĂƟŽŶĐƚϮϬϬϯ;ĞīĞĐƟǀĞ:ĂŶƵĂƌǇϮϬϬϲͿ͘dŚĞŵĞƌŝĐĂŶ
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Pharmacists Association (AphA) and the National Association of Chain 
Drug Stores (NACDS) Foundation (American Pharmacist Association, 
ϮϬϬϱͿ͕ďƵŝůĚŝŶŐŽŶƚŚĞĐŽŶƐĞŶƐƵƐĚĞĮŶŝƟŽŶŽĨĞůĞǀĞŶnational pharmacy 
organizations, developed a model framework for implementing effective 
MTM services in a community pharmacy setting. This model describes 
core elements of MTM services that can be provided by pharmacists 
across the spectrum of community pharmacy. This model is intended for 
pharmacists to use with all patients in need of MTM services, whether or 
not they are covered by private or public benefit. The patients or 
caregivers will receive MTM services at the pharmacy where they filled 
their prescriptions and from a pharmacist with whom they have an 
ongoing relationship, and the services will be provided in a private or 
semiprivate area, by a pharmacist whose time is devoted to the patient 
during this service. In this model, the patient meets the pharmacist for 
an annual comprehensive medication therapy review and has additional 
visits throughout the year. The number of visits required will depend 
upon the complexity the patient's medication therapy problems, the 
extent of coverage by the patient' health plan or both. A typical patient 
might need up to four visits per year, but additional visits would be 
available when necessary. 
To be eligible for MTM patients must have multiple, chronic, high 
drug cost conditions such as heart failure, chronic obstructive pulmonary 
disease (COPD) and diabetes and be prescribed multiple medicines. 
Centers for Medicare and Medicaid Services (CSM) defined a threshold 
drug cost at which a patient would become eligible for MTM program, 
ƐĞƚĂƚh^Ψϰ͕ϬϬϬĨŽƌϮϬϬϲ͘ 
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MTM in community pharmacy includes five core components: 
ϭ- Medication therapy review, 
Ϯ- A personal medication record, 
ϯ- A medication action plan, 
ϰ- Intervention and referral, and 
ϱ- Documentation and follow- up. 
 
 
 
ϭ͘Ϯ͘ϭ͘ϭ͘ϭϯ͘ϲ  Prescriptive Authority 
Some states approved some sort of prescriptive authority to 
pharmacists, which varies from prescribing under formulary, protocols 
to collaboration with physicians. 
One of the first pieces of legislation to expand the role of the 
pharmacists was passed in 1986 in Florida. This legislation granted 
pharmacists the ability to prescribe drugs that are listed on a strict 
formulary. This formulary has been expanded since it was originally 
passed on 1986. New Mexico and many other states allow pharmacists to 
prescribe and administer vaccines under protocol arrangements 
(Wertheimer, 2005 a). Prescribing by collaboration with physicians, 
describes the situation in which the physician diagnose and make initial 
treatment decisions, and the pharmacist as a medication expert continues 
with the patient to select, initiate, monitor, change, or discontinue patient’ 
medications in order to reach therapeutic goals and positive patient 
outcomes through cost effective means. The pharmacist in this situation 
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will have a dependent prescriptive authority and will share with the 
collaborating physicians the risk and responsibilities associated with the 
patient's overall health outcome (Bertin, 2005). As of 2003 the total 
number of states with statutes authorizing some form of collaborative 
drug therapy was 35 states (Wertheimer, 2005 b). 
 
ϭ͘Ϯ͘ϭ͘ϭ͘ϭϰ-Conclusion 
Pharmacists patient care and pharmaceutical care practice in USA 
is mostly driven by universities, research centers and pharmacy 
association and organizations. There is no unified system for practice 
regarding pharmaceutical care through the different states. Data shows 
that community pharmacists mostly involved in a sort of disease 
management programs which are done mostly by private managed care 
and to some extent in public insurance projects. Disease management 
programs mostly targets chronic disease states as Diabetes, Asthma and 
Hyperlipidemia. Projects like Asheville and its extensions in different 
states proved to be successful in disease management. Pharmacists are 
remunerated or paid for providing service in some of the projects but 
the general trend is the remuneration for traditional dispensing. 
The most promising program for pharmaceutical care is the 
recently approved Medication Therapy Management program approved 
under the Medicare ModerŶŝǌĂƟŽŶĐƚ;ĞīĞĐƟǀĞϮϬϬϲͿ͘ 
Although USA is the cradle of shift of pharmacy practice towards 
patient-centered practice (clinical pharmacy and pharmaceutical care), 
the progress in the community pharmacy is considered very slow. The 
pharmacy education by adopting the professional degree PHARM D 
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;ĨƌŽŵϮϬϬϮͿ͕ŝƐƉƌĞƉĂƌŝŶŐƚŚĞǁŽƌŬĨŽƌĐĞĨŽƌƚŚĞĨƵƚƵƌĞĞǆƚĞŶĚĞĚƌŽůĞƐŽĨ
the pharmacists, but still other barriers for implementation in practice 
exists. 
Prescribing roles are given to pharmacists, and this extends from 
minor ailments to collaborative models for disease management. 
Telepharmacy, to solve pharmacy practice in remote areas, is one of the 
innovative practices in USA. Patient counseling is required by 
pharmacists and is practiced as a requirement of OBRA regulations. 
In general the traditional dispensing activities is mostly prevalent, 
with some portion of community pharmacists involved is disease 
mangement, Pharmaceutical care and patient counseling. 
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ϭ͘Ϯ͘ϭ͘ϮKDDhE/dz PHARMACY PRACTICE IN THE UNITED KINGDOM 
 
ϭ͘Ϯ.ϭ͘Ϯ͘ϭ/ŶƚƌŽĚƵĐƟŽŶ 
United Kingdom is, located in Western Europe, and consists of 
islands including the northern one sixth of the island of Ireland between 
the North Atlantic Ocean and the North Sea, northwest of France, it 
extends in total area of Ϯϰϰ͕ϴϮϬ^YKm, and border country is Ireland. 
WŽƉƵůĂƟŽŶŶƵŵďĞƌŝƐϲϬ͕ϳϳϲ͕Ϯϯϴ;:ƵůǇϮϬϬϳĞƐƚ͘Ϳ͘dŚĞĞƚŚŶŝĐŐƌŽƵƉƐŝŶ
United Kingdom are White  ϵϮ͘ϭй͕ ůĂĐŬϮй͕^ŽƵƚŚƐŝĂŶƐϰ͘Ϭй͕DŝǆĞĚ
ϭ͘Ϯй͕ŚŝŶĞƐĞϬ͘ϰй͕KƚŚĞƌƐϬ͘ϰй͘dŚĞƚǇƉĞŽĨƚŚĞŐŽǀĞƌŶŵĞŶƚŝƐa 
constitutional monarchy. 
/ŵƉŽƌƚĂŶƚŚĞĂůƚŚŝŶĚŝĐĂƚŽƌƐ͗/ŶĨĂŶƚŵŽƌƚĂůŝƚǇƌĂƚĞϱ͘ϬϭĚĞĂƚŚƐͬϭ͕ϬϬϬůŝǀĞ
births. Life - ĞǆƉĞĐƚĂŶĐǇĂƚďŝƌƚŚĨŽƌƚŽƚĂůƉŽƉƵůĂƟŽŶϳϴ͘ϳǇĞĂƌƐ;dŚĞ
ǁŽƌůĚ&ĂĐƚďŽŽŬ͕ϮϬϬϳͿ͘ 
ϭ͘Ϯ͘ϭ͘Ϯ͘Ϯ,ĞĂůƚŚĐĂƌĞƐǇƐƚĞŵŝŶƚŚĞhŶŝƚĞĚ<ŝŶŐĚŽŵ 
Healthcare is mostly publicly run and it is free at the point of need. 
The private sector has a role also in supplying and funding some 
buildings, and services within the National Health system (NHS) (BBC 
ĐƟŽŶEĞƚǁŽƌŬ͕ϮϬϬϳͿ͘ 
ϭ͘Ϯ͘ϭ͘Ϯ͘ϯWŚĂƌŵĂĐĞƵƟĐĂů^ĞƌǀŝĐĞƐ 
Community pharmacists practice either independently or through 
contracting with the NHS. In order to be able to dispense NHS 
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prescriptions from a registered pharmacy, the pharmacist must hold a 
ĐŽŶƚƌĂĐƚǁŝƚŚƚŚĞůŽĐĂů,ĞĂůƚŚƵƚŚŽƌŝƚǇ;,Ϳ;^ƚŽŶĞĂŶĚƵƌƟƐ͕ϮϬϬϮĂͿ͘ 
The professional body, the Royal Pharmaceutical Society of Great 
Britain, has complete jurisdiction over the practice of pharmacy and 
controls the registration (licensure) of all pharmacists and pharmacies 
;EŽǇĐĞ͕ϭϵϵϳͿ͘ 
ϭ͘Ϯ͘ϭ͘Ϯ͘ϰŽŶƟŶƵŝŶŐƉƌŽĨĞƐsional development for pharmacists 
Continuing professional development (CPD) had not been a 
mandatory requirement for registration of pharmacists in UK in previous 
years . Recently it has been requested as mandatory for all pharmacists. 
The society introduced (CPD) standards as good practice under the code 
ŽĨĞƚŚŝĐƐŽŶϭst DĂƌĐŚϮϬϬϵ͘/ƚŝƐĞǆƉĞĐƚĞĚƚŚĂƚďǇϮϬϭϮƚŚĂƚĂůƉƌĂĐƟĐŝŶŐ
pharmacists and registered technicians will be required to periodically 
demonstrate their continuous fitness to practice.(Uptodate 
ŽƌŐĂŶŝǌĂƟŽŶ͕ϮϬϭϬͿ͘ 
ϭ͘Ϯ͘ϭ͘Ϯ͘ϱůĂƐƐĞƐŽĨŵĞĚŝĐŝŶĂůƉƌŽĚƵĐƚƐŝŶh< 
dŚĞDĞĚŝĐŝŶĞƐdϭϵϲϴƌĞŐƵůĂƚĞƐƚŚĞŵĂŶƵĨĂĐƚƵƌĞ͕ĚŝƐƚƌŝďƵƟŽŶ
and importation of a) medicines for human use; b) medicines for 
administration to animals; and c) medicated animal feeding stuffs. The 
Act also deals with the registration of retail pharmacies and provides 
that medicines may be supplied to the public only from pharmacies, 
except those medicines, which can with reasonable safety be sold 
without the supervision of a pharmacist. In England, Wales, and Scotland 
the Royal Pharmaceutical Society, has duties of enforcement in 
connection with pharmacies and retail distribution of medicines 
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;ƉƉĞůďĞĂŶĚtŝŶŐĮĞůĚ͕ϭϵϵϯĂͿ͘/Ŷh<ƚŚĞƌĞĂƌĞƚŚƌĞĞĐůĂƐƐĞƐŽĨ
products under the Medicines Acƚϭϵϲϴ͕ŶĂŵĞůǇ͗ 
(ϭ) General sale list medicines (GSL) 
(Ϯ) Pharmacy medicines (P) 
(ϯ) Prescription-only medicines (POM). 
A private prescription must be retained for two years from the date 
on which the prescription -only medicine was sold or supplied, or, for a 
repeat prescription, the date on which the medicine was supplied for the 
ůĂƐƚƟŵĞ;ZŽǇĂůWŚĂƌŵĂĐĞƵƟĐĂů^ŽĐŝĞƚǇŽĨ'ƌĞĂƚƌŝƚĂŝŶ͕ϮϬϬϳďͿ͘ 
ϭ͘Ϯ͘ϭ͘Ϯ͘ϲ&ĂĐƐŝŵŝůĞƚƌĂŶƐŵŝƐƐŝŽŶŽĨƉƌĞƐĐƌŝƉƟŽŶƐ 
Any pharmacist who decided to dispense a prescription-only 
medicine against a fax must ensure that the integrity of the original 
prescription is maintained, and that the prescription will be in his 
possession within a short time. Controlled medicines listed in Schedules 
ϮŽƌϯŽĨƚŚĞDŝƐƵƐĞŽĨƌƵŐƐZĞŐƵůĂƟŽŶƐϮϬϬϭĐĂŶŶŽƚďĞĚŝspensed 
against a fax. 
ϭ͘Ϯ͘ϭ͘Ϯ͘ϳWƌĞƐĐƌŝƉƟŽŶƌĞĐŽƌĚƐ 
Records can be in form of a bound book or electronically. Every 
person lawfully conducting a registered retail pharmacy business or a 
registered pharmacy within a hospital is required to keep a record in 
respect of every sale or supply of a prescription-only medicine, unless: 
(a) It is a sale or supply in pursuance of a "health prescription" or a 
prescription for an oral contraceptive; or 
(b) A separate record of the sale or supply is made in the Controlled 
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Drugs register; or 
(c) The sale is by way of wholesale dealing and the order or invoices 
(or copies) relating to the sale is retained for two years. 
The entry must be made on the day the sale or supply takes place or 
the next following day. The prescription-only record must be preserved 
by the owner of the retail pharmacy business for a period of two years 
from the date of the last entry in the register (Royal Pharmaceutical 
Ž^ĐŝĞƚǇŽĨ'ƌĞĂƚƌŝƚĂŝŶ͕ϮϬϬϳĐͿ͘ 
ϭ͘Ϯ͘ϭ͘Ϯ͘ϴĞǀĞůŽƉŝŶŐĂŶĚŝŵƉůĞŵĞŶƟŶŐƐƚĂŶĚĂƌĚŽƉĞƌĂƟŶŐ procedures 
for dispensing 
From January 1, 2005, the Royal Pharmaceutical Society 
introduced a requirement for pharmacists to put in place and operate 
written Standard Operating Procedures (SOPs) within individual 
pharmacies covering the dispensing process, including the transfer of 
prescribed items to patients. The requirement applies to both hospital and 
community sectors and covers all of the activities which occur from the 
time that prescriptions are received in the pharmacy or by a pharmacist 
until medicines or other prescribed items have been collected or 
transferred to the patient (Royal Pharmaceutical Society of Great 
Britain,2007d). 
ϭ͘Ϯ͘ϭ͘Ϯ͘ϵ Internet pharmacy 
Internet pharmacy or On-line pharmacy services is accepted as a 
pharmacy practice in UK. The Royal Pharmaceutical Society's Practice 
ĂŶĚYƵĂůŝƚǇ/ŵƉƌŽǀĞŵĞŶƚŝƌĞĐƚŽƌĂƚĞ;ŶŽŶǇŵŽƵƐ͕ϮϬϬϲͿŚĂƐƉƌŽĚƵĐĞĚ
new guidance for pharmacists who provide pharmacy services through 
the internet or are planning to do so. 
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ϭ͘Ϯ͘ϭ͘Ϯ͘ϭϬŽŶƚƌŽůĞĚƌƵŐƐ 
The Misuse ŽĨƌƵŐƐZĞŐƵůĂƟŽŶƐϮϬϬϭĐůĂƐƐŝĮĞĚƚŚĞƐĞĚƌƵŐƐŝŶĮǀĞ
schedules according to different levels of control. They are classified CD 
Lic (hallucinogenic), CD POM (opiates), CD No Register (minor 
stimulants) POM, CD Benz POM (benzodiazepines), CD Anab POM 
(anabolic steroids), or CD Inv. P or POM (codeine , morphine in low 
strength), according to the controls which apply to each. 
ϭ͘Ϯ͘ϭ͘Ϯ͘ϭϬ͘ϭWƌĞƐĐƌŝƉƟŽŶƐĨŽƌŽŶƚƌŽůĞĚƌƵŐƐ 
No prescription is required under the Misuse of Drugs Regulations 
for supply by a phĂƌŵĂĐŝƐƚŽĨĂƐĐŚĞĚƵůĞϱĚƌƵŐďƵƚ͕ĨŽƌƉƌĞƉĂƌĂƟŽŶƐ
above certain strengths, a prescription is required under the Medicines 
Đƚϭϵϲϴ͘WƌĞƐĐƌŝƉƟŽŶƐĂƌĞŶĞĐĞƐƐĂƌǇĨŽƌĂůŽƚŚĞƌĐĂƚĞŐŽƌŝĞƐŽĨ
Controlled Drugs which are always prescription-only medicines. The 
ƌĞƋƵŝƌĞŵĞŶƚƐŽĨďŽƚŚƚŚĞDŝƐƵƐĞŽĨƌƵŐƐĐƚϭϵϳϭĂŶĚƚŚĞDĞĚŝĐŝŶĞƐ
Đƚϭϵϲϴ͘ 
It is not lawful for a practitioner to issue a prescription containing 
ĂŽŶƚƌŽůĞĚƌƵŐŽƚŚĞƌƚŚĂŶĂĚƌƵŐƐƉĞĐŝĮĞĚŝŶ^ĐŚĞĚƵůĞϰŽƌϱŽƌ
temazepam, or for a pharmacist to dispense it, unless it complies with 
the following: to be signed by the practitioner; dated; written as to be 
indelible, the prescriber address (NHS prescriptions exempted); for 
private prescriptions to be on a standardized form, when dispensed on a 
community pharmacy or GP practice. The forms issued in England, 
Đ^ŽƚůĂŶĚŽƌtĂůĞƐ͕ĂƌĞĐĂůĞĚ&WϭϬW͕WW;ϭͿĂŶĚtWϭϬW͕
respectively; should contain the private prescriber's identification 
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number, specify the dose to be taken, the total quantity ( in both words 
and figures) of dosage units, as appropriate, to be supplied; in any other 
case, the total quantity (in both words and figures) of the Controlled 
Drug to be supplied; have written on it, if issued by a dentist, the words 
"for dental treatment only"; specify the name and address of the person 
for whose treatment is issued. 
WƌĞƐĐƌŝƉƟŽŶƐĨŽƌ^ĐŚĞĚƵůĞϮĂŶĚϯŽŶƚƌŽůĞĚƌƵŐƐĚŽŶŽƚŚĂǀĞƚŽ
be written in the hand writing of the prescriber. A part from the 
prescriber's signature, the entire prescription, including the date, may be 
computer generated. A Controlled Drug other than a drug specified in 
Đ^ŚĞĚƵůĞϰŽƌϱŵƵƐƚŶŽƚďĞƐƵƉƉůŝĞĚďǇĂŶǇƉĞƌƐŽŶŽŶĂƉƌĞƐĐƌŝƉƟŽŶ͗ 
- Before the appropriate date on the prescription; 
- >ĂƚĞƌƚŚĂŶϮϴĚĂǇƐĂŌĞƌƚŚĞĂƉƉƌŽƉƌŝĂƚĞĚĂƚĞon the prescription. 
The date must be marked on the prescription at the time of supply of a 
ŽŶƚƌŽůĞĚƌƵŐŽƚŚĞƌƚŚĂŶĨŽƌ^ĐŚĞĚƵůĞϰŽƌϱ͘ZĞƉĞĂƚƉƌĞƐĐƌŝƉƟŽŶƐĨŽƌ
Đ^ŚĞĚƵůĞϮĂŶĚϯŽŶƚƌŽůĞĚƌƵŐƐĂƌĞŶŽƚĂůŽǁĞĚ͘ 
ϭ͘Ϯ͘ϭ͘Ϯ͘ϭϬ͘ϮĞƐƚƌƵĐƟŽŶŽĨŽŶƚƌŽůĞĚDrugs 
Pharmacists are required by regulations to keep records of 
Đ^ŚĞĚƵůĞϭĂŶĚϮŽďƚĂŝŶĞĚĂŶĚƐƵƉƉůŝĞĚ͘dŚĞƌĞĨŽƌĞƚŚĞǇŵĂǇŽŶůǇ
destroy their stock of such drugs (including out of date stock) in the 
presence of a person authorized as a witness by the Secretary of state 
either personally or as a member of a class. Pharmacists (and persons 
conducting a retail pharmacy business) that produce (i.e. manufacture or 
ĐŽŵƉŽƵŶĚͿ^ĐŚĞĚƵůĞϯŽƌϰŽŶƚƌŽůĞĚƌƵŐƐĂƌĞƌĞƋƵŝƌĞĚƚŽŬĞĞƉ
records relating to this activity. Therefore they must have destruction of 
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these drugs witnessed. There are no requirement for the destruction of 
Đ^ŚĞĚƵůĞϱŽŶƚƌŽůĞĚƌƵŐƐ;ŶĞŝƚŚĞƌƐƚŽĐŬŶŽƌƉĂƟĞŶƚƌĞƚƵƌŶĞĚ
medication) to be witnessed by and authorized person, regardless of the 
activity. 
ϭ͘Ϯ͘ϭ͘Ϯ͘ϭϬ͘ϯWĂƟĞŶƚƌĞƚƵƌŶĞĚŽŶƚƌŽůĞĚƌƵŐƐ 
A pharmacist (or a practitioner) may destroy Controlled Drugs 
returned to him by a patient or a patient's representative, from their 
own homes without the presence of an authorized person. Pharmacists 
are encouraged to destroy the returned drugs as soon as possible, and 
not wait for the authorized witness to visit. It is a good practice to have 
the destruction witnessed by another person and to keep a note. Not in 
the Controlled Drugs register, of what was destroyed (Royal 
WŚĂƌŵĂĐĞƵƟĐĂů^ŽĐŝĞƚǇŽĨ'ƌĞĂƚƌŝƚĂŝŶ͕ϮϬϬϳĞͿ͘ 
ϭ͘Ϯ͘ϭ͘Ϯ͘ϭϭWĂƟĞŶƚ-oriented practice in the United Kingdom 
In UK although different reports and white papers participated in 
suggesting extended role for the pharmacists in general and the 
community pharmacist in particular, two important reports participated 
effectively in devising the new face of the community pharmacy 
ƉƌĂĐƟĐĞ͘dŚŽƐĞǁĞƌĞƚŚĞEƵĸĞůĚZĞƉŽƌƚŝŶϭϵϴϲ;dƵƌŶĞƌ͕ϭϵϴϲͿĂŶĚ
WŚĂƌŵĂĐǇŝŶĂEĞǁŐĞ;W/EͿ/Eϭϵϵϱ-ϭϵϵϲ;ZŽǇĂůWŚĂƌŵĂĐeutical 
SŽĐŝĞƚǇŽĨ'ƌĞĂƚƌŝƚĂŝŶ͕ϭϵϵϲͿ͘ 
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Other Strategies and Plans for improving pharmacy practice in 
UK 
More strategies and plans were devised either by the National 
Health Service (NHS) or by the local authorities for implementing a new 
vision for pharmacy. 
Examples of these strategies are : Pharmacy in the future 
;ĞƉĂƌƚŵĞŶƚŽĨ,ĞĂůƚŚϮϬϬϬͿ͖ǀŝƐŝŽŶŽĨƉŚĂƌŵĂĐǇŝŶƚŚĞŶĞǁE,^
;ĞƉĂƌƚŵĞŶƚŽĨ,ĞĂůƚŚ͕ϮϬϬϯͿ͖tĂůĞƐƐƚƌĂƚĞŐǇ͞ZĞŵĞĚŝĞƐĨŽƌ^ƵĐĐĞƐƐ͟
;E,^tĂůĞƐ'/'zDZh͕ϮϬϬϯͿ͖^ĐŽƚůĂŶĚƐƚƌĂƚĞŐǇ͞dŚĞƌŝŐŚƚ medicine” 
;^ĐŽƫƐŚǆĞĐƵƟǀĞ͕ϮϬϬϮͿ͘ 
ϭ͘Ϯ͘ϭ͘Ϯ͘ϭϭ͘ϭWŚĂƌŵĂĐĞƵƟĐĂůĐĂƌĞƉƌĂĐƟĐĞ 
In UK the preferred term for pharmaceutical care processes is 
"medicines management" a term which may be taken as to imply a 
multidisciplinary approach. However, the two terms have been used in 
ƉĂƌĂůĞůĂŶĚƚŽĐĞƌƚĂŝŶĞǆƚĞŶƚŝŶƚĞƌĐŚĂŶŐĞĂďůǇ;^ƚŽŶĞĂŶĚƵƌƟƐ͕ϮϬϬϮďͿ͘ 
In Scotland two types of schemes were offered by community 
pharmacists: 
ϭͿ Chronic Medication Service (CMS). 
ϮͿ Pharmaceutical care model schemes (PCMS): IntroduĐĞĚŝŶϭϵϵϵ͕
for palliative care, frail elderly and mental health. By the end of 
ϮϬϬϯĂƚŚŝƌĚŽĨĐŽŵŵƵŶŝƚǇƉŚĂƌŵĂĐŝĞƐǁĞƌĞƉĂƌƟĐŝƉĂƟŶŐĂŶĚ
annual funding of one million sterling pounds were made 
available. Other schemes for diabetes, hypertension and 
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angŝŶĂͬŵǇŽĐĂƌĚŝĂůŝŶĨĂƌĐƟŽŶǁĞƌĞĚĞǀĞůŽƉĞĚĚƵƌŝŶŐϮϬϬϱ
;ůĞŶŬŝŶƐŽƉƉĂŶĚĞůŝŶŽ͕ϮϬϬϲͿ͘ 
ϭ͘Ϯ͘ϭ͘Ϯ͘ϭϭ͘ϮŽŵŵƵŶŝƚǇƉŚĂƌŵĂĐŝƐƚΖƐĐŽŶƚƌĂĐƚƵĂůĨƌĂŵĞǁŽƌŬϮϬϬϱ 
Community pharmacies are independent contractors, who offer 
NHS services, in a similar manner to GPs, dentists and optometrists. 
They hold a "contract" with the local primary care trust(PCT) or primary 
care organization ( PCO ). Pharmacy contractors are not paid a salary by 
the PCTs, PCOs or the NHS. However, in return for providing NHS 
services, community pharmacy contractors are paid a number of 
nationally agreed fees and allowances (National Treatment Agency for 
Ƶ^ďƐƚĂŶĐĞDŝƐƵƐĞ͕ϮϬϬϲĂͿ͘ 
dŚĞŶĞǁĐŽŵŵƵŶŝƚǇƉŚĂƌŵĂĐǇĐŽŶƚƌĂĐƚƵĂůĨƌĂŵĞǁŽƌŬϮϬϬϱ
reflects many of the extended roles recommended in the Nuffield 
report, PIANA, Pharmacy in future and other strategies. The NHS 
community pharmacy contract is made up of three levels: 
- Essential services 
- Advanced services 
- Enhanced services. 
Implementation of the new contract is being phased over time. 
Essential services were ƉƌŽǀŝĚĞĚĨƌŽŵϭƉƌŝůϮϬϬϱ͘ĚǀĂŶĐĞĚƐĞƌǀŝĐĞƐ
ǁĞƌĞŝŶƚƌŽĚƵĐĞĚĚƵƌŝŶŐϮϬϬϱͬϬϲ. Essential services are mandatory; 
however advanced services and locally commissioned enhanced services 
are two optional tiers of service provision. Pharmacists who have 
completed certain training and work in pharmacies that have particular 
facilities are able to provide advanced services. The enhanced services 
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are locally commissioned by PCTs and PCOs in response to local health 
priorities (National Treatment Agency for Substance DŝƐƵƐĞ͕ϮϬϬϲďͿ͘ 
ϭ͘Ϯ͘ϭ͘Ϯ͘ϭϭ͘Ϯ͘ϭƐƐĞŶƟĂůƐĞƌǀŝĐĞƐŽīĞƌĞĚďǇĂůƉŚĂƌŵĂĐǇĐŽŶƚƌĂĐƚŽƌƐ 
These are seven essential services: 
- Dispensing  
- Repeat dispensing 
- Disposal of unwanted medicines 
- Promotion of healthy lifestyle (public health) 
- Signposting  
- Support of self care 
- Clinical governance  
ϭ͘Ϯ͘ϭ͘Ϯ͘ϭϭ͘Ϯ͘ϮĚǀĂŶĐĞĚƐĞƌǀŝĐĞƐ 
The only advanced service currently is Medicines Use Review & 
Prescription Intervention. 
The medicines use reviews (MURs) are undertaken periodically, 
and in response to the need as prescription intervention during 
dispensing process. They are about helping patients use their medicines 
more effectively and of identification of problems which patients may 
face with their medicines use. Recommendations made to the prescriber 
may also relate to the clinical or cost effectiveness of treatment .The 
review requires face to face contact with the patient and will normally 
be carried in the community pharmacy. The service requires a 
consultation area which should be clearly designated as an area for 
confidential consultation, distinct from the general public areas of the 
pharmacy, Candidates for this service can be patients with multiple 
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medicines and those with long term conditions, for whom it can be 
ĐŽŶĚƵĐƚĞĚĞǀĞƌǇϭϮŵŽŶƚŚƐ͘dŚĞƐĞƌĞŐƵůĂƌDhZƐ͕ŝŶŝƟĂƚed by the 
pharmacist, must only be provided for patients who have been using the 
pharmacy for dispensing of prescriptions for at least the previous three 
months. Pharmacists may accept referrals for MUR from other health 
care professionals or patients direct requests as long as they fall within 
criteria mentioned. The requirement for the review to be undertaken 
may be highlighted by the pharmacist identifying a significant problem 
during dispensing of regular prescription. This service requires the 
pharmacist to be accredited and should pass an assessment based on 
the nationally agreed competencies for the service. Records of the 
review will be made on the patient's pharmacy record, and summary of 
the review and any recommendations will be sent to the patient's GP, 
using nationally agreed recording template. A copy of the review 
summary and recommendations will be given to the patient 
;WŚĂƌŵĂĐĞƵƟĐĂů^ĞƌǀŝĐĞEĞŐŽƟĂƟŶŐŽŵŵŝƩĞĞ͕W^E͕ϮϬϬϰ-^ϭͿ͘ 
ϭ͘Ϯ͘ϭ͘Ϯ͘ϭϭ͘Ϯ͘ϯŶŚĂŶĐĞĚƐĞƌǀŝĐĞƐ 
This may include the following services: 
- Supervised Administration (Consumption of Prescribed Medicines) 
- Needle and Syringe Exchange  
- -On Demand Availability of Specialist Drugs 
- Stop Smoking 
- Care Home 
- Medicines Assessment and Compliance Support 
- Medication Review (Full Clinical Review) 
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- Minor Ailment Service 
- Out of Hours (Access to medicines) 
- -Supplementary Prescribing by Pharmacists 
- Emergency contraception hormonal service. 
Medication Review (Full Clinical Review) 
The aims of this service include: ensuring patients are on optimum 
therapy by reviewing patient's medicines and making recommendations 
to improve therapy to the prescriber regarding effectiveness, 
appropriateness, safety of the treatment (and where the pharmacist is a 
prescriber to make changes to the patient treatment as agreed with the 
doctor) and to improve patients compliance (Primary care contracting: 
E,^ ͕ϮϬϬϱͿ͘ 
Minor Ailment Service 
In this service the pharmacy will provide advice and support to 
people on the management of minor ailments, including where 
necessary, the supply of medicines for treatment of the minor ailment 
(including selling of over the counter medicines; OTC), for those people 
who would have otherwise gone to their GP for a prescription, and this 
will be within agreed local formulary. The pharmacy will operate a triage 
system, including referral to other health and social care professionals, 
where appropriate (Pharmaceutical Service Negotiating Committee, 
W^EϮϬϬϰ-EϴͿ͘ 
Supplementary Prescribing by Pharmacists 
The service is based on voluntary partnership between an 
independent prescriber (doctor or dentist) and a supplementary 
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prescriber, to implement an agreed patient specific plan (CMP) with the 
patient's agreement. The supplementary prescriber will need to be able 
to access patient' medical records (Pharmaceutical Service Negotiating 
ŽŵŵŝƩĞĞ͕W^EϮϬϬϰ-EϭϬͿ͘ 
ϭ͘Ϯ͘ϭ͘Ϯ͘ϭϮŽŶĐůƵƐŝŽŶ 
The health care system in UK is generally controlled by the 
government National Health Service (NHS), and private type of services 
is limited. There is generally a unified vision for pharmacy practice in all 
administrative areas, with slight differences. The system is characterized 
by presence of well structured strategies for pharmacy practice targeting 
public and individual health. Community pharmacists are contracting 
with the government through the Community Pharmacists contract. This 
type of contracts with the government, gives a type of managed practice 
to attain specified targets, and especially extending the pharmacists role 
into medicines use review (MUR), minor ailment, chronic disease 
management, public health issues as smoking cessation and disease 
prevention, syringes exchange, drug misuse ...etc. , with remuneration in 
the services given by the pharmacists. 
Pharmaceutical care is not the preferred term, instead 'medicines 
management', is preferred, meaning a multi-professional work. 
Medicines management implies activities on the macro level (system), 
and the micro level (individual). 
Pharmacy education is an amalgam of science and practice. The 
Royal Pharmaceutical Association has an active role in registering and 
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training pharmacists in different aspects of patient-centered practices, 
and in providing continuing education and professional development. 
Pharmacists prescribing is practiced as supplementary prescribing, 
and recently independent prescribing is approved. 
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1.2.1.3 COMMUNITY PHARMACY PRACTICE IN AUSTRALIA 
 
ϭ͘Ϯ͘ϭ͘ϯ͘ϭ-Introduction 
Australia is a continent located between the Indian Ocean and the 
Ž^ƵƚŚWĂĐŝĮĐKĐĞĂŶ͕ĞǆƚĞŶĚŝŶŐŝŶĂƚŽƚĂůĂƌĞĂŽĨϳ͕ϲϴϲ͕ϴϱϬ sq km, and 
ǁŝƚŚƉŽƉƵůĂƟŽŶŽĨϮϬ͕ϰϯϰ͕ϭϳϲ;:ƵůǇϮϬϬϳĞƐƚ͘Ϳ͘/ƚŝƐĐŽŶƐŝĚĞƌĞĚƚŚĞ
world's smallest continent but sixth-largest country; population 
concentrated along the eastern and southern coasts. The government is 
ĨĞĚĞƌĂůĐŽŵŵŽŶǁĞĂůƚŚ͕ǁŝƚŚϲƐƚĂƚĞƐĂŶĚϮƚĞƌƌŝƚŽƌŝĞƐ͕ƵƐƚƌĂůŝĂŶĂƉŝƚĂů
Territory, New South Wales, Northern Territory, Queensland, South 
Australia, Tasmania, Victoria, and Western Australia. The ethnic groups 
ŽĨƚŚĞƉŽƉƵůĂƟŽŶĂƌĞ͗ǁŚŝƚĞϵϮй͕ƐŝĂŶϳй͕ĂďŽƌŝŐŝŶĂůĂŶĚŽƚŚĞƌϭй͘ 
Important healtŚŝŶĚŝĐĂƚŽƌƐ͗ƚŽƚĂůŝŶĨĂŶƚŵŽƌƚĂůŝƚǇƌĂƚĞŝƐϰ͘ϱϳ
ĚĞĂƚŚƐͬϭ͕ϬϬϬůŝǀĞďŝƌƚŚƐ͘>ŝĨĞĞǆƉĞĐƚĂŶĐǇĂƚďŝƌƚŚĨŽƌƚŽƚĂůƉŽƉƵůĂƟŽŶŝƐ
ϴϬ͘ϲϮǇĞĂƌƐ;dŚĞtŽƌůĚ&ĂĐƚďŽŽŬϮϬϬϳͿ͘ 
ϭ͘Ϯ͘ϭ͘ϯ͘Ϯ-Australian health care system 
ŝ^ŶĐĞϭϵϴϰ͕ƚŚĞďƵůŬŽĨĐƵƌƌĞŶƚŚĞĂůƚŚĐĂƌĞƉƌŽǀŝƐŝon in Australia 
has been based upon the commonwealth-funded health insurance 
scheme, Medicare. Through the Pharmaceutical Benefit Scheme (PBS), 
the Australian government makes a range of necessary prescription 
medicines available at reduced prices to all Australian residents 
(Gallagher and Baily-&ůŝƩĞƌ͕ϮϬϬϳͿ͘ 
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ϭ͘Ϯ͘ϭ͘ϯ͘ϯ-Pharmacy and the Australian health care system 
dŚĞƌĞĂƌĞĂďŽƵƚϱ͕ϬϬϬĐŽŵŵƵŶŝƚǇƉŚĂƌŵĂĐŝĞƐŝŶƵƐƚƌĂůŝĂ;ŽŶĞĨŽƌ
ĞǀĞƌǇϯ͕ϴϬϬƉĞŽƉůĞĐŽŵƉĂƌĞĚǁŝƚŚŽŶĞƉĞƌϰ͕ϱϬϬƉĞŽƉůĞŝŶh<Ϳ͘
Pharmacy ownership is largely restricted to registered pharmacists, and 
in most states, one pharmacist can own, at the most, three pharmacies. 
Pharmacy chains and “supermarket pharmacy” do not really exist, 
although this situation has been challenged by the government. 
Department stores and companies, are interested in owning pharmacies, 
although in the first instance, independent pharmacists will be invited to 
rent out space, rather than the companies opening pharmacies 
themselves. 
All pharmacists are required to undertake four years of university 
education and then one year of practical pre-registration training  
;DĂƐŽŶ͕ϮϬϬϯĂͿ͘ 
Pharmacies and pharmacists require registration. Pharmacy 
practice is regulated via the pharmacy boards in each state. States differ 
slightly in their regulations. In Victoria, for example, the registration of 
the pharmacists for the first time requires completion of prescribed 
period of practical training, passing the Board Registration Examination, 
and the pharmacist also should provide Basic First Aid Certificate, or 
such evidence of being proficient in administering first aid as may be 
acceptable by the board; evidence of successful completion of an 
approved management course. Prior to lodging an application for initial 
registration, applicant must have satisfactorily completed a pharmacy 
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pre-registration training program, and an extemporaneous product 
ĂƐƐĞƐƐŵĞŶƚ;WŚĂƌŵĂĐǇŽĂƌĚŽĨsŝĐƚŽƌŝĂ͕ϮϬϬϰĂͿ͘ 
ϭ͘Ϯ͘ϭ͘ϯ͘ϰ-Continuing education and continuous professional 
development 
In general it is not a mandatory requirement for pharmacists to 
submit evidence of continuing education or professional development 
(CPD) activities for the annual re-registration. However states differ in 
ƚŚĞŝƌĂƉƉƌŽĂĐŚƚŽƚŚŝƐŝƐƐƵĞ͘ǇϮϬϬϳ͕ϰŽƵƚŽĨƚŚĞĐŽƵŶƚƌǇ͛Ɛϴ
jurisdictions required pharmacists to demonstrate or show proof of their 
involvement in lifelong learning activities. Although each jurisdiction 
determines how this lifelong education requirements has to be 
demonstrated, the Pharmacists Society of Australia (PSA) devise the 
recommended framework for the recording of CPD (Driesen and 
sĞƌďĞŬĞĞƚĂů͕ϮϬϬϳͿ͘ 
There is recently a trend towards competency-based re-
registration in the states, examples were: 
- Program of ENRICH in South Australia, and a similar ENRICHVIC 
progrĂŵŝŶsŝĐƚŽƌŝĂ;WŚĂƌŵĂĐǇŽĂƌĚŽĨsŝĐƚŽƌŝĂ͕ϮϬϬϴͿ͘ 
ϭ͘Ϯ͘ϭ͘ϯ͘ϱ-Medicines Categories in Australia 
Medicines in Australia are categorized into: prescription-only 
medicines (POM) and over-the-counter (OTC) medicines. OTC medicines 
categorized in three categories. First, pharmacist-only medicines (e.g. 
ƐƚĞƌŽŝĚĂůŶĂƐĂůƐƉƌĂǇƐ͕ŚǇĚƌŽĐŽƌƟƐŽŶĞĐƌĞĂŵϭƉĞƌĐĞŶƚͿ͕ǁŚŝĐŚŵƵƐƚďĞ
sold in a pharmacy under the supervision of a pharmacist and are not 
available for self-selection. Secondly, pharmacy-only medicines (e.g. 
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ibuprofen, larger packs of paracetamol, some cough and cold 
preparations), which can be sold only in a pharmacy but need not be 
placed behind the counter. And thirdly, general sale list medicines, 
ǁŚŝĐŚĐĂŶďĞƐŽůĚŝŶŽƚŚĞƌŽƵƚůĞƚƐ;DĂƐŽŶ͕ϮϬϬϯďͿ͘ 
Where a drug substance represents a potential hazard to the 
community or requires professional advice about its correct use, the 
States/Territories restrict access by 'scheduling' drug substances. The 
National Drugs and Poisons Scheduling decide the scheduling of 
substances Committee (NDPSC). The Schedules fall into two broad 
categories - ƚŚŽƐĞƚŚĂƚƌĞůĂƚĞƚŽŵĞĚŝĐŝŶĞƐ;^ĐŚĞĚƵůĞϮ͕ϯ͕ϰĂŶĚϴͿĂŶĚ
ƚŚŽƐĞƚŚĂƚƌĞůĂƚĞƚŽƉŽŝƐŽŶƐ;^ĐŚĞĚƵůĞϱ͕ϲĂŶĚϳͿ͘/ŶĂĚĚŝƟŽŶ^ĐŚĞĚƵůĞϵ
covers substances that are prohibited (TGA healtŚ͕ϮϬϬϭͿ͘ 
ϭ͘Ϯ͘ϭ͘ϯ͘ϲ-Dispensing prescriptions 
The professional standards set by the pharmaceutical society 
requires that the pharmacist should be aware of systems of good 
dispensing practice and can implement them. The pharmacist is required 
to keep dispensing procedure document in the place of practice. The 
dispensing procedure should address the three phases of the dispensing 
process; before dispensing; preparation phase; and provision of the 
medicine. 
The consumer's medication history should be adequately 
reviewed and updated before dispensing (and it should include also non-
prescription or OTC items); it should contain all patient information 
including previous medical conditions, allergies and adverse drug 
reactions. Every dispensed medicine should be recorded in the 
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consumer's medication history. The pharmacist should document any 
interaction with the prescriber. Medicines should be labeled with eligible 
and unambiguous labels with all proper information about the drug and 
proper instructions (in addition to pharmacy address, date of dispensing 
and prescriber name). Dispensing records should show which pharmacist 
dispensed the medicine (s). Initial the prescription and the label (as a 
good practice), when the issuing pharmacist is not the dispensing 
pharŵĂĐŝƐƚ;WŚĂƌŵĂĐĞƵƟĐĂů^ŽĐŝĞƚǇŽĨƵƐƚƌĂůŝĂ͕ϮϬϬϴĂͿ͘ 
ϭ͘Ϯ͘ϭ͘ϯ͘ϲ͘ϭ-Counseling 
On every occasion a medicine is dispensed, a pharmacist must 
counsel or offer to counsel, that person or the person's agent about the 
medication. The patient rights to privacy and confidentiality must be 
obtained at all times during counseling. Full and extensive counseling is 
given or offered to the following groups of patients: 
Patients with acute severe illness; patients with multiple drug regimens 
or multiple disease states; elderly patients, psychiatric patients, Patients 
with history of poor compliance, inadequate therapy response or 
adverse drug reactions; patients from non-English background; patients 
with a harm minimization program (e.g. methadone); and patients on 
drugs which may affect driving or ability to operate machinery. 
ϭ͘Ϯ͘ϭ͘ϯ͘ϲ͘Ϯ- Collection of medicines for disposal 
Pharmacists are encouraged to collect unwanted medicines from 
members of the public for safe disposal.  
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ϭ͘Ϯ͘ϭ͘ϯ͘ϲ͘ϯ-Facsimile prescriptions 
 Prescriptions may be received by facsimile transmission. 
Medicines dispensed from prescriptions received by facsimile must not 
be supplied to a patient or agent until the pharmacist who dispensed the 
prescription, or a pharmacist who has checked that dispensed medicines 
has the original prescription (or the duplicate of the original prescription 
and a national health service valid repeat authorization) in his or her 
possession and has checked it thoroughly against the dispensed 
medicines (Pharmacy Board of Victoria ͕ϮϬϬϰďͿ͘ 
ϭ͘Ϯ͘ϭ͘ϯ͘ϲ͘ϰ-Brand substitution 
 The pharmacist should ensure the consumer fully understands the 
nature of brand substitution (and confirm consumer consent), and 
should inform the consumer of the less expensive brand where they are 
available and consistent with the prescriber intent and desired health 
outcomes .The pharmacist should record in the dispensing record and on 
the medicine label when brand substitution occurs. Prescriber should 
endorse the prescription with 'no substitution' where they have 
determined substitution would be disadvantageous to the consumer. 
ϭ͘Ϯ͘ϭ͘ϯ͘ϳ-Internet pharmacy 
All legal requirements of the physical pharmacy are required for 
the Internet pharmacy including registration of pharmacists and 
pharmacies and the receiving of a proper prescription for a prescription-
ŽŶůǇŵĞĚŝĐŝŶĞWŚĂƌŵĂĐĞƵƟĐĂů^ŽĐŝĞƚǇŽĨƵƐƚƌĂůŝĂ͕ϮϬϬϴďͿ͘ 
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ϭ͘Ϯ͘ϭ͘ϯ͘ϴ-Controlled substances 
A narcotic register should be kept in the pharmacy, in which 
writing should be in ink. Every record, invoice and other documents of 
any transaction related to narcotic substances should be retained for not 
ůĞƐƐƚŚĂŶϮǇĞĂƌƐĨƌŽŵƚŚĞůĂƚĞƐƚĚĂƚĞŽŶǁŚŝĐŚŝƚǁĂƐŵĂĚĞŽƌĂĐƚĞĚ
upon. 
Storage of controlled substances in the pharmacy 
Controlled substances should be stored apart from other goods in 
an enclosure that is secured in a approved manner, and when not used 
ƐŚŽƵůĚďĞƐĞĐƵƌĞůǇůŽĐŬĞĚ;dŚĞWŚĂƌŵĂĐǇŽĂƌĚŽĨdĂƐŵĂŶŝĂ͕ϮϬϬϮͿ͘ 
Destruction of controlled substances 
This should be done by a registered medical practitioner, 
pharmacist, veterinary practitioner or dentist in the presence of another 
registered health practitioner. Details of destruction should be recorded. 
;sŝĐƚŽƌŝĂŶ>ĞŐŝƐůĂƟŽŶĂŶĚWĂƌůŝĂŵĞŶƚĂƌǇŽĐƵŵĞŶƚƐ͕ϮϬϬϲͿ͘ 
ϭ͘Ϯ͘ϭ͘ϯ͘ϵ-Telepharmacy 
There is no clear regulations or legitimation of practice of 
telepharmacy in Australia, although several pilot studies were conducted 
to assess the possibility of introducing the practice especially in remote 
ĂƌĞĂƐ;<ŝŵďĞƌĂŶĚWĞƚĞƌƐŽŶ͕ϮϬϬϲͿ͘ 
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ϭ͘Ϯ͘ϭ͘ϯ͘ϭϬ-Patient-oriented practice in community pharmacy 
ϭ͘Ϯ͘ϭ͘ϯ͘ϭϬ͘ϭ-Pharmacy Education 
Undergraduate pharmacy education is based on Bachelor of 
Pharmacy degree. Bachelor of Pharmacy programs are four-year full-time 
degree based on a subject mix combination of pure science, specialized 
pharmacy subjects and other trends towards clinical role including 
substantial training in therapeutics, pharmacoepidemiology and Quality 
Use of Medicine (QUM) issues (Kowalski, 2004). 
ϭ͘Ϯ͘ϭ͘ϯ͘ϭϬ͘Ϯ-QUALITY USE OF MEDICINES STRATEGY 
The comprehensive strategy which influence pharmacy practice in 
Australia, both in hospital or community setting, and promote the 
rational drug use, is the National Strategy for Quality Use of Medicine 
(QUM), Which is considered one of the central objectives of Australia's 
National Medicines Policy. Quality Use of Medicines means: selecting 
management options wisely, considering the use of medicines or other 
ways than medicines, choosing suitable medicines if a medicine is 
considered necessary so that the best available option is selected and 
using medicines safely and effectively to get the best possible results. 
The strategy in general involves the team work concept of all the 
health professionals concerned with the use of the medicine, starting 
with the consumer and including, doctors, pharmacists and nurses. 
;ƵƐƚƌĂůŝĂŶ'ŽǀĞƌŶŵĞŶƚ͕ĞƉĂƌƚŵĞŶƚŽĨ,ĞĂůƚŚĂŶĚŐŝŶŐ͕ϮϬϬϮͿ͘ 
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ϭ͘Ϯ͘ϭ͘ϯ͘ϭϬ͘ϯ-Community Pharmacy Agreements 
The community pharmacy is practicing through “community 
pharmacy agreements”, which is negotiated with the Australian 
government by the Pharmacy Guild of Australia on behalf of community 
pharmacy owners. This agreements is of a five-year duration. The 
agreement offers incentive payments to community pharmacy to 
provide services to consumers that are designed to improve the use of 
medication. These payments are administered by Medicare Australia. 
The current agreement is the ‘Fourth Community Pharmacy Agreement’, 
ǁŚŝĐŚƐƚĂƌƚƐŝŶϭĞĐĞŵďĞƌϮϬϬϱƚŽϯϬ:ƵŶĞϮϬϭϬ͘ The current 
agreement, together with the previous agreements contains elements of 
the QUM strategy. 
The Fourth Community Pharmacy Agreement 
The priorities for funding during the Agreement are: 
a. Medication Management Review. Funding under this Program will 
ďĞΨϭϱϬŵŝůŝŽŶ͘ 
b. Rural Pharmacy allowance and Support. 
c. Indigenous Access. This program aims to improve access to 
community pharmacy services by indigenous Australians by taking 
account of cultural issues in meeting Indigenous health needs. 
d. Better Community Health. This include asthma pilot program, 
diabetes pilot program, prevention of communicable diseases 
...etc. 
According to this agreement the dispensing fee for the pharmacist 
ǁŝůďĞϱ͘ϭϱΨĂƐŽĨϭ July ϮϬϬϲ͕ƐƉĞĐŝĂůŚĂŶĚůŝŶŐĨĞĞϮ͘ϳϭΨĂŶĚ
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ĞǆƚĞŵƉŽƌĂŶĞŽƵƐƉƌĞƉĂƌĂƟŽŶĨĞĞϮ͘ϬϰΨ;dŚĞWŚĂƌŵĂĐǇ'ƵŝůĚŽĨ
ƵƐƚƌĂůŝĂ͕ϮϬϬϱĂͿ͘ 
ϭ͘Ϯ͘ϭ͘ϯ͘ϭϬ͘ϰ- Community pharmacy patient oriented services 
The Australian professional standards give idea about the areas of 
practice of the community pharmacist. The following services is the main 
service, other than traditional dispensing activities, done by the 
community pharmacists: 
ϭ͘Ϯ͘ϭ͘ϯ͘ϭϬ͘ϰ͘ϭŽŵƉƌĞŚĞŶƐŝǀĞƉŚĂƌŵĂĐǇĐĂƌĞ͗in which the pharmacist 
adopts a structured approach to reviewing, evaluating and monitoring 
the consumer’s use of medicines to ensure safe effective therapy. This 
practice involves components of pharmaceutical care, and chronic 
diseases management. 
ϭ͘Ϯ͘ϭ͘ϯ͘ϭϬ͘ϰ͘Ϯ- Comprehensive Medication Review: in which the 
pharmacist systematically reviews and evaluates the consumer's 
medication treatment regimen and takes appropriate action to optimize 
therapeutic outcomes and ensure their access to regular reviews. 
ϭ͘Ϯ͘ϭ͘ϯ͘ϭϬ͘ϰ͘ϯ-Home Medicines Review (HMR): This also known as 
‘Domiciliary Medication Management Review, DMMR’. This service is 
considered as collaborative model, provided to consumers in the 
community, and funded through the Community Pharmacy Agreement. 
It requires Accreditation of the pharmacist to undergo this service. 
Referral is initiated by the general practitioner through a referral form, 
which is then verified by the pharmacist. The community pharmacist is 
responsible for ensuring that the examination of the medication and the 
consumer review are conducted at a place and time suitable to the 
Please purchase PDFcamp Printer on http://www.verypdf.com/ to remove this watermark.
  
ϲϳ 
consumer. Confirmed arrangements for this and the name of the 
accredited pharmacist must be communicated to the general 
practitioner before the appointment. Conducting the interview in the 
consumer's home is the best opportunity to assess how the person is 
managing their medications in their own environment. However, 
consumers have the right to nominate another location if they prefer 
that these activities do not take place in their own home .A patient 
profile and proper documentation should be maintained. An agreed 
medication management plan should also be maintained, which will 
serve as the basis for the general practitioner and the pharmacist's 
follow-up of the consumer. 
ϭ͘Ϯ͘ϭ͘ϯ͘ϭϬ͘ϰ͘ϰ- Opioid Substitution Program:  Opioid substitution 
WŚĂƌŵĂĐŽƚŚĞƌĂƉǇŚĂƐďĞĞŶƵƐĞĚŝŶƵƐƚƌĂůŝĂƐŝŶĐĞϭϵϲϵ͘/ƚŝƐƌĞĐŽŐŶŝǌĞĚ
as an effective public health measure and a vital component of harm 
reduction. In this service the pharmacist follows established procedures 
to provide directly supervised Opioid substitution treatment to optimize 
therapeutic outcomes and quality. 
ϭ͘Ϯ͘ϭ͘ϯ͘ϭϬ͘ϰ͘ϱ-Smoking cessation service: In which the pharmacist 
follows established procedures to optimize therapeutic outcomes and 
quality of life for the consumer and to contribute to the reduction of 
harm associated with tobacco use. 
ϭ͘Ϯ͘ϭ͘ϯ͘ϭϬ͘ϰ͘ϲ-Needle and Syringe Program: This service applies to the 
supply of sterile needles and syringes, the collection and disposal of used 
needles and syringes, and the provision of advice and information 
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relevant to injecting drug users (IDUs). IDUs are referred to other health 
professionals when appropriate. 
ϭ͘Ϯ͘ϭ͘ϯ͘ϭϬ͘ϰ͘ϳ-Monitoring and Case Detection:  The service includes 
measurement of blood pressure, blood glucose and blood cholesterol. 
Monitoring refers to the regular checking of specific clinical parameters 
to assist individuals under treatment for specific health conditions. The 
results of monitoring should be discussed with the consumer in the 
context of the therapeutic goals established with their health care 
provider. Active liaison with the consumer's health care provider is 
therefore an essential component of this service. Case detection 
describes the process of identifying people at risk of disease in an 
opportunistic manner in a pharmacy practice setting. 
ϭ͘Ϯ͘ϭ͘ϯ͘ϭϬ͘ϰ͘ϴ-Health Promotion: This is a process involves health 
education, health promotion information to individuals, or communities 
through campaigns, meeting groups, organizations, schools ...etc. 
;WŚĂƌŵĂĐĞƵƟĐĂů^ŽĐŝĞƚǇŽĨƵƐƚƌĂůŝĂ͕ϮϬϬϴĐͿ͘ 
ϭ͘Ϯ͘ϭ͘ϯ͘ϭϬ͘ϰ͘ϵ-Consumer Medicine Information: Consumer Medicine 
Information (CMI) is provided to consumers in community pharmacies 
through a program known as Medicines Information to Consumers 
(MIC). Brand-specific written information about medicinal products is 
targeted to consumers. 
 In addition to these services is a quality assurance platform, 
(which is also funded through the Fourth community pharmacy 
agreement). This program known as the Quality Care Pharmacy Program 
(QCPP), which incorporates standards including professional services, 
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retail skills, business management and loss prevention. Pharmacists 
were offered a number of financial incentives to become accredited with 
this program, and as further incentives for accreditation, the 
remuneration for certain cognitive services has subsequently been 
ůŝŶŬĞĚƚŽƚŚŝƐƉƌŽŐƌĂŵ;^ŚĂůŽŵĂŶĚůŝƐŽŶ͕ϮϬϬϱďͿ͘ 
ϭ͘Ϯ͘ϭ͘ϯ͘ϭϬ͘ϰ͘ϭϬ-Pharmaceutical care and disease management 
 The national Quality Use of Medicines (QUM) strategy, which 
ƐƚĂƌƚĞĚŝŶƚŚĞĞĂƌůǇϭϵϵϬƐŝŶƌĞƐƉŽŶƐĞƚŽƚŚĞŐƌŽǁŝŶŐĚĂƚĂŽŶŽǀĞƌƵƐĞ͕
underuse, inappropriate use and adverse health consequences of 
medicines, particularly in older people is considered as the main driver 
for pharmaceutical care implementation in Australia. In common with 
the Minnesota model it focuses on the burden of medication-related 
problems and aims to ensure that medicines are used appropriately, 
safely, effectively and conveniently. However, medication related 
problems are seen as problem with the system rather than the 
individual, and the focus is therefore on system change (Anonymous 
ϮϬϬϭͿ͘ 
 The Fourth community pharmacy Agreement includes many 
components of pharmaceutical care. These components can be seen 
through the various community pharmacists’ activities such as 
domiciliary and residential medication reviews or through chronic 
disease management programs through the community pharmacies. 
 A survey for community pharmacist done as part of the National 
WŚĂƌŵĂĐǇĂƚĂďĂƐĞWƌŽũĞĐƚĂƚϮϬϬϯƌĞǀĞĂůĞĚƚŚĂƚĞŶŚĂŶĐĞĚƐĞƌǀŝĐĞƐ
with trained staff were evident at high level for the following disease 
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states: asthma, diabetes, hypertension (The Pharmacy Guild of Australia, 
ϮϬϬϯͿ͘ 
ϭ͘Ϯ͘ϭ͘ϯ͘ϭϬ͘ϰ͘ϭϭ-Prescribing by Pharmacists 
 Four models for pharmacist's prescribing are suggested. The first 
model concerns Residential Aged Care Facilities; the second one for 
hospital pharmacists; the third and the fourth ones can involve 
community pharmacy, and these are: protocol management (e.g. 
anticoagulant management) and Pharmacist's Formulary. 
In general the practice of pharmacists prescribing is not till now 
well developed in Australia and awaits different changes in legislations 
and regulations after validation of the demonstration projects expected 
ƚŽďĞĚŽŶĞ;dŚĞWŚĂƌŵĂĐǇ'ƵŝůĚŽĨƵƐƚƌĂůŝĂ͕ϮϬϬϱďͿ͘ 
ϭ͘Ϯ͘ϭ͘ϯ͘ϭϭ-Conclusion 
 The most important driving force for pharmaceutical care or 
patient-centered practice in Australia is the government strategy 
“Quality Use of Medicines”. In community pharmacy this strategy is 
implemented through the community pharmacy contract with the 
government (Community Pharmacy Agreement). 
The Australian pharmacist Society has an active role in training 
and devising guidelines for development of pharmacy practice. Like UK 
pharmacy education is an amalgam of science and practice. 
 There is a concentration on the Rural Areas and the indigenous 
population. There is a set of pharmacy programs targeting this 
population e.g. allowances for pharmacy education of students from the 
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area, incentives for opening pharmacies, and improving pharmacy access 
by the Indigenous residents. 
 One service which found a good ground in pharmacy practice is 
‘Home Medication Review, HMR’ in which the pharmacist will solve 
medication problems with patients bound to their homes. Pharmacists 
were remunerated for participating in these services. 
 Other service given by community pharmacists is the 'Consumer 
Medicine Information, CMS'. In which patients are given a patient 
oriented leaflet in a more easy language and detailed information about 
the medicine. Pharmacists are also remunerated for this service. 
There is a system of improving quality of community pharmacy, 
through a 'Quality Care Program, QCP', which gives accreditation for 
community pharmacies, and considered as a perquisite for contracting in 
a HMR service. 
Pharmacists are also participating in disease management 
programs for chronic diseases including: Diabetes, Asthma, although 
traditional roles of distribution dominate. 
Pharmacists’ prescribing is not yet implemented, although models 
of practice were suggested.
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ϭ͘Ϯ͘Ϯ COMMUNITY PHARMACY PRACTICE IN GULF COUNTRIES 
ϭ͘Ϯ͘Ϯ͘ϭCommunity Pharmacy practice in Saudi Arabia 
1.2.2.1.1-Introduction: 
Kingdom of Saudi Arabia is bordering the Persian Gulf and the Red 
Ğ^Ă͕ŶŽƌƚŚŽĨzĞŵĞŶ͘dŚĞ<ŝŶŐĚŽŵĞǆƚĞŶĚƐŝŶĂƚŽƚĂůĂƌĞĂŽĨϮ͕ϭϰϵ͕ϲϵϬ
ƐƋŬŵ͕ǁŝƚŚƉŽƉƵůĂƟŽŶŽĨϮϴ͕ϭϰϲ͕ϲϱϲ;ŝŶĐůƵĚŝŶŐϱ͕ϱϳϲ͕ϬϳϲŶŽŶ-
nationals) acĐŽƌĚŝŶŐƚŽ:ƵůǇϮϬϬϴĞƐƟŵĂƟŽŶ͘ 
EĂƟŽŶĂůŚĞĂůƚŚŝŶĚŝĐĂƚŽƌƐƐŚŽǁƚŽƚĂůŝŶĨĂŶƚŵŽƌƚĂůŝƚǇƌĂƚĞŽĨϭϭ͘ϵϰ
ĚĞĂƚŚƐͬϭϬϬϬůŝǀĞďŝƌƚŚƐĂŶĚĂůŝĨĞĞǆƉĞĐƚĂŶĐǇƌĂƚĞĨŽƌƚŽƚĂůƉŽƉƵůĂƟŽŶĂƐ
ϳϲ͘ϬϵǇĞĂƌƐ͘ĚŵŝŶƐƚĞƌĂƟǀĞůǇƚŚĞĐŽƵŶƚƌǇŝƐĚŝǀŝĚĞĚŝŶƚŽϭϯƉƌŽǀŝŶĐĞƐ͗ů
Bahah, Al Hudud Al Shmaliyah, Al Jawf, Al Madinah, Al Qasim, Riyadh, Al 
Sharqiyah, Asir, Ha’il, Jizan, Makkah, Najran, Tabuk (The Worldfactbook 
ϮϬϬϴͿ͘ 
Healthcare system in Saudi Arabia is well developed and 
ƐƚƌƵĐƚƵƌĞĚǁŝƚŚƚŽƚĂůĞǆƉĞŶĚŝƚƵƌĞŽŶŚĞĂůƚŚĞƋƵĂůϰ͘ϲ% of gross 
ĚŽŵĞƐƟĐƉƌŽĚƵĐƚ;'WͿ;dŚĞtŽƌůĚ,ĞĂůƚŚZĞƉŽƌƚϮϬϬϰͿ͘dŚĞŚĞĂůƚŚĐĂƌĞ
facilities are predominantly governmental, offering services to all 
citizens. 
ϭ͘Ϯ͘Ϯ͘ϭ͘Ϯ-Pharmacy practice 
ϭ͘Ϯ͘Ϯ͘ϭ͘Ϯ͘ϭ- Pharmacy education: The number of universities in Saudi 
ƌĂďŝĂŝƐŐƌŽǁŝŶŐǁŝƚŚϭϲƵŶŝǀĞƌƐŝƟĞƐĐƵƌƌĞŶƚůǇŽƉĞƌĂƟŶŐ͘dŚĞ
ŐŽǀĞƌŶŵĞŶƚŽǁŶϭϰŽĨƚŚĞƐĞƵŶŝǀĞƌƐŝƟĞƐĂŶĚƚŚĞƌĞŵĂŝŶŝŶŐϮĂƌĞ
ƉƌŝǀĂƚĞůǇŽǁŶĞĚ͘KŶůǇϵŽĨƚŚĞϭϲƵŶŝǀĞƌƐŝƟĞƐŚĂǀĞƉŚĂƌŵĂĐǇƉƌŽŐƌĂŵ
(Al-ƌŝĮDE͘͘ĞƚĂů͕ϮϬϬϳͿ͘dŽĂĚĚƌĞƐƐƚŚĞŶĞĞĚĨŽƌĂĚǀĂŶĐed 
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practitioners a PharmD degree is now offered in most of pharmacy 
ƐĐŚŽŽůƐ;<ŚĞŝƌE͘ĞƚĂůϮϬϬϵͿ͘WŚĂƌŵĂĐǇƉƌĂĐƟĐĞƌĞƐŝĚĞŶĐǇƉƌŽŐƌĂŵ
;WWZWͿŝƐĐƵƌƌĞŶƚůǇ;ϮϬϬϳͿĂƉƉƌŽǀĞĚůŽĐĂůǇďǇƚŚĞ^ĂƵĚŝŽŵŵŝƐƐŝŽŶŽĨ
Medical Specialties. This program serves to train pharmacists to provide 
patient-centered pharmaceutical care at hospital setting (Saudi 
ŽŵŵŝƐƐŝŽŶŽĨDĞĚŝĐĂů^ƉĞĐŝĂůƟĞƐ͕ϮϬϬϳͿ͘ 
The practice of pharmacy in hospitals is more developed than in 
private community pharmacies. Community pharmacy is considered one 
of the cornerstones of practice in Saudi Arabia when we consider the 
ůĂƌŐĞŶƵŵďĞƌĂǀĂŝůĂďůĞ͘dŚĞƌĞĂƌĞĂďŽƵƚϰϳϰϳƉƌŝǀĂƚĞƉŚĂƌŵĂĐŝĞƐǁŝƚŚĂ
ƌĂƚĞŽĨŽŶĞƉŚĂƌŵĂĐǇͬϰϵϴϴƉĞŽƉůĞ͘dŚĞƌĞĂƌĞĂƉƉƌŽǆŝŵĂƚĞůǇϲϮϳϯ
registered pharmacists in the private sector, of ƚŚĞƐĞϰϳϰϳƉŚĂƌŵĂĐŝƐƚƐ
ǁŽƌŬŝŶĐŽŵŵƵŶŝƚǇ;ƐŽŵĞƟŵĞƐŵŽƌĞƚŚĂŶŽŶĞƉŚĂƌŵĂĐŝƐƚ͕ĂŶĚϭϱϮϲŝŶ
ƉƌŝǀĂƚĞĚŝƐƉĞŶƐĂƌŝĞƐĂŶĚŚŽƐƉŝƚĂůƐ͘ϵϵйŽĨƚŚĞƉŚĂƌŵĂĐŝƐƚƐŝŶƚŚĞ
community pharmacy are foreign expatriates. Most of the Saudi 
pharmacists prefer to work in governmeŶƚĂůŝŶƐƟƚƵƚĞƐ;DK,ϮϬϬϲϭϰϮϳ
H). 
Saudi Arabia has an active pharmaceutical society which is 
ĞƐƚĂďůŝƐŚĞĚŝŶϭϰϬϴ,;^ĂƵĚŝWŚĂƌŵĂĐĞƵƟĐĂů^ŽĐŝĞƚǇ͕ϮϬϬϴͿ͘ 
ϭ͘Ϯ͘Ϯ͘ϭ͘Ϯ͘Ϯ- Rules and Regulations 
The rules and regulations in Saudi Arabia necessitate that the 
owner of the pharmacy or one of the partners should be a pharmacist. 
The pharmacy should have separate area for prescription medicines with 
a waiting area for customers; cosmetics and nutritional products area; 
compounding area (optional); a separate place for providing 
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pharmaceutical care, by clinical pharmacists (if available), for chronic 
diseases patients. 
The following registers should be available in the pharmacy: 
ϭ- Register for preparing and compounding prescriptions and for 
dispensing repeated prescriptions with complete information. 
Ϯ- Register for psychotropic controlled medicines, stamped by 
Ministry of Health stamp, with all information about the patient, 
medicines, and prescriber. 
ϯ- Register for narcotics and poisons, stamped by Ministry of Health 
stamp, with all information about the patient, medicines, and 
prescriber. 
ϰ- Computer for saving and printing medication instructions on 
proper labels. The labels should carry name of the pharmacy, the 
pharmacy address, pharmacy telephone number, name of the 
medication, strength and expiry date, patient name, instructions, 
ĚĂƚĞŽĨĚŝƐƉĞŶƐŝŶŐĂŶĚƉŚĂƌŵĂĐŝƐƚƐŝŐŶĂƚƵƌĞ;DK,ϮϬϬϰͿ 
ϭ͘Ϯ͘Ϯ͘ϭ͘Ϯ͘ϯ- Dispensing of controlled medicines: 
Guidelines for prescribing and dispensing psychotropic 
medications (CPM) IN Saudi Arabia were ƵƉĚĂƚĞĚŝŶϭϵϴϴ;DK,ϭϵϵϴͿ͘
The guidelines were adapted from the International Narcotic Control 
Board (INCB). Controlled psychotropic medications are classified into 
three groups (The Green List) that include:  
ϭ-Group one which includes drugs under international control. This 
ŐƌŽƵƉĐŽŶƚĂŝŶƐĨŽƵƌ Đ^ŚĞĚƵůĞƐ͗ Đ^ŚĞĚƵůĞϭǁŚŝĐŚŝŶĐůƵĚĞƐ
hallucinogenic drugs which must not be imported nor exported and 
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their prescribing is strictly prohibited. Schedule II, III, and IV are those 
which include, hypnotics, tranquilizers, stimulants and sedatives or 
their preparations. The law requires that these medications shall be 
treated as narcotics in case of importation, prescribing and dispensing. 
Ϯ-Group two includes a heterogeneous group of substances judged by 
MOH to carry high potential for abuse or addiction and classified as 
controlled drugs under Saudi law. These substances were treated 
similar to Group one drugs. 
ϯ- Group three includes other psychotropic drugs which were not 
included in the previous groups. These drugs are treated as non 
controlled drugs in importation. However these drugs have some 
restrictions on prescribing. Examples of such drugs include, 
Amytryptyline, Imipramin and Haloperidol 
A special prescription form must be used for prescribing 
controlled psychotropic drugs. The prescription must have a pink 
original with triplicate carbonated copies with different colors, and the 
term "Not valid for dispensing" must be printed on each copy. Each 
prescription must contain a single item with quantity not exceeding 
two weeks for the drugs of Group one and two of the green list and 
forty-five days for the drugs of Group three from the same list. 
Prescriptions for psychotropic substances must not be dispensed 
after seven days from the date of issuance. The original of the 
prescription is to be retained by the pharmacy and the patient should 
be given one copy for follow-up; the second copy to be kept in the 
patient’s file; and the third copy is to remain in the prescription book. 
Please purchase PDFcamp Printer on http://www.verypdf.com/ to remove this watermark.
  
ϳϲ 
The original and the patient’s copy are to be stamped with the seal of 
the pharmacy after the prescription has been dispensed. The name and 
address of the pharmacy are to be indicated clearly, as well as the 
license number, the date of dispensing and the word “Dispensed”. 
ϭ͘Ϯ͘Ϯ͘ϭ͘ϯ-Patient-oriented pharmacy practice 
There is general acceptance by pharmacy academics and the 
pharmacists in general of the patient-oriented practices as defined in 
clinical pharmacy or pharmaceutical care (Al-ƌŝĮDE͘͘ĞƚĂů͕ϮϬϬϳͿ͘dŚĞ
pharmaceutical society is actively promoting the concept. As a result of 
all these efforts a directorate of pharmaceutical care is established in 
directorate of health affairs in each region as per the Ministerial 
ĞĐŝƐŝŽŶŶŽϮϵͬϭͬϮϮϴϲĚĂƚĞĚϮϴͬϵͬϭϰϮϮ,͕ĂŶĚĂůƚŚĞƐĞďƌĂŶĐŚĞƐĂƌĞ
reporting centrally to the pharmaceutical care directorate in the 
Ministry of Health. Each pharmaceutical care directorate is composed 
of six sections: 
- Pharmaceutical services development. 
- Training and continuous education. 
- Follow up of rational drug use. 
-  Data bases section. 
- Administration affairs section (Directorate of pharmaceutical care, 
:ĂǌĂŶ͕ϮϬϬϵͿ͘ 
The effect of the introduction of these departments of pharmaceutical 
care is something to be evaluated in the future and whether it is calling 
for a more pharmacy patient-oriented practice or traditional roles in a 
new name is not clear till now. 
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Clinical pharmacy is implemented in some of the ministry of health big 
hospitals, university, defense and specialist hospitals (Executive Office of 
Ministers of HĞĂůƚŚĨŽƌ'ĐŽƵŶƚƌŝĞƐ͕ϮϬϬϱͿ͘ 
Community pharmacy practice in Saudi Arabia has not yet reached the 
level of development as that of hospital pharmacy practice. There is no 
documented evidence of patient-oriented practice, and the role is 
mainly focusing in distribution activities .The concept of pharmaceutical 
care is being widely discussed among health professionals and efforts 
are underway to introduce pharmaceutical care in the entire country (Al-
ƌŝĮDE͘͘ĞƚĂů͕ϮϬϬϳͿ͘ZĞŐƵůĂƟŽŶƐƉĞƌŵŝƚƉƌĂĐƟĐĞŽĨƉŚarmaceutical 
care by clinical in community pharmacies with proper availability of 
consultation room for that purpose, but still no implementation is 
documented. Although community pharmacists are among the health 
professionals targeted to report adverse drug reactions through the 
Adverse Drug Reactions (ADR) program in the country their response is 
very limited and some barriers for implementation were reported 
;ĂǁĂǌŝƌ^͘͘ϮϬϬϲͿ͘ 
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ϭ͘Ϯ͘Ϯ͘ϮŽŵŵƵŶŝƚǇWŚĂƌŵĂĐǇƉƌĂĐƟĐĞŝŶhŶŝƚĞĚƌĂďŵŝƌĂƚĞƐ 
ϭ͘Ϯ͘Ϯ͘Ϯ͘ϭ-Introduction: 
United Arab Emirates (UAE) is bordering the Gulf of Oman and the 
Persian Gulf, between Oman and Saudi Arabia. It is extending in a total 
ĂƌĞĂŽĨϴϯ͕ϲϬϬƐƋŬŵ͕ǁŝƚŚĂƚŽƚĂůƉŽƉƵůĂƟŽŶŽĨϰ͕ϲϮϭ͕ϯϵϵ;:ƵůǇ͕ϮϬϬϴ
est.). The ethnic groups of the populatŝŽŶŝƐŵŝƌĂƟϭϵй͕ŽƚŚĞƌƌĂďĂŶĚ
/ƌĂŶŝĂŶϮϯй͕^ŽƵƚŚƐŝĂŶϱϬй͕ŽƚŚĞƌĞǆƉĂƚƌŝĂƚĞƐ;ŝŶĐůƵĚĞƐtĞƐƚĞƌŶĞƌƐ
ĂŶĚĂƐƚƐŝĂŶƐͿϴй;ϭϵϴϮͿ͘dŚĞŐŽǀĞƌŶŵĞŶƚƚǇƉĞŝƐĨĞĚĞƌĂƟŽŶǁŝƚŚ
specified powers delegated to the UAE federal government and other 
powers reserved to member emirates. Administeratively the country is 
ĚŝǀŝĚĞĚŝŶƚŽϳĞŵŝƌĂƚĞƐ͕ďƵŚĂďŝ͕ũŵĂŶ͕ů&ƵũĂŝƌĂŚ͕^ŚĂƌũĂŚ͕ƵďĂŝ͕
Ra’s al Khayma, Umm al Qaywayn. 
'ĞŶĞƌĂůŚĞĂůƚŚŝŶĚŝĐĂƚŽƌƐ͗/ŶĨĂŶƚŵŽƌƚĂůŝƚǇƌĂƚĞ͕ƚŽƚĂůŝƐϭϯ͘ϭϭ
ĚĞĂƚŚƐͬϭϬϬϬůŝǀĞďŝƌƚŚƐ͘>ŝĨĞĞǆƉĞĐƚĂŶĐǇĂƚďŝƌƚŚ;ƚŽƚĂůͿ͗ϳϱ͘ϴϵǇĞĂƌƐ;dŚĞ
ǁŽƌůĚĨĂĐƚďŽŽŬ͕ϮϬϬϴͿ͘ 
Pharmacy education is mainly private, and with Sharja university 
as semi-ŐŽǀĞƌŶŵĞŶƚĂů͘dŚĞƌĞĂƌĞĐƵƌƌĞŶƚůǇϲƉƌŝǀĂƚĞĐŽůĞŐĞƐĚŝƐƚƌŝďƵƚĞĚ
in the different emirates (Commission for academic AccƌĞĚŝƚĂƟŽŶ͕ϮϬϬϵͿ͘ 
The health system services are considered free at point of access, 
mostly for national inhabitants and governmental expatriates employee. 
Private employees undergo private insurance for attaining health 
services. Directorates of pharmacy are responsible of licensing 
pharmacists, assistant pharmacists and pharmacies in the private sector. 
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dŽƚĂůŶƵŵďĞƌŽĨƉŚĂƌŵĂĐŝĞƐŝƐϭϭϮϮ͕ǁŝƚŚƚŽƚĂůŶƵŵďĞƌŽĨ
ƉŚĂƌŵĂĐŝƐƚƐĂƐϮϬϬϱĂŶĚĂƐƐŝƐƚĂŶƚƉŚĂƌŵĂĐŝƐƚƐĂƐϴϱϳ;DK͘͘,͕ϮϬϬϴͿ͘
UAE pharmacy practice is following minimum standard guidelines 
adapted from the Good Pharmacy Practice (GPP) guidelines .These 
guidelines entail: 
Generals 
- availability of a computer in each pharmacy 
- Internet access and e-mail access is strongly recommend. 
- Availability of telephone, a fax machine is recommended. 
- The pharmacy must enforce a strict "no smoking" policy within the 
pharmacy. 
- Pharmaceutical waste must be disposed of in accordance with 
UAE laws and regulation with special approved companies and 
this should always be recorded. 
- Controlled medicines must be stored in a lockable cupboard. 
- All environmental conditions related to sanity, safety should be 
taken account off. 
Documents 
Files 
Each pharmacy must keep the following files: 
- A general file: which must be divided into two parƚƐ͗ƉĂƌƚϭ͗DK,
ĐŝƌĐƵůĂƌƐ;ƵŶůĞƐƐƚŚĞƌĞŝƐĂĐĐĞƐƐƚŽƚŚĞƐĞǀŝĂƚŚĞŝŶƚĞƌŶĞƚͿ͘WĂƌƚϮ͗
copies of staff licenses, MOH approval of staff leave and training 
positions, pharmacy operating procedures … etc. 
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- Price file: for the MOH price list and updates (electronic version is 
acceptable). 
- Controlled medicines prescriptions files: for psychotropic and 
semi-psychotropic drugs. 
Registers 
- Each pharmacy should have the following registers for controlled 
medicines: 
ϭ- Psychotropic drugs register. The register is obtained from Ministry 
of Health after payment of the specified fees and is labeled ‘CD-
͟ Zͬ͘Wͬ'ƌŽƵƉϰ͘ 
Ϯ- Semi-controlled drugs register, labeled “CD-͟ ͬ͘Wͬ'ƌŽƵƉϱ͘ 
- Delivery notes for controlled medicines must be filed (according to 
ĂŐĞŶƚͿĂŶĚŬĞƉƚĨŽƌĂƚůĞĂƐƚϭϮmonths after delivery. Controlled 
ŵĞĚŝĐŝŶĞƉƌĞƐĐƌŝƉƟŽŶƐŵƵƐƚďĞŬĞƉƚĨŽƌϱǇĞĂƌƐĨƌŽŵƚŚĞĚĂƚĞŽĨ
ĚŝƐƉĞŶƐŝŶŐ;ŵŝŶŝŵƵŵŽĨϮǇĞĂƌƐŝŶƚŚĞƉŚĂƌŵĂĐǇ͕ƌĞŵĂŝŶŝŶŐϯ
ǇĞĂƌƐĐĂŶďĞŝŶƐĞĐƵƌĞƐƚŽƌĂŐĞͿ;DK͘͘,͕ϮϬϬϯͿ͘ 
 
ϭ͘Ϯ͘Ϯ͘Ϯ͘Ϯ-Dispensing of controlled medicines 
The controlled medicines are divided into three classes: 
EĂƌĐŽƟĐƐ͗ƚŚĞƐĞĂƌĞŵĞĚŝĐŝŶĞƐĂƐůŝƐƚĞĚŝŶ^ĐŚĞĚƵůĞϭ-ϲŽĨh
&ĞĚĞƌĂůůĂǁϭϰĨŽƌϭϵϵϱĞ͘Ő͘ŵĞƚŚĂĚŽŶĞĂŶĚŵŽƌƉŚŝŶĞ;ŶĂƌĐŽƟĐƐĂƌĞ
available only for use in hospitals). 
CD-A: These as listed in schedule ϳĂŶĚϴ͕ƚŚĞƐĞĂƌĞŵĞĚŝĐŝŶĞƐƚŚĂƚ
has potential for abuse and/or could be diverted for illegal use e.g. 
diazepam, tramadol and haloperidol. 
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CD-B: These are medicines used for psychotropic conditions, or 
Ɛ͞ĐŚĞĚƵůĞϯ͟ŵĞĚŝĐŝŶĞƚŚĂƚĂǀŽŝĚƐŶĂƌĐŽƟĐĐŽŶƚƌŽůĚƵe to its 
formulation or, any other medicine that requires stricter control than 
that of “prescription” e.g. amytriptyline and tretinoin. 
The UAE has promoted some medicines to narcotic status due to 
concerns about their potential abuse e.g. amphetamine 
(internationally considered as psychotropic). Some drugs have been 
controlled due to abuse of a different kind e.g. Misoprotol (Cytotec) 
tablets which can be used as an illegal abortion inducing drug (CD-A), 
and isotrentinoin (Roaccutane) which is controlled due to high risk of 
teratogencity (CD-B). 
on the status of the prescriber, as follows: 
'ĞŶĞƌĂůƉƌĂĐƟƟŽŶĞƌϯĚĂǇƐ͖ƐƉĞĐŝĂůŝƐƚϮǁĞĞŬƐ͖ĐŽŶƐƵůƚĂŶƚϰ
ǁĞĞŬƐ͖WƐǇĐŚŝĂƚƌǇ^ƉĞĐŝĂůŝƐƚŽƌŽŶƐƵůƚĂŶƚϰǁĞĞŬƐ 
/ŶĂĐĐŽƌĚĂŶĐĞǁŝƚŚ&ĞĚĞƌĂů>ĂǁŽ͘ϰ;ϭϵϴϯͿƚŚĞƌĞĂƌĞƐƉĞĐial 
requirements for out-patient prescription written for a CD-A, which 
includes: 
- use of a controlled drug prescription format form 
- Written in permanent ink. 
- Name and address of the patient 
- Amount of medicine and dose instructions 
- The prescription must havĞďĞĞŶǁƌŝƩĞŶŶŽƚŵŽƌĞƚŚĂŶϮĚĂǇƐ
ĞĂƌůŝĞƌĂƐĞĂĐŚĐŽŶƚƌŽůĞĚƉƌĞƐĐƌŝƉƟŽŶŝƐŽŶůǇǀĂůŝĚĨŽƌϯĚĂǇƐ
;ĨĞĚĞƌĂůůĂǁϰ͕ϭϵϴϯͿ͘ 
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- The dose must be within manufacturers’ dose range of the 
medicine. 
- No repeat can be issued without approval of the prescriber at the 
time of dispensing. 
There are no special prescription-requirements for ordering 
psychotropic CD-B drugs for in or out-patients and therefore these are 
ordered using a normal medical prescription. All invoices and 
prescriptions for CD-A drugs should be kept in the private pharmacy for 
ϱǇĞĂƌƐ͘ 
Private pharmacies must submit to pharmacy section in the ministry 
of health monthly report of receipts and consumption of narcotic and 
ƉƐǇĐŚŽƚƌŽƉŝĐƐ;',^ Ϯ͕ϬϬϳͿ͘ 
ϭ͘Ϯ͘Ϯ͘Ϯ͘ϯ-Patient-oriented practice in the UAE 
Pharmacy practice is mainly focused on distribution traditional 
activities. There is scanty information about clinical pharmacy practice 
(except in limited number of hospitals) .There are some preliminary 
research reports on pharmaceutical care done at AL-Ain hospital (Elnour 
ĞƚĂů͕ϮϬϬϴĂŶĚ^ĂĚŝŬĞƚĂů͕ϮϬϬϱͿ͘ 
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ϭ͘Ϯ͘Ϯ͘ϯKDDhE/dzW,ZDzWZd//E^h>dEdK&KDE 
1.2.2.3.1-Introduction: 
Sultanate of Oman is located in the southern corner of the Arabian 
Peninsula. It border the Kingdom of Saudi Arabia and the United Arab 
Emirates in the west, the Republic of Yemen in the south, the Strait of 
Hormuz in the north and the Arabian Sea in the east. The Sultanate 
ĞǆƚĞŶĚƐŝŶĂƚŽƚĂůĂƌĞĂŽĨĂƉƉƌŽǆŝŵĂƚĞůǇϯϬϵ͘ϱƚŚŽƵƐĂŶĚƐƋŬŵ͕ǁŝƚŚ
ƚŽƚĂůƉŽƉƵůĂƟŽŶŽĨϮ͕ϱϬϴ͕ϴϯϳ͖ϮϲйŽĨƚŚĞŵĂƌĞŶŽŶ-KŵĂŶŝ;ϮϬϬϱĞƐƚ͘Ϳ͘
dŚĞ^ƵůƚĂŶĂƚĞŝƐĂĚŵŝŶŝƐƚƌĂƟǀĞůǇĚŝǀŝĚĞĚŝŶƚŽϱƌĞŐŝŽŶƐ;DK͘͘,͕ϮϬϬϲͿ͕
ĂŶĚϰ'ŽǀĞƌŶĂƚĞƐǁŝƚŚϲϭtŝůĂǇĂƚĞƐ͘ 
Health service is free at point of access for Omani’s and 
ĞǆƉĂƚƌŝĂƚĞƐŐŽǀĞƌŶŵĞŶƚĞŵƉůŽǇĞĞ;DK͘͘,͕ϮϬϬϬͿ͘ 
There are two public colleges for assistant pharmacists in Oman, 
and two private colleges for pharmacists. Pharmacy education for 
ƉŚĂƌŵĂĐŝƐƚƐŝƐƌĞĐĞŶƚůǇŝŶƚƌŽĚƵĐĞĚ;DŝŶŝƐƚƌǇŽĨ,ŝŐŚĞƌĞĚƵĐĂƟŽŶ͕ϮϬϬϵͿ͘ 
ϭ͘Ϯ͘Ϯ͘ϯ͘Ϯ-PHARMACISTS LICENSING 
Pharmacists in the private sector are licensed though written and 
oral exams which are done by the department of pharmacy in the 
directorate of pharmaceutical affairs and drug control. The directorate is 
also supporting continuous education programs through an annual 
workshop, and through a pharmaceutical newsletter which is published 
quarterly and distributed to community pharmacists. 
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Pharmacy practice in private pharmacies is mainly focusing in 
distribution activities. There are some pockets of practice of clinical 
pharmacy in the public hospitals e.g. Royal hospital and Sultan Qaboos 
university hospital. Community pharmacy is practiced in:  
-  chain pharmacies : owned by some of the wholesalers. 
- Independent pharmacies: owned by individuals. 
- Pharmacies linked to private polyclinics. 
- Pharmacies linked to large supermarkets: recently introduced. 
dŽƚĂůŶƵŵďĞƌŽĨƉƌŝǀĂƚĞƉŚĂƌŵĂĐŝĞƐŝƐϯϱϬĂƐŽŶϯϭͬϭϮͬϮϬϬϳ;DK͘͘,͕
ϮϬϬϳͿ͘ 
Community pharmacists are keeping ministry of health circulars in 
special file, and a copy of price lists, which is distributed by the ministry, 
in the pharmacy. 
Community pharmacists are not involved in adverse drug reactions 
ƌĞƉŽƌƟŶŐ;DK͘͘,͕ϮϬϬϵͿ͘ 
Oman has developed a National Centre for, monitoring adverse drug 
ƌĞĂĐƟŽŶƐƐŝŶĐĞϭϵϵϮ͕ǁŚŝĐŚŚĂƐďĞĐŽŵĞĂĐĐƌĞĚŝƚĞĚŵĞŵďĞƌ of the 
international center in Sweden. Sultanate of Oman has a National Drug 
WŽůŝĐǇƐŝŶĐĞϮϬϬϬĂŶĚĂĚŝƌĞĐƚŽƌĂƚĞŽĨZĂƟŽŶĂůĚƌƵŐƵƐĞŝƐĞƐƚĂďůŝƐŚĞĚ
ƌĞĐĞŶƚůǇ;DK͘͘,͕ϮϬϬϵͿ͘KŵĂŶWŚĂƌŵĂĐĞƵƟĐĂů^ŽĐŝĞƚǇŝƐĞƐƚĂďůŝƐŚĞĚŝŶ
ϮϬϬϳ͕ǁŝƚŚĂŵĂŝŶǀŝƐŝŽŶŽĨĂĚǀĂŶĐŝng pharmaceutical care to 
ŝŶƚĞƌŶĂƟŽŶĂůůĞǀĞůƐ;KŵĂŶWŚĂƌŵĂĐĞƵƟĐĂů^ŽĐŝĞƚǇ͕ϮϬϬϵͿ͘ 
ϭ͘Ϯ͘Ϯ͘ϯ͘ϯ-DISPENSING OF NARCOTICS AND PSYCYCHOTROPICS: 
ϭ͘Ϯ͘Ϯ͘ϯ͘ϯ͘ϭ-CLASSIFICATION 
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Controlled drugs are classified into three groups according to the 
international narcotic control board. 
Group -ϭ: Narcotic Drugs: 
Narcotics are classified into five schedules: 
Schedule-ϭ͗ consists of narcotic drugs such as cocaine, methadone and 
morphine,  
Schedule-Ϯ͗ consists of drugs such as codeine and codeine derivatives;  
Schedule-ϯ consists of preparations containing low percentage of 
Narcotic substances; 
Đ^ŚĞĚƵůĞϰ͗ consists of fentanyl derivatives, heroin …etc.; 
Schedule-ϱ͗ consists of plants not permitted for cultivation or import as 
Cannabis Sativa.; and  
Schedule-ϲ͗ parts of plants excluded from the law and which are not 
easy to be planted. 
Group-Ϯ : Psychotropic substances; these are classified into four 
schedules : 
Schedule-ϭ͗ consists of Hallucinogenic compounds; 
Schedule-Ϯ: stimulants;  
Schedule-ϯ: sedative hypnotics;  
Schedule-ϰ: anxiolytic substances. 
Group-ϯ͗sŽůĂƟůĞƐƵďƐƚĂŶĐĞƐ;DK͘͘,͕ϭϵϵϵ-a ). 
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ϭ͘Ϯ͘Ϯ͘ϯ͘ϯ͘Ϯ-DISPENSING 
Private pharmacies should keep these drugs in their original 
packing and in a well secured cabinet. Prescriptions should be written in 
inedible ink and stamped by the licensed doctor. Pharmacists should not 
dispense prescriptions after three days from issuance date. Prescriptions 
for controlled drugs should be retained in the pharmacy after 
dispensing, and dispensing date and the serial number in the controlled 
drugs register should be written. Prescriptions information should be 
entered in the controlled drugs register, which is stamped by ministry of 
health (which will be ready for auditing at any time). A stamped 
photocopy of the prescription can be given to the patient. 
A quarterly stamped statement containing the received, 
dispensed and the balance amounts should be sent to directorate of 
pharmacy- ĚĞƉĂƌƚŵĞŶƚŽĨĚƌƵŐĐŽŶƚƌŽů;DK͘͘,͕ϭϵϵϵ-b). 
Psychotropic drugs prescriptions for private sector are green in 
color, and for public sector are yellow. Narcotic drugs prescriptions for 
ƉƵďůŝĐŚŽƐƉŝƚĂůƐĂƌĞƌĞĚŝŶĐŽůŽƌ;DK͘͘,͕ϮϬϬϴͿ͘ 
ϭ͘Ϯ͘Ϯ͘ϯ͘ϰ-CONTROLLED NON PSYCHOTROPIC DRUGS 
These are controlled due to certain concerns about their misuse or 
safety. The schedule, which is subject to updating, is consisting of: 
· vaccines 
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· xanthines derivatives in pediatric syrup form only. 
· sildenafil 
· amineptine 
· misoprostol 
· dextromethorphan 
· apomorphine hydrochloride 
· tadalafil 
· isotretinoic acid 
· tretinoin 
· biologicals- carisoprodol products 
 
This group, like narcotic and psychotropic drugs, requires proper file 
for prescriptions, book register and quarterly statement of the stock and 
balance to be sent to the ministry of health, department of drug control. 
Amounts dispensed should not exceed doƐĞƐĨŽƌϳĚĂǇƐ͕ƉƌĞƐĐƌŝƉƟŽŶŝƐ
ŶŽƚĚŝƐƉĞŶƐĞĚĂŌĞƌϯĚĂǇƐĨƌŽŵƚŚĞĚĂƚĞŽĨŝƐƐƵĂŶĐĞĂŶĚŝƚƐŚŽƵůĚƐŚŽǁ
ĐůĞĂƌůǇƚŚĞƐƚĂŵƉŽĨƚŚĞĚŽĐƚŽƌĂŶĚƚŚĞĐůŝŶŝĐ;DK͘͘,͕ϮϬϬϱͿ͘ 
ϭ͘Ϯ͘Ϯ͘ϯ͘ϱ-CONCLUSION 
In general the pharmacy practice in community pharmacies is 
completely following the traditional distribution system and there is no 
pharmaceutical care or cognitive services provided. The seventh (five 
ǇĞĂƌŶĂƟŽŶĂůŚĞĂůƚŚĚĞǀĞůŽƉŵĞŶƚƐƚƌĂƚĞŐŝĐƉůĂŶϮϬϬϲ-ϮϬϭϬͿŝƐ
concentrating mainly in distribution activities of the pharmacist in public 
hospitals with some trend towards focusing in providing drug counseling 
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to certain patients with special emphasis on geriatric patients in 
hospitals. 
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CONCLUSON OF PHARMACY PRACTCE IN GULF COUNTRIES 
In general most of the Gulf countries reached a consensus about 
embracing pharmaceutical care as a philosophy of practice. They started 
formulation of plans and strategies for the gradual implementation. All 
these were expressed in their “Pharmaceutical care standards and the 
strategic plans for development in GCC countries” (Executive office of 
DŝŶŝƐƚĞƌƐŽĨŚĞĂůƚŚ͕'ĐŽƵŶƚƌŝĞƐ͕ϮϬϬϳͿ͘dŚŝƐĚŽĐƵŵĞŶƚĚĞƐĐƌŝďĞƐƚŚĞ
future vision for pharmacy practice in hospitals and in community 
pharmacy in Gulf area. 
In community pharmacy the document emphasizes the 
importance of: 
- Patient information recording by pharmacists. 
- Documentation of pharmacist's interventions. 
- Access to patients laboratory results for pharmacotherapy follow-
up. 
- Proper counseling of patients and special care for elderly and 
patients with chronic diseases. 
- Communication with other health care providers. 
- Adverse drug reactions reporting. 
The document suggested the implementation of pharmaceutical care 
in a chosen groups of patients, at least in the starting period e.g. elderly, 
pediatrics, psychiatric and cancer patients, and for the pharmacists to 
have at least: a pharmacotherapy certificate in the specific disease, a 
residency training in certain diseases or Pharm D to be able to practice 
pharmaceutical care. 
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From all GCC countries, Saudi Arabia appears to be the promising 
country for initiation of pharmaceutical care in the region. This is due to 
the availability of resources, suitable number of pharmacy graduates, 
good number of pharmacy colleges with a lot of PhD holders who are 
embracing the wave of pharmaceutical care implementation. In Oman 
and the Emirates the process is still very slow. Saudi Arabia started by 
making pharmaceutical care directorates in each region, but the general 
understanding incorporates all pharmacy activities and is not specific for 
a clear direct patient care practice. 
In GCC countries although their unified document about 
pharmaceutical care standards follows exactly the ideal picture of 
practice in USA and other developing countries, their implementation is 
still dominated by the traditional roles of distribution and lack of 
understanding of what is meant by “ pharmaceutical care’. 
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CHAPTER TWO 
2. METHODOLOGY 
2.1 Study Design:  
The study used two types of tools: Internet and survey questionnaires. 
General survey in the internet was done using Midline (Silver platter), for 
searching the term: community pharmacy, followed by search for the 
Term: pharmaceutical care, in Pubmedcentral, Medscape. Search was 
done also in pharmacy societies and other health authority sites. 
The survey questionnaires done for: community pharmacists, doctors and 
pharmacy customers. The three questionnaires were cross sectional 
surveys to measure responses at one time. 
2.2 Study area: 
Study area is Khartoum state. Khartoum state is divided administratively 
to seven provinces, with an area of 20,140 km2 and population of 
6182401. The number of community pharmacies were 874 at the 
commencement of this study (Directorate of pharmacy, 2007). 
2.3 Study population: 
The study population comprises three categories: 
- Community pharmacists: The registered pharmacist responsible 
for each pharmacy was chosen. 
- Doctors: doctors in the three main governmental hospitals 
(Khartoum, Omdurman and Bahari) were chosen. Doctors were chosen as 
medical officers and consultants. 
- Customers of the community pharmacy: Two customers were 
chosen from each pharmacy in the same pharmacy where the community 
pharmacist received the questionnaire. Inclusion criteria is adults (20 
years and above). 
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2.4 INTERNET SEARCH TOOLS: 
2.4.1 General Literature Search: A General survey was made in 
University of Sultan Qaboos, Faculty of medicine library, using Medline 
(Silver platter). The general term used was: community pharmacy .The 
search was made for the period 1985-2006, and selected on-line papers 
were collected accordingly. For the period of 2006-2010, other tools used 
were Pubmedcentral and Medscape, using community pharmacy and 
“pharmaceutical care" as terms of search. Original journals, through hand 
search were also referred to, especially: The Pharmaceutical journal, The 
Annals of Pharmacotherapy and American Journal of Health System 
Pharmacists. Text books in the field of Community Pharmacy practice, 
Clinical pharmacy and Pharmaceutical care were also referred to. 
Published on-line or hard PHD and Master Dissertations in the field of 
pharmacy practice were also sometimes used.Govermental health 
authorities’ sites and on-line pharmaceutical care centers sites were used. 
Some papers were also obtained by contacting the authors through their 
E- Mails. 
2.5 Questionaires:  
Three questionnaires were developed, which include: 1- Community 
pharmacists survey 2- Pharmacy customers survey 3- doctors survey .The 
research setting is Khartoum state. All questionnaires were piloted and 
content and face validity was ascertained either by literature or by 
academic experts or pharmacists of professional experience. After the 
ethical approval from Faculty of Pharmacy, University of Khartoum 
ethical research committee, questionnaires were distributed. Concerned 
authorities were contacted through official letters to collect the necessary 
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data about the sample frame (community pharmacists and doctors). 
Distribution of the questionnaires started in the period of December 2008-
December 2009. Some of the questionnaires were distributed and 
collected by the researcher in his vacation time , and others were 
distributed and collected by an assigned pharmacist trained by the 
researcher to collect data. Random close supervision and check is done 
for the trained pharmacist to confirm adherence to the research 
procedures .The aim of the questionnaires was explained verbally or 
through a covering letter for each responder. The response of the 
pharmacists and doctors was either obtained at the same time or collected 
at a later time . Customers surveys were obtained at the same time. 
2.5.1 Community pharmacists’ questionnaire: The survey was piloted in 
10 community pharmacies (retail-pharmacies) and minor changes were 
made accordingly. The questionnaire consisted of 9 parts (8 papers); each 
section is preceded by briefing of what is meant by the heading where 
that was relevant: 
-Demographic and pharmacy information: which include: gender, age, 
year of graduation, university, qualifications and information about 
number of employees, location, and ownership. 
-General information: This section is for checking the availability of 
certain items (13-items),categorized according to needs assessment and 
demand, in the pharmacy, and respondents were asked to indicate their 
answer by ' available" or "not available' e.g. Telephone, internet, file for 
controlled prescriptions, consultation room …etc 
- Dispensing, Compounding and Drug information: This section was 
devised as 5-points response Scale and respondents were asked to 
indicate the frequency of performing (16) activities, when dispensing a 
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prescription, in a range of: a-at all the time=5, b- frequently=4, c- not 
sure=3, d- sometimes=2, e- not at all=1. 
-Pharmaceutical care and patient centered practice: A 5-points Lickert 
scale was used to measure the attitudes of the community pharmacists 
towards pharmaceutical care .This part consists of two questions. In Q1 
Respondents were asked to indicate the level of their agreement or 
disagreement with (13-statements) of pharmaceutical care components 
ranging from awareness to knowledge and perceptions. The scale used is: 
a- strongly agree=5 b- agree=4 c- neutral=3 d- disagree=2 e- strongly 
disagree=1. In Q2 respondents were asked to indicate the degree of the 
importance of (21) barriers towards the application of pharmaceutical 
care, using a 5-points scale: a-very important, b-important, c-not sure, d-
less important, e-not important.  
- Chronic Disease Management: A 5-point Lickert scale ,measuring the 
level of agreement, was used to measure attitudes of community 
pharmacists towards chronic disease management through six different 
statements was used. 
- Health promotion: This section consists of three parts: 
 Part one: To measure the degree of involvement of the community 
pharmacists in eleven health promotion activities, using a 5-points 
response scale: a- very involved=5, b- involved=4, c- not certain=3, d- 
uninvolved=2, e- very much uninvolved=1. 
Part two: To measure attitudes and perceptions of pharmacists towards 
"Health promotion", by asking respondents to indicate their degree of 
agreement or disagreement for 10 statements, using a 5-points Lickert 
scale.  
Part three: Respondents were asked about the feasibility of doing about 7 
services in the pharmacy, ranging from blood glucose testing to 
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vaccination, and whether these services can be done in the community 
pharmacy or not (more than one answer can be chosen).  
Responding to symptoms : Q1 to measure the frequency of doing some of 
responding to symptoms activities (4 activities), using a 5-points scale 
,ranging from a- at all the time=5 to, e- not at all=1. Q2, Q3, Q4, Q5 and 
Q6 are direct (yes or no) questions about responding to symptoms. 
-Continuous Education: This consists of two parts: Q1 in which 
respondents were asked about the time they are spending in each month 
for updating their professional knowledge (5-points ranging from "nil" to 
10 hours). In Q2 respondents were asked to choose the most important 
source of information they are using in updating their professional 
knowledge from 8 methods (more than one method can be chosen). e.g. 
of the methods: drug leaflets, mass media, internet …etc. 
- Final pharmacist’s comments: This is an open-ended part in which 
pharmacists were invited to express any suggestions for the developments 
of community pharmacy practice either in Arabic or English. 
2.5.2 CUSTOMERS QUESTIONNAIRE: The survey is meant to 
measure the perceptions of the pharmacy customers about the community 
pharmacist’s role and to investigate the public opinion about suggested 
non-dispensing services, including pharmaceutical care, to be done in the 
pharmacy by the community pharmacist. The questionnaire (4-papers) 
with a covering letter, explaining the aims of the study, was distributed to 
two pharmacy customers in each pharmacy; the first one chosen 
randomly and the second one was the fifth one entering the pharmacy. 
Customers were invited to participate in the survey and those who 
accepted were provided with the questionnaire. The questionnaire was 
either completed by the customer or by the researcher or a trained 
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pharmacist, representing the researcher, in cases where the customer is 
illiterate or not able to fill the information for other reason.  
The questionnaire was piloted in 10 pharmacies in a way that each two 
customers were chosen from each pharmacy. 
The questionnaire was constructed in Arabic for Sudanese customers and 
consisted of 8 parts: 
- Demographic information: This consisted of: Gender, age, occupation. 
-  General information: In this section participants were asked to state 
the frequency of their visiting the pharmacy (how many times per month), 
whether they use the same pharmacy, why they chose that particular 
pharmacy, and the reasons for their visiting the pharmacy.  
- Customer and the role of the pharmacist : This section to investigate 
whether customers consider the community pharmacist as part of the 
health care team and whether they are consulting the pharmacists for 
general health information (most of the questions are direct yes or no 
questions). 
- Pharmacist counseling and advice: This section about the extent of 
counseling and advice given to the customer when a prescription was 
dispensed, and whether sufficient time and advice was given, and whether 
pharmacist refer the customer to other health care practitioner. Most of 
the questions are direct yes or no questions. 
- Pharmaceutical care: This question started with a definition of what is 
meant by pharmaceutical care (in simple words), and the customer was 
then asked to indicate the level of his/her  
Agreement or disagreement, in a 5-points scale, of giving this service in 
the community pharmacy. 
- Other services : In this section participants were asked to choose ,from 
a list of health services ranging from screening ,vaccination to advice in a 
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separate consultation room, the services which can be provided by the 
pharmacist in the community pharmacy(more than one choice can be 
given). 
- Drug problems: In this section customers were requested to choose the 
type of their problems with drug use, from a list of problems, these 
problems summed in: compliance problems, ineffectiveness and high cost 
or other problems to be specified by the responder. 
-Customer's comments: this section is an open-ended question, in which 
participants were asked to state any additional suggestions for other non-
dispensing services which can be provided in the community pharmacy. 
2.5.3 DOCTORS QUESTIONNAIRE: The questionnaire (4-papers) 
was devised to measure views and perceptions of consultants and general 
practitioners on the community pharmacist extended roles, including 
pharmaceutical care. Survey area is the main three governmental 
hospitals in Khartoum state: Khartoum hospital, Omdurman hospital and 
Bahari hospital. The questionnaire was piloted with 10 doctors and minor 
changes were made accordingly. Distribution of the questionnaire was 
done either by the researcher, or assigned pharmacist, representing the 
researcher, in each hospital. The questionnaire consists of the following 
parts: 
Demographic and personal information: This includes; Place of 
practice, Occupation, Date of graduation, University; and age. 
Contact and communication with community pharmacist : This 
investigate the frequency of contact with the community pharmacist 
(every day, once in a week, more than once per week, once in a month, 
once in three months and once above three months), method of contact 
and reasons of contact. 
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Views about extended role of community pharmacist: In this section 
respondents were asked to indicate the level of their agreement or 
disagreement, in a 5-points Lickert scale, for 19 activities to be done by 
the community pharmacist in the pharmacy. These activities range from 
reporting adverse drug reactions to blood screening, health promotion 
activities, medication reviews, referrals to management of chronic 
diseases in a team work. 
Perceptions on pharmaceutical care practice: This part was meant to 
measure perceptions of doctors about "pharmaceutical care”. Brief 
definition of the concept of the pharmaceutical care was 
illusterated.Respondents, were, then, asked to describe their level of 
agreement or disagreement with for 9 statements measuring views and 
willingness of doctors about pharmaceutical care, using a 5-points Lickert 
scale. 
Negative Experiences with community pharmacist : In this section 
respondents were asked to choose the most common negative 
experiences(from 9 chosen experiences) they face, in practice, with the 
community pharmacist (more than one answer can be chosen). 
Respondents were also asked to specify other experiences (if any), which 
were not mentioned in the list. Examples of the negative experierences: 
wrong information, wrong doses, giving drugs not mentioned in the 
prescription…etc. 
Final comments: In this section doctors were invited, in an open-ended 
question, to state any additional comments about the new role of the 
community pharmacist (Either in Arabic or English). 
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2.6 SAMPLING PROCEDURE: 
2.6.1 Internet search tools: Sites chosen from internet after the general 
search through Midline were the proper journal sites, governmental sites 
and pharmaceutical society’s sites. 
2.6.2 The Surveys: 
2.6.2.1 Pharmacists survey: A sample-frame was obtained from 
Directorate of pharmacy, MOH, Khartoum. Total number of community 
pharmacies (dated 19 July 2007) at the commencement of the  study was : 
874 .The calculation of the sample size use tables of sample size as in the 
WHO reference by ( Lwanga and Lemeshow,1991). Table 1, a was used. 
The Sample size was chosen from the table which should give the 
following: 95% confidence interval, 8% percision, 0.5% anticipated 
proportions or prevalence. The sample size (150), from the table, was 
then adjusted according to Cochran's (1977) correction formula, since the 
population was small and sample size (150) exceeded 5% of the 
population. The adjustment was done according to the following formula:  
 
n1=          n0 
      1 +       n0 
             Population 
 
 
n1=   150 
      1 + 150 
             874  
Where n1 = the final adjusted sample size, population size =874. no= 
sample size from table 1, a (150). Thus, the final sample size used was 
128 community pharmacies. The sample was chosen randomly, using 
random numbers tables ( Lwanga et al, 1999). A Stratified random 
= 128 
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sample was selected using pharmacies in the 7 localities in Khartoum 
state. The number of pharmacies chosen, in the seven localities, was as 
follows:  
Khartoum:  
40; Eastern Nile12; Bahari 18; Omdurman 21; Um bada 13; Karari 12; 
Jabal Awlia 12.  
Questionnaires were distributed to all the pharmacies to the qualified 
pharmacist in-charge at the time of the distribution. 
2.6.2.2 Customers survey : The sample size for the community pharmacy 
customers was calculated from the aforementioned community 
pharmacies number(128).From each pharmacy two customers were 
recruited, the first one chosen randomly and the second one was the fifth 
customer entering the pharmacy (this rule was not strictly adhered to due 
to some customers being in a hurry and did not give their consent to 
participate in the survey). Inclusion criteria was: male and female adults 
of 21 –years and above. The sample size was calculated to be: 128x2 = 
256. The questionnaire was piloted in 10 pharmacy customers and minor 
amendment was done. 
2.6.2. 3 Doctors survey: The sample frame for the consultants and the 
general practitioners for the three governmental hospitals: Khartoum 
hospital; Omdurman hospital; Bahari hospital, was obtained from each 
hospital (official letters were directed to each hospital administration). 
Sample size was obtained by calculation from a total population of: 661 
(2008 lists), table 1,a was used and adjusted as per Cochran’ adjustment, 
previously mentioned, to have a final sample size of: 122 .The sample 
size obtained will give 95% confidence interval and 8% precision with 
0.5% prevalence. Stratified random sampling procedure was used. 
Selection of participants was done using tables of random numbers. The 
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questionnaire was piloted with 10 doctors and minor amendment was 
done accordingly. Distribution of the sample was as follows: 
Hospital Consultants   General practitioners  
Khartoum hospital 23 44 
Omdurman hospital   13 14 
Bahari hospital 8 20 
2.7 DATA ANALYSIS   : 
The first step in data processing, of the three questionnaires (pharmacist, 
doctors and customers), is the collation of all the returned questionnaires 
data for coding. Coding frame for each response was made and data were 
entered after coding in Microsoft Excel Software and checked for 
accuracy. Data were then loaded in SPSS (version 11.5). The following 
statistical procedures were used for data analysis: 
1- Descriptive statistical analysis: 
Frequencies, percentage distribution, means and standard deviations were 
used for direct and (yes/no) questions. 
2- T-test and One-Way ANOVA:  
These tests were used to measure possible association between socio-
demographic characteristics and Lickert scale attitude responses( e.g. 
attitudes to pharmaceutical care).T-test was used to compare responses of 
two independent groups (e.g. males& females). One-Way ANOVA was 
used to assess the difference of responses of more than one group (e.g. 
different age grades). 
3- Reliability and internal consistency: Reliability and internal  
consistency of attitude scales     were measured, using Cronbach Alfa. 
4- Statistical significance:  P- values were calculated and results of less 
than 0.05 were interpreted as significant.  
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CHAPTER THREE 
 RESULTS AND DISCUSSION 
ϯ͘ϭCOMMUNITY PHARMACY PRACTICE IN SUDAN 
3.1.1 Introduction: 
The history of the profession of pharmacy in Sudan is not 
aĐĐƵƌĂƚĞůǇƌĞĐŽƌĚĞĚ͘DƵŬŚĂŝƌ/͘';ϭϵϴϮͿƚƌĂĐĞƐŝƚďĂĐŬƚŽƚŚĞďĞŐŝŶŶŝŶŐ
of the migration of Arab tribes to Sudan. The Arabs brought with them 
Arab medicines which put together the art of disease and the art of 
healing, which complement the already available heritage of the 
traditional medicines used among the Sudanese African inhabitants. 
The recent history of pharmacy is linked with the entrance of the 
Turks to Sudan. The domination of the Turks speed their ambition to add 
the Sudan to their domain, and when Sudan fall into the hands of the 
Turks, physicians were brought in with the invading army. After the 
reconquest of the Anglo Egyptian forces under the command of 
Kitchener these forces also has amongst them physicians and 
pharmacists. The pharmacists were mostly Lebanese and of whom one 
was Mr. G. N Morhig; later resigned from army service and opened a 
private pharmacy in Khartoum. In general the initiation of pharmacy 
profession in Sudan follows the same trend as most African and 
neighboring Middle East countries. 
Most work in private sector was initiated by Greeks, Syrians and 
Egyptians. The first Sudanese pharmacists were graduated from 
Egyptian, French or Lebanese universities (American university in Beirut). 
The school of pharmacy was established in university of Khartoum in July 
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ϭϵϲϰ͕ĂŶĚƚŚŝƐƐƚĂƌƚĞĚĂŶĞǁĞƌĂŽĨƚŚĞƉƌŽĨĞƐƐŝŽŶŝŶ^ƵĚĂŶ;,ĂŵĞĚ͕>-
Őŝď͕ϮϬϬϯͿ͘^ƵĚĂŶŶŽǁŚĂƐŵĂŶǇƉŚĂƌŵĂĐǇĐŽůĞŐĞƐ;ϭϮĐŽůĞŐĞƐ
ƌĂŶŐŝŶŐĨƌŽŵƉƵďůŝĐƚŽƉƌŝǀĂƚĞͿǁŚŝĐŚƉƌŽǀŝĚĞĂďŽƵƚϭϱϬϬŐƌĂĚĂƚĞƐ
ĂŶŶƵĂůǇ;DŽŚĂŵĞĚ^͘^͕ϮϬϬϵ). 
dŚĞƌĞŐŝƐƚĞƌĞĚƉŚĂƌŵĂĐŝƐƚƐŝŶ^ƵĚĂŶŶŽǁĂƌĞĂƉƉƌŽĂĐŚŝŶŐϱϬϬϬ;DĞĚŝĐĂů
ĐŽƵŶĐŝů͕ϮϬϬϳͿ͘ 
Practice in Sudan 
In general the practice of pharmacy is either in public or private 
settings. Community pharmacy (retail pharmacy) attracts most of the 
graduates and ŵŽƌĞƚŚĂŶϲϬйŽĨƚŚĞƉŚĂƌŵĂĐŝƐƚƐĂƌĞǁŽƌŬŝŶŐŝŶƌĞƚĂŝů
ƉŚĂƌŵĂĐŝĞƐ;DK,͕ϮϬϬϱͿ͘/Ŷ^ƵĚĂŶƚŚĞƌĞĂƌĞƚǁŽƚǇƉĞƐŽĨƌĞƚĂŝů
pharmacy: 
- Commercial Private pharmacies : The source of drugs and 
pharmaceuticals in this type of pharmacies is private wholesalers. 
- People's Pharmacies: these are quasi-public establishments 
retailing drugs and medical supplies at below market prices to 
improve access and availability of pharmaceuticals. They were 
ĨŽƵŶĚĞĚŝŶƚŚĞĞĂƌůǇϭϵϴϬĂƐĂƉŝůŽƚƐƚƵĚǇĨŽƌĂĚƌƵŐĐŽƐƚƌĞĐŽǀĞƌǇ
system. They differ from private commercial pharmacies; in 
having access to the Central Medical Supplies Public Organization 
(CMSPO) drugs i.e. generic and large pack products, in addition to 
brand products from the private wholesalers, and in being owned 
by public organizations (e.g. hospitals), people's committees, 
trade unions and non-ŐŽǀĞƌŶŵĞŶƚĂůŽƌŝŐŝŶĂƟŽŶƐ;E'KͿ͘ϭϯŽƵƚŽĨ
ϴϯƉĞŽƉůĞΖƐƉŚĂƌŵĂĐŝĞƐŝŶ<ŚĂƌƚŽƵŵƐƚĂƚĞĂƌĞŽǁŶĞĚďǇƚŚĞƐƚĂƚĞ
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MOH and managed by the revolving drug funds (RDF) (Mohamed 
'͘<Ś͕͘ϮϬϬϬͿ͘ 
Khartoum State 
Khartoum state is divided administratively to seven provinces, 
ǁŝƚŚĂŶĂƌĞĂŽĨϮϬ͕ϭϰϬŬŵϮĂŶĚƉŽƉƵůĂƟŽŶŽĨϲϭϴϮϰϬϭ͘dŚĞŶƵŵďĞƌŽĨ
ƉŚĂƌŵĂĐŝƐƚƐŝŶƉƵďůŝĐƐĞĐƚŽƌŝƐϭϬϵ;DK,͕ ϮϬϬϳͿ͕ĐŽŵƉĂƌĞĚƚŽϴϳϰŽƌ
more in private pharmacies (Directorate of ƉŚĂƌŵĂĐǇ͕ϮϬϬϳͿ͘ 
Pharmacy Regulations 
Pharmacy and pharmacists licensing is under the responsibility of 
the Federal Pharmacy and Poisons Board. The practice is governed by 
ƉŚĂƌŵĂĐǇĂŶĚƉŽŝƐŽŶůĂǁϮϬϬϭ;^ƵĚĂŶDĞĚŝĐĂůŽƵŶĐŝů͕ϮϬϬϭ). Final 
registering of the pharmacist takes place in the Sudan Medical Council. 
Pharmacies ownership is not limited to pharmacists but each pharmacy 
should be registered under a pharmacist name. Pharmacy license is 
renewed annually. Wholesale selling in private pharmacies should be 
only under approval of MOH for specified medicines and quantities for 
specified persons. Prescriptions are authorized only for doctors, 
veterinary doctors and medical or veterinary units.  
EĂƌĐŽƟĐĂŶĚƉƐǇĐŚŽƚƌŽƉŝĐůĂǁ;ϭϵϵϰͿŐŽǀĞƌŶƐĚŝƐƉĞŶƐŝŶŐŽĨƚŚĞƐĞ
ƚǇƉĞƐŽĨŵĞĚŝĐŝŶĞƐ͘dŚĞƉŽŝƐŽŶƐƚĂďůĞŝƐĐŽŵƉƌŝƐĞĚŽĨϯƉĂƌƚƐ͗ƉĂƌƚŽŶĞ͗
dangerous narcotics which can lead to addiction; part two: poisons 
which are not considered as dangerous and should be dispensed by 
registered pharmacist; part three: poisons used for purposes other than 
human or animal treatment. 
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 Pharmacy Strategies : 
Ƶ^ĚĂŶŚĂƐĂEĂƟŽŶĂůƌƵŐWŽůŝĐǇ;EWͿ;DK,͕ϭϵϵϳͿ͕ĂŶĚĂ
EĂƟŽŶĂůŚĞĂůƚŚƐƚƌĂƚĞŐǇ͕ĨŽƌϮϱǇĞĂƌƐ͘ 
dŚĞƐƚƌĂƚĞŐǇŽĨƉŚĂƌŵĂĐǇĨŽƌƚŚĞϮϱǇĞĂƌƐŝŶĐůƵĚĞĞŵƉŚĂƐŝƐŽŶƚŚĞ
new patient-centered role for the pharmacists or pharmaceutical care 
(and on changes in education, training of expertise to carry on the new 
roles ...etc). 
For community pharmacy the emphasis of the strategy is on: 
utilization of pharmacists in proper counseling for patients; role in 
improving medication compliance and adherence; continuous education 
and professional development; and contribution of community 
pharmacists in primary health care programs (e.g. heath education and 
disease prevention). In general a patient-centered type of practice is 
expected for community pharmacists. The strategy calls for a national 
strategy of pharmaceutical care in community pharmacy to be devised 
ďǇƉŚĂƌŵĂĐǇŽƌŐĂŶŝǌĂƟŽŶ;DK,͕ϮϬϬϱͿ͘ 
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RESULTS 
Table 3.1: Distribution of participating community pharmacists  
 
Area Number Percentage(%) 
Khartoum 25 39.0 
Omdurman 27 42.2 
Bahari 12 18.8 
Total 64 100 
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Table 3.2: Demographic characteristics of community pharmacists& 
pharmacies (n=64)* 
                   Community pharmacists Number 
responding 
Percentage 
Sex    
Female  40 62.5 
Male  24 37.5 
Age (years)   
21-30 47 73.4 
31-40 09 14.1 
41-50 04 6.3 
51-60 03 4.7 
61 and above 01 1.6 
Education    
B Pharm  60 93.8 
Diploma  01 1.6 
M Pharm. 03 4.7 
PHD 0 0 
                            Community pharmacies   
Pharmacy Location    
Residential  14 22.6 
Near private clinic  16 25.8 
Near hospital/ health center 11 17.7 
Market area  21 33.9 
Ownership   
Pharmacist 41 73.2 
Non-pharmacist 15 26.8 
Number of pharmacists working   
None 0 0 
One 18 29.50 
Two 25 41.0 
Three 13 21.3 
Four 2 3.3 
More than Four 3 4.9 
Number of counter Assistants working    
None 29 45.3 
One 25 39.1 
Two 8 12.5 
Three 1 1.6 
Four 0 0 
More than four 1 1.6 
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*number of respondents may not always add to 64 due to non-response to some items 
in the questionnaire. 
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Table 3.3: Availability of certain items in community pharmacy 
  
Item Number 
responding(available 
answer) 
Percentage 
Telephone  49 76.6 
Computer  15 23.4 
 Internet 04 6.3 
Refrigerator  60 93.8 
Consultation room  03 4.7 
Special laboratory  area  45 70.3 
Secured cabinet   13 20.3 
Register for controlled  prescriptions  04 6.3 
Register for patient medication record  02 3.1 
Ministry of health registered products 
list  
16 25 
File for ministry  of health circulars. 06 9.4 
File for controlled prescriptions  06 9.4 
System for reporting adverse drug 
reactions 
04 6.6 
. 
Table 3.4: Response of community pharmacists to “Is there a written 
procedure for dispensing to be followed by the 
staff”?(n=58) 
Response Number responding percentage 
Yes 9 15.5 
No 49 84.5 
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Table 3.5: Activities done by community pharmacists when 
dispensing prescriptions (n=64). 
Items  Mean 
score*  
S. D % positive  
Response** 
 Checking name,sex,age,medicines,dose and 
duration in each prescription. 
4.20 1.14 78.2 
 Explaining instructions for use verbally. 4.48 1.03 86.0 
 Explaining instructions verbally + hand writing. 4.47 1.02 87.5 
 Explaining instructions verbally+ printed 
information 
1.82 1.3 6 15.2 
 Providing oral counseling on the dispensed 
medicines 
3.63 1.30 57.8 
 Asking the patient about any drug allergies or 
Hypersensitivities before handing medicines. 
2.97 1.40 45.3 
 Dispensing prescription medicines without 
prescription 
2.50 1.24 28.2 
 Tracing any prescribing errors, drug or food 
interaction in the Prescription. 
3.53 1.24 60.9 
 Asking each patient about previous drugs he is 
using 
2.66 1.34 32.8 
10. Asking each patient about current medical 
condition 
2.63 1.26 29.7 
11. Counter assistant is dispensing prescriptions and 
instructing patients on use of medicines 
2.63 1.47 31.3 
12. Explaining side effect of medicines to the patients 2.66 1.35 34.4 
13. Doing medication review/checking proper use of 
medicines for patients who bring their home 
medicines to the pharmacy. 
3.83 1.28 65.6 
14. Correcting any prescription errors by contacting 
the prescriber 
2.87 1.46 39.1 
Correcting errors in  prescription without referring to 
the prescriber . 
2.87 1.46 39.1 
Giving proper generic alternatives without referring to 
the doctor 
3.14 1.47                 50.0 
*Mean score is the mean score of Likert scale for each item: At all the 
time =5; frequently =4; not sure =3; Sometimes =2; Not at all =1(above 3 
considered as positive response. S.D=standard deviation. 
              **percentage positive response is the summation of (frequently/at all the 
time). 
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Table 3.6: Community pharmacist attitudes towards pharmaceutical 
care (n=64).  
Statements Mean score * 
( ± SD) 
% positive  
Response ** 
You are already aware and know about 
the concept of pharmaceutical care.    
3.98 (0.90) 72.9 
You support introduction of 
pharmaceutical care practice, as a patient 
care practice, in community pharmacy . 
4.39(0.73) 89.0 
Traditional role (product oriented) is 
better than patient oriented practice© 
3.34 (1.26) 48.5 
The pharmacist can establish and 
strengthen relationship with patients 
3.74(0.66) 92.2 
Many patients visiting the pharmacy 
have medication related problems  
3.74(0.91) 59.4 
You prefer solving medication problems 
in  any prescription regardless of type of 
disease 
3.14 (1.28) 48.4 
You prefer solving medication problems 
in specific high risk patients e.g. chronic 
disease 
3.28(1.34) 51.6 
Pharmaceutical care is not important in 
our developing countries © 
4.46 (1.06) 87.6 
The present knowledge and skills of the 
pharmacist are inadequate for patient 
centered practice© 
2.56 (1.13) 18.8 
You are willing to be trained  in 
pharmaceutical care concepts 
4.48(0.80) 85.9 
You have no enough time to practice 
pharmaceutical care©  
3.38 (1.27) 50 
You lack knowledge about therapeutic 
outcome    ©  
3.20(1.15) 42.2 
It is difficult to have constant meetings 
with patients for follow up and 
counseling © 
2.48(1.20) 26.6 
*Mean score is the mean score of Likert scale for each item: strongly 
agree =5; agree =4; neutral =3; disagree =2; strongly disagree =1( scores 
above 3 considered as positive response). SD=standard deviation. 
              **percentage positive response is the summation of (agree/strongly agree)  
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© negative items reversed for summation of results. 
 
 
Table 3.7: Statistically significant association between demographic 
variables and attitudes to pharmaceutical care.  
FACTORS T F P.values 
<0.05 
Gender VS It is difficult to have constant 
meetings with patients for follow up and 
counseling* 
2.99 - 0.004 
Age VS Pharmaceutical care is not 
important in our developing countries** 
- 3.59 0.011 
 
*  Statistical method used (T-test):more females report that it is 
possible to have constant meetings with patients. 
**  Statistical method used(One-way Anova):age ranges of 21-60 show 
positive response to this item(only one in 61-and above range show 
acceptance for this item) 
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Table 3.8: Barrier for implementation of pharmaceutical care in 
community pharmacy (n=64). 
Statements  Mean score  
( ± SD)* 
% 
positive  
Response
(importa
nt/very 
importan
t) 
 Lack of payment 3.85(1.19) 46 
 Lack of time 3.98(1.02) 78.1 
 Lack of space in the pharmacy 3.76(1.13) 67.2 
 lack of software for medication assessment 3.90(1.23) 77.2 
 lack of financial capital to implement changes 3.89(1.00) 62.5 
 No clinical patient data available 4.19(0.93) 81.3 
 Lack of understanding of pharmacist new role 4.26(0.79) 85.9 
 Lack of trained assistant staff. 3.92(1.26) 71.9 
 Lack of access to drug information 4.03(0.96) 75.1 
. Lack of protocols or consensus -reports for 
treatment 
4.08(0.96) 71.9 
. Pharmacists not aware of the new patient focused 
practice 
3.84(1.10) 62.5 
. Physicians and other health care professionals are 
not aware of the pharmacists' patient focused 
practice 
4.25(0.84) 82.8 
. Attitudes and opinions of pharmacy owners   3.83(1.167) 65.7 
. Lack of clinical education 4.27(0.73) 87.5 
. Lack of therapeutic knowledge 4.13(0.94) 81.3 
. Lack of communication skills  4.07(0.100) 75.0 
. Lack of concept of team work with other health 
professionals 
4.21(6.94) 82.8 
Lack of documentation skills 3.92(1.11) 74.0 
Fear of patient’s rejection  3.27(1.177) 45.4 
Legislation barriers 3.20(1.03) 28.1 
Structure of the health system 3.92(1.09)      73.5 
*Mean score is the mean score of Likert scale for each item: very 
important=5; important =4; not sure =3; less important=2; not important 
=1(scores above 3 considered as positive response). SD=standard 
deviation. 
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Table 3.9: Statistically significant association between demographic  
variables and barriers to pharmaceutical care*. 
FACTORS  T F P.values 
<0.05 
Gender VS  Lack of therapeutic 
knowledge** 
2.27 - 0.027 
 
*statistical method used(T-test) 
**more scores given to this item by females .   
Table 3.10 : Community pharmacist’s attitudes towards chronic 
disease management (n=64)  
Statements  Mean score 
   ( ± SD) 
  % positive  
Response 
(agree/strongly 
agree) 
You don’t have the proper knowledge 
about chronic diseases© 
3.37 (1.36) 51.6 
Community pharmacist should play 
important role in chronic disease 
prevention and management 
4.54(0.74) 95.3 
You accept team work with doctors and 
other health care professionals in long 
term conditions management 
4.46(0.74) 87.5 
You  think patients will not accept any 
community pharmacist role in chronic 
disease management© 
3.40(1.21) 54.7 
Many patients visiting the pharmacy 
require chronic  disease management  
3.61(1.01) 61.0 
Chronic disease prevention and 
management is not the concern of the 
community pharmacist© 
4.02(1.15) 70.3 
© negative items reversed for summation of results. 
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Table 3.11: Community Pharmacists involvement in health 
promotion activities (n=64) 
Statements Mean score 
* 
 ( ± SD) 
% positive  
Response 
(involved/very 
involved) 
Smoking cessation (stopping) 4.15(1.01) 76.1 
Healthy diet e.g. diabetic and 
hypertensive patients 
4.38 (0.76) 89.1 
Exercise especially for certain patients 3.93(0.83) 76.6 
Maintenance  normal blood cholesterol  3.57(1.05) 57.8 
Obesity and weight reduction 4.15(0.78) 78.1 
Dental or oral health information 3.64(0.94) 57.8 
Skin cancer 2.92(1.25) 31.3 
Contraception methods and medicines  3.98(0.95) 73.4 
AIDS awareness and prevention 3.57(1.07) 57.6 
Unused or waste medicines  3.87(1.03) 64.1 
Medical health devices: for measuring 
blood pressure, Blood glucose etc. 
3.87(1.19) 67.2 
 
*Mean score is the mean score of Likert scale for each item: very 
involved=5; involved =4; not certain =3; uninvolved=2; very uninvolved 
=1(scores above 3 considered as positive response). SD=standard 
deviation. 
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Table 3.12: Pharmacists attitudes towards health promotion (n=64). 
Statements  Mean score      
( ± SD)  
% Positive 
response 
(agree/very 
strongly 
agree)  
 You don’t have the sufficient base of 
knowledge  for  advising patients on health 
promotion and disease  prevention© 
3.56(1.30) 60.7 
 Pharmacists should be part of the health 
promotion activities 
4.56(0.76) 90.6 
 You are not interested in health promotion 
services© 
4.16(1.01) 73.5 
 You don’t have the time to educate patients 
on health issues© 
3.42(1.10) 46.9 
 You think other health professionals will not 
accept pharmacist  role in health promotion© 
2.95(1.35) 37.4 
 Public will accept contribution of the 
pharmacist in health  promotion services  
4.08(0.94) 78.7 
 It is not important for community  pharmacist 
to practice health promotion© 
4.23(0.94) 79.7 
 You are willing to be trained in health 
promotion concepts 
4.33(0.89) 82.8 
 If there is no payment for health promotion 
activities I will not include it in my practice© 
3.69(1.15) 59.4 
10. You are willing to participate in any health 
campaigns (activities)  for disease prevention 
4.30(0.84) 81.3 
 
© negative items reversed for summation of results.  
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Figure 3.1. Activities that can be done in the community 
pharmacy  
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Table 3.13: Involvement of community pharmacists in responding to 
symptoms activities  
Statements  Number of 
respondents  
% At all the 
time/frequently 
Dispensing medicines without 
prescription for minor diseases e.g. 
cough-diarrhea 
58 90.6 
Asking the patient about his/her 
symptoms before giving medicines 
60 93.8 
Referring patients to the doctor for 
further checkup if I suspect other 
problems 
60 93.8 
Recording some cases of clinical 
importance in special patient record 
10 15.6 
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Table 3.14: Pharmacists attitudes towards responding to symptoms. 
 
Statements  Number/ 
Percentage 
(Yes ) 
Number/ 
Percentage 
(No) 
. Is there a recorded counseling procedure for 
minor diseases followed by all the staff: 
10(15.6) 53(82.8) 
. You are aware about the level at which 
symptoms will indicate serious  disease: 
57(89.1) 05(7.8) 
. There is specific list of minor conditions and 
drugs to be used for them in the pharmacy : 
18 (125) 48(75.0) 
. There is a written form for referring patients 
to the doctor when required: 
09(14.1) 55(85.9) 
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Fig 3.2: Responses to the question: How you can describe your     
knowledge about minor diseases? (n=64). 
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Figure 3.3: How much time you spend each month updating your 
professional knowledge? (n=63) 
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Figure 3.4:Methods used for updating community pharmacists 
knowledge. 
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Table-3.15 :Distribution of Doctors in Khartoum State Main 
Hospitals. 
Occupation Khartoum 
hospital 
Omdurman 
hospital 
Bahari hospital 
Medical officers 27 7 13 
Consultants 20 5 8 
Total 47 12 21 
Percentage 58.75% 15% 26.25% 
 
 
Table 3.16: Demographic characteristics of Doctors , n=80* 
OCUPPATION : NUMBER PERCENTAGE 
   
1.Medical officer 47 58.7 
2. consultant 33 41.3 
AGE(years) :   
21-30 27 34.2 
31-40 36 45.0 
41-50 9 11.4 
51-60 5 6.3 
61 and above 2 2.5 
TOTAL 79  
PLACE OF WORK:   
Private clinic 3 3.7 
Private hospital 2 2.5 
Governmental hospital 75 93.8 
 
*numbers may not all add to 80 due to non-response to some items. 
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Figure 3.5: How often consultants and medical officers contact 
community pharmacists (total numbers 77: 47 med. 
Officers, 30 consultants) 
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Figure 3.6: Method of contact of doctors with community    
pharmacists  
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Table 3.17: Statistically significant association between occupation 
(consultants vs. medical officers) and method of contact 
with community pharmacists, n=80. (T-test used) 
Statements Medical 
officers 
(number) 
Consultants 
(number) 
T Significance 
(p<0.05) 
Occupation VS method of 
contact with community 
pharmacist” Direct visit”.* 
43 3 2.360 0.025 
 Occupation VS method of 
contact with community 
pharmacist” Telephone”.* 
39 19 -
2.385 
0.020 
*Medical officers contact community pharmacists more by direct visit  
and consultants use telephone more. 
Table 3.18: Statistically significant association between Age and 
method of contact with community pharmacists (one way 
ANOVA used). 
Factors F Significance 
(p<0.05) 
AGE VS method of contact with community 
pharmacist”Telephone”.* 
4.19 0.002 
*younger generation (21-30,31-40yrs)were not using telephone 
frequently compared to older one(41-and above). 
 
Table 3.19: Reasons for contact between doctors and community 
pharmacists (more than one answer is required). 
Reason of contact Number 
responding 
Percentage 
Checking availability of medicines 42 52.5 
Scientific information about medicine 45 56.3 
Checking error in dispensing 13 16.3 
Checking  price of medicine 17 21.3 
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Table  3.20: Views of doctors about extended role of community 
pharmacists(n=80). 
Statements Mean Score 
(± SD)* 
Percentage 
positive 
response** 
Reporting adverse drug reactions 4.35(1.04) 85.1 
Increased role in managing minor illness 
e.g. cough, diarrheoa, cold 
2.60(1.43) 30.1 
Informing public about healthy diet 3.95(1.17) 67.6 
Advice patients about healthy lifestyle e.g. 
exercise 
3.92(1.19) 73.8 
Advice on drug abuse/misuse. 4.45(1.03) 82.5 
Advice on  chronic disease prevention 3.52(1.25) 51.3 
Screening for blood glucose, glycosuria 2.87(1.33) 23.8 
Screening for  blood pressure 2.95(1.35) 41.3 
Screening for blood lipids 2.72(1.33) 32.5 
Urine testing for pregnancy. 2.75(1.33) 36.3 
Vaccination for children 3.08(1.42) 45.1 
Prescribing under protocol 3.40(1.33) 51.3 
Advice and education for long term 
conditions 
3.88(1.04) 70.0 
Health promotion e.g smoking cessation 
Obesity and weight reduction 
4.22(0.84) 85 
Participate in a team work with doctors and 
other    health care professionals in 
management of chronic diseases. 
4.39(0.91) 87.5 
Ensure compliance and adherence to drug 
regimen in long term conditions.  
4.25(0.97) 85.1 
Undergo medication review for all 
medicines used by patients with chronic 
diseases through scheduled meetings  
3.99(1.06) 68.8 
Review and advice on repeat prescriptions 3.96(1.14) 68.8 
Refer patients to the doctor for further 
checkup when suspecting problems  
4.41(1.12) 77.5 
*Mean score is the mean score of Likert scale for each item: strongly 
agree =5; agree =4; neutral =3; disagree =2; strongly disagree =1(above 3 
considered as positive response. SD=standard deviation. 
**percentage positive response is the summation of (agree/strongly 
agree). 
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Table 3.21: Statistically significant association between Doctors’ 
occupation (consultants vs. medical officers) and 
extended roles of community pharmacists, n=80. (T-test 
used) 
Statements Medical 
officers 
(number) 
Consultants 
(number) 
T Significance 
(p<0.05) 
Occupation VS pharmacists 
extended role “advice on 
drug abuse/misuse”* 
36 30 2.081 0.041 
*Consultants show more acceptance than medical officers. 
 
Table 3.22: Statistically significant association between Doctors’ Age 
(young vs. old) and extended roles of community 
pharmacists (one way ANOVA used). 
Factors F Significance 
(p<0.05) 
AGE VS views about extended role of 
pharmacists: Advice and education for long term 
conditions** 
2.82 0.022 
AGE VS views about extended role of 
pharmacists: Health promotion e.g. smoking 
cessation Obesity and weight reduction** 
5.41 0.006 
AGE VS views about extended role of 
pharmacists: Participate in a team work with 
doctors and other    health care professionals in 
management of chronic diseases** 
4.62 0.001 
AGE VS views about extended role of 
pharmacists: Ensure compliance and adherence to 
drug regimen   in long term conditions**  
3.41 0.008 
AGE VS views about extended role of 
pharmacists: Undergo medication review for all 
medicines used   by patients with chronic diseases 
through scheduled meetings**  
2.58 0.033 
**In all these extended roles age ranges of 31-40 yrs show more 
acceptance than younger generation of(21-30). 
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Table 3.23 Attitudes of doctors towards pharmaceutical care (n=80). 
Statements Mean score     
(± SD) 
Percentage 
positive 
response 
(strongly 
agree/agree) 
Activities for preventing and resolving drug-
related problems will improve quality of patient 
care 
4.65(0.62) 93.8 
Many patients have problems related to drug use 4.17(0.80) 83.8 
Pharmaceutical care practice will augment and   
support doctors role in patient care  
4.22(0.95) 81.3 
Pharmacists by practicing pharmaceutical care, 
will interfere with our medical role© 
3.62(1.32) 63.8 
The commercial side of the community pharmacy 
practice will not make it suitable for 
pharmaceutical care practice© 
3.05(1.18) 33.8 
Pharmacist role shall be only to dispense 
prescriptions© 
3,91(1.14) 70.0 
Pharmaceutical  care will not add benefit to my  
practice© 
4.09(1.19) 77.5 
I will be willing to participate in any team work  
including pharmaceutical care practice  
4.13(1.10) 78.8 
I will be interested to know more about this 
concept of pharmaceutical care 
4.33(1.00) 87.5 
© negative items reversed for summation of results. 
Table 3.24: Statistically significant association between Doctors’ 
occupation (consultants vs medical officers) and attitudes 
to pharmaceutical care , n=80. (T-test used) 
Statements Medical 
officers 
(number) 
Consultants 
(number) 
T Significance 
(p<0.05) 
Occupation VS attitudes towards 
pharmaceutical care “Many 
patients have problems related to 
drug use”.* 
43 14 2.170 0.033 
Occupation VS attitudes towards 
pharmaceutical care 
“Pharmaceutical care will not add 
benefit to my practice”.** 
32 30 -2.666 0.009 
*Medical officers showed more positive attitudes towards this item  than 
consultants. 
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** Consultants showed more positive attitude towards this item than 
Medical officers.  
Table 3.25: Statistically significant association between Doctors’ Age 
(young vs old) and attitudes towards pharmaceutical 
care, n=80. (One-way Anova used) 
Factors F Significance 
(p<0.05) 
I will be willing to participate in any team 
work  including pharmaceutical care practice * 
4.98 0.001 
I will be interested to know more about this 
concept of pharmaceutical care* 
8.83 0.013 
*for both items age ranges of 31-40 years show more acceptance than 
younger generation of(21-30). 
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Table 3.26 : Frequency of negative experiences of doctors with 
community pharmacists (more than one answer is 
required), n=80. 
Negative Experience Frequency(yes 
answer) 
Percentage% 
 Pharmacist is scaring/frightening patients 
by giving too much information about 
drugs 
20 25.0 
Pharmacists give wrong drug or dosage. 28 35 
 Pharmacist changed the instruction or 
directions I gave to patient.   
35 43.8 
Pharmacist gives drug not indicated in the 
prescription. 
25 31.3 
Pharmacist not acting professionally, 25 31.3 
 Pharmacist gives wrong alternatives for 
drugs I prescribe 
36 45.0 
Pharmacist dispensing drugs for serious 
medical condition without prescription 
28 35 
Pharmacist is making skin preparations as 
cosmetics which cause serious effects to 
the patient.   
25 31.3 
 Pharmacist give wrong information to 
patient about his disease 
20 25.0 
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Table 3.27: Demographic characteristics of community pharmacy 
customers.* 
Demographic 
characteristics 
Number responding Percentage 
Gender:   
Female 53 41.4 
Male 75(total=128) 58.6 
Age :   
21-30 58 45.7 
31-40 31 24.4 
41-50 25 19.7 
51-60 8 6.3 
Above 60 5(total=127,1 missing) 3.9 
Job:   
No work 19 15.2 
Student 20 16 
Business/Merchant 24 19.2 
Officer 62(total=125,3missing) 49.6 
Place of work’:   
Private 70 81.4 
Government 16(total=86*,3  
missing) 
18.6 
*Thirty nine of respondents either students or unemployed(no work). 
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Figure 3.7: The frequency of use of community pharmacy by the 
customers (Gender comparison) 
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Figure 3.8: Response to question: Do you use the same pharmacy 
always? 
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Table 3.28  : Response of customers to various factors affecting 
choice of the community pharmacy (n=128). 
Statements Number 
responding 
% positive 
response 
(important/very 
important)* 
Staff know me  76 59.3 
Able to speak to the pharmacist 87 68 
Convenient location 87 68 
The layout and design inside the pharmacy 
is comfortable 
80 62.5 
 Pharmacist is happy to talk to me 91 71.1 
 Good prices 89 69.6 
 Availability of medicines 109 85.2 
 Pharmacist  provide good advice on request 111 86.8 
*Positive response is the summation of important/very important . 
 
 
Table 3.29: Customers’ reasons for visiting community pharmacy 
(n=127, more than one answer is chosen). 
Statements Number 
responding(yes 
answer) 
 
Percentage 
Dispense/collect prescription drugs 107 84.3 
Dispense/collect drugs without 
prescription for minor disease 
90 70.9 
To purchase medicines for any medical 
condition without visiting the doctor 
28 22 
Ask advice concerning medical condition 52 41.7 
Ask advice on certain drugs you are  
always using 
37 29.1 
Cosmetic, fragrance advice or purchase 47 37.0 
Purchase of baby goods 40 31.5 
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Figure 3.9 : Customers’ response: whom you prefer for advice in 
your health problems. 
 
Figure 3.10 : Customers’ response : Do you think pharmacists are 
health professionals as doctors and nurses? (n = 126) 
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Figure 3.11: Customers response: Have you asked your pharmacist 
for advice on a medical condition in the past 12 months? 
(n = 124). 
Table 3.30:Customers’ response : If you need advice on any of these 
conditions, would you think of approaching you 
pharmacist?n=128 (more than one answer is chosen) 
Statements Number responding 
(yes answer) 
Percentage 
Smoking cessation 18 14.1 
weight/healthy diet 44 34.4 
Contraception 24 18.8 
Disease prevention 37 28.9 
Drug misuse 63 49.2 
I will not think of meeting the 
pharmacist for any of the above 
conditions 
23 18 
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Figure 3.12 . Customers’ response: Do you find difficulty to know 
which person is the pharmacist when you enter the 
community pharmacy? (n = 124) 
 
 
Figure 3.13 . Customers’ response : Did you find the pharmacist easy  
to approach and talk to about your medicines? (n = 127) 
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Table 3.31 : Customers’ response to community pharmacist advice 
and counseling, n=127, one missing (yes=108,no=19). 
Statements Number 
responding (yes 
answer) 
Percentage 
Did the pharmacist hand you your 
medicines personally? 
101 79.5 
Pharmacist talked to you about your 
medicines? 
96 75.6 
Did  the pharmacist give you other 
material, written or other , in relation to 
the prescription? 
52 40.9 
Did you feel that the pharmacist allowed 
you enough time to have all your 
questions answered? 
99 77.9 
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Figure 3.14 .customers’ response: Do you think pharmacist advice 
helped you in the use of your medication? (n = 112) 
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Figure 3.15: Customers’ response: Did the pharmacist refer you to 
other health professional or institution for further 
advice or treatment? (n = 108) 
 
Figure 3.16: Customers’ response to application of pharmaceutical 
care in community pharmacies . (n = 127) 
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Figure 3.17: Participant’s opinion on application of pharmaceutical 
care in community pharmacy. (n = 127) 
Table 3.32: Customers’ response to services which can be delivered 
in the community pharmacy (n=125,3 missing)). 
Statements Number 
responding(yes 
answer) 
Percentage 
1.Smoking cessation clinic 48 38.4 
2.Medication review 104 83.2 
2.Blood pressure check 72 57.6 
4.Blood glucose screening 56 44.8 
5.Pregnancy testing 37 29.6 
6.Vaccination for childern 36 28.8 
7.Private consulting room for 
advice 
64 51.2 
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Table  3.33 .Customers response: Drug related problems encountered 
by customers (n=125, 3 missing) 
Statements Number 
responding(yes answer) 
Percentage 
I can't get my drugs 
because they are 
expensive 
39 31.2 
The medicine is not 
effective for my case 
24 19.2 
forgetting to take my 
medicines 
40 32.0 
Problems with 
completing the 
required course of 
medicine 
43 34.4 
problems with opening 
medicine bottle 
12 9.6 
I don’t have any of the 
above problems 
30 24.0 
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DISCUSSION 
3.1 .2 Community pharmacists questionnaire: 
The survey achieved a response rate of 50% (64/128). The distribution of  
the responding community  pharmacists in Khartoum state main three 
areas (Khartoum, Omdurman and Bahari ) is shown in table 3.1. 
  The socio –demographic characteristics of the respondents is shown in 
table 3.2.About two third of the respondents were female (62.5%). Most 
of the respondents, (73.4) were from young generation “21-31 years”, 
other age ranges show little response. Most of the respondents were 
having B. Pharm. qualification (93.85%). The community pharmacies 
location in Market areas is the highest (33.9% ) , about similar  in 
residential areas (22.6%),near private clinic (25.8%) and near 
hospital/health center (17.7%).Pharmacies are mainly owned by 
pharmacists (73.2%). Most pharmacies work with two pharmacists (41%) 
or one pharmacist (29.5%). Most of the community pharmacies work 
without counter assistant (45.3%) or use only one counter assistant 
(39.1%). 
3.1.2.1 Availability of certain items in community pharmacies: 
The response is shown in table 3.3. The most available items reported 
were: Refrigerator (93.8%), Telephone (76.6%) and special laboratory 
area (70.3%). Only (23.4%) reported availability of computer in the 
pharmacy. 
The general profile of the availability of items in the community 
pharmacy shows that community pharmacies has only the basic items i.e 
refrigerator, telephone and laboratory area). Less tendency to availability 
of new innovations which can assist in developing a patient-oriented 
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practice was observed e.g computer, Internet, consultation room and 
patients records). There is a lack of presence of registers and proper files 
for the practice e.g. register for controlled prescriptions (6.3%), file for 
ministry of health circulars (9.4%), and file for controlled prescriptions 
(9.4). This shows clearly that there is no recording for drugs such as 
psychotropic medicines e.g. Diazepams, and that their prescriptions are 
returned to patients after issuance and not kept in the pharmacy. This 
situation is different from similar developing Gulf countries where there 
are proper files and records for these type of medicines, and records were 
checked by ministry of health officials. Community pharmacist in 
Khartoum state were not involved in any system for adverse drug 
reactions reporting (6.6% respondents only), a system which if available 
will protect the vast population who visit the community pharmacies due 
to drug related problems. Such system should be initiated by directorate 
of pharmacy in the country to complement the adverse reactions expected 
to be reported by doctors. 
3.1.2.2 Dispensing and drug information: 
3.1.2.2.1 Response to the question “is there a written procedure for 
dispensing to be followed by the staff?” 
Results are shown in table 3.4. 
Most of the participating pharmacists agreed to the lack of such system 
(84.5%). In U.K it is advised to have this system. Although it is not clear 
whether the availability of such system will change the behavior of 
pharmacists, but it is beneficial in case of new staff or trainees, and also 
in improving work in pharmacies with large staff or pharmacies with 
many branches or multiples. 
3.1.2.2.2 Activities done by community pharmacists when dispensing 
prescriptions: 
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 The results were illustrated as mean score (for 5-reponse scale: at all the 
time=5, frequently=4, not sure=3, sometimes=2, not at all=1. Results 
above 3 considered as positive response) with standard deviations and 
percentage positive response (at all the time/frequently) in table 3.5. 
Interventions of community pharmacists which showed high scores were: 
explaining instructions of the prescription verbally + handwriting 
(87.5%), explaining instructions of drug use verbally (86.0%), checking 
age, sex, medicines, dose and duration in each prescription (78.2%). 
Other interventions with moderate response were: providing oral 
counseling on the dispensed medicines (57.8%), tracing any prescription 
errors, drug or food interaction in the prescription (60.9%), doing 
medication review for medicines brought by patients (65.6%). Activities 
which show low profile were: explaining instructions of medicines 
verbally+ printed information (15.2%), asking each patient about current 
medical condition (29.7%), asking each patient about previous drugs 
he/she is using (32.8), and explaining side effects to the patient (34.4%). 
The results showed that the community pharmacists were involved in 
traditional roles of dispensing with less communication with patients 
about their conditions and  the drug problems they are facing , and this 
can be explained by their focusing in short interventions, avoiding time 
consuming activities, or  may be due to patients not expecting further 
roles from pharmacists. 
3.1.2.3 Pharmaceutical care and patient oriented practice. 
3.1.2.3.1 Community pharmacists’ attitudes towards pharmaceutical 
care: 
Results are shown in table 3.6 as mean scores (for 5-reponses: strongly 
agree=5, agree=4, neutral=3, disagree=2, very strongly disagree=1. 
Scores above 3 considered positive) and percentage positive response 
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(agree/strongly agree). 13 statements were formulated covering different 
aspects of the questionnaire include: awareness, willingness and present 
knowledge of community pharmacists. The reliability of the 
questionnaire was determined using Cronbach’ alpha and was found to 
be: 0.7 (6513), for the 13 items. Scores above 3.0 in the mean score were 
interpreted to be positive responses. The coding of negatively worded 
items, as per 5-response Lickert scale, were reversed for analysis, and this 
denoted by(c) in the table. 
The highest rating, 4.5873 (92.2%) was given to the attitude item 
showing that the community pharmacist can establish and strengthen 
relation with patients. Other high score items were: pharmacist support to 
introduction of pharmaceutical care, 4.387 (89.0%), pharmaceutical care 
is important in our developing countries, 4.4603 (87.6%) and the 
willingness of pharmacists to be trained in pharmaceutical care practice, 
4.4839 (85.9 %). Most of the respondents had attitude scores rating above 
the midpoint 3.0 on the scale, indicating highly favorable disposition 
towards pharmaceutical care, with 67.2% awareness of the concept. Two 
out of 13 attitude items received below average rating. These were: 
difficulty in having constant meetings with patients, for which only 
26.6% of the respondents disagreed, and only 18.8% of the respondents 
reported that the present knowledge and skills of the pharmacists about 
pharmaceutical practice are adequate. 
Statistically significant difference (Table 3.7) is found between gender 
and the response “it is difficult to have constant meetings with patients 
for follow up and counseling” (by doing t-test): although only 26% of the 
respondents think that it is possible to have meetings with patients ,most 
of this response was reported by females. Statistically significant 
difference was also found between age and the response (One way anova 
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done) (Table 3.7): Pharmaceutical care is not important in our developing 
countries. Most  age groups (21-60 years) showed more positive response 
than the age of 61 and above :(only one respondent who showed negative 
response) and this can be explained by the fact that most of respondents 
are within range of (21-60) years, and only one responder was from age 
61 and above. 
Reports from different countries indicate that pharmacists have shown 
favorable disposition towards pharmaceutical care. Study done in New 
Zealand on attitudes of community pharmacists showed that over 60% of 
the pharmacists surveyed had a correct understanding of pharmaceutical 
care. Approximately the same percentage felt that the future of pharmacy 
would depend on the provision of services other than dispensing. The 
general results are in agreement with results of this study (Dunlop and 
Shaw, 2002).  A questionnaire survey (Oparah and Eferakeya, 2005) that 
was conducted on attitudes of Nigerian pharmacists in different settings 
(hospitals, community pharmacies, administrative and industry) showed 
that three quarters (75%) of the respondents indicate positive disposition 
towards pharmaceutical care. Another study in Saudi Arabia which 
surveyed the attitudes of pharmacist in institutional settings and in 
community pharmacies indicated that more than 70% of the pharmacists 
had favorable understanding of pharmaceutical care. Approximately more 
than 89% of respondents felt that the future of pharmacy would depend 
on the provision of professional services other than dispensing (AL-Arifi 
et al, 2007). These results are in agreement with the present study. The 
present study focus solely on community pharmacy setting. 
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3.1.2.3.2 Barriers for application of pharmaceutical care in 
community pharmacies: 
Results were shown in table 3.8 as mean scores and percentage positive 
response (very important/important). The five Likert scale measure the 
degree of the importance of the barrier towards implementation of 
pharmaceutical care (very important=5, important=4, not sure=3, less 
important=2, not important=1. Scores above 3 considered positive). The 
results indicate that more than 70% of respondents cited the following: 
lack of time, software for medication  assessment, clinical data for 
patients, understanding pharmacists new role, trained assistant staff, 
access to drug information,  protocols for treatment, physicians and other 
health care professionals are not aware of the pharmacists' patient focused 
practice, clinical education, therapeutic knowledge ,communication skills, 
concept of team work with other health professionals, documentation 
skills and Structure of the health system as important barriers to 
pharmaceutical care. The highest rating was for lack of clinical education 
(87.5%), understanding of pharmacist new role (85.9%), and concept of 
team work with other health professionals (82.2%). Also Physicians and 
other health care professionals are not aware of the pharmacists' patient 
focused practice (82.2%). Factors which receive less importance as 
barriers were: legislations (28%), lack of payment (46%) and fear of 
patient rejection (45.4%). The weak perception of legislations and 
regulations as a barrier may be due to unawareness of pharmacists about 
their importance at this stage of preparing first, their own knowledge and 
training and; second of convincing other health professionals. Payment 
may be thought of after pharmacists prepare themselves by clinical 
education. Fear of rejection by patients is not considered as main barrier 
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since pharmacist felt that patients are really in need of the pharmacists’ 
advice from their daily routine practice. 
Statistically significant difference (T-test) (Table 3.9) was found between 
gender regarding: Lack of therapeutic knowledge. Females give more 
scores for this item as a barrier, than males.  
The barriers in this study can be summarized as follows:  
1- Barriers related to pharmacists’ education and training. 
2- Barriers related to technology for drug information 
3- Barriers related to time and assistant staff 
4- Barriers related to understanding of the new pharmacists role by 
other healthcare professionals. 
   
This necessitates a change in educational courses of undergraduates and 
introduction of postgraduate programs which focus on patient oriented 
practices. Use of technology systems for checking drug information, drug 
related problems and for recording patient information or receiving 
patient data from other health professional is required. Availability of 
trained assistant pharmacists will help in giving time for the pharmacists 
to be involved in patient oriented practices or services other than 
dispensing. Because pharmaceutical care depends on team work with 
other health professionals, it is important to orient other health 
professionals involved in patient care about the concept of 
pharmaceutical care and to clarify that it is a system of improving quality 
of care given to patients and it is not an encroachment to the domain of 
doctors or other health professionals. 
The results of this questionnaire is compared to other studies. The study 
among community pharmacists in New Zealand (Dunlop and Shaw, 
2002) cited the following as major barriers for pharmaceutical care 
Please purchase PDFcamp Printer on http://www.verypdf.com/ to remove this watermark.
  
ϭϱϭ 
application: Insufficient time, absence of reimbursement system, and lack 
of therapeutic knowledge/clinical problem solving skills. In the present 
study reimbursement or payment in not considered as a major barrier. A 
study in attitudes of Saudi pharmacists towards pharmaceutical care 
((AL-Arifi et al, 2007) , in which more than 60% of respondents cited 
lack of therapeutic knowledge ,lack of clinical solving problems, 
insufficient time, lack of support from owner or administration as 
important factors. More than half of the respondent also regarded lack of 
self confidence and lack of communication skills as other contributing 
factors. The lack of access to medical records was cited by more than 
60% to be an obstacle for provision of pharmaceutical care. In a recent 
survey study investigating pharmacists’ perceptions on pharmaceutical 
care in community pharmacy in Northwest China the respondents 
reported the following as main barriers: lack of external conditions for 
developing pharmaceutical care ,lack of time and skills, absence of 
information and economic incentive and lack of full support from other 
health professionals(You Fang et al, 2010). The Chinese study investigate 
also the perceived frequency of pharmaceutical care activities, which is 
not investigated in the present study. Lack of economical incentive is not 
considered as a barrier in the present study. 
3.1.2.4 Chronic Disease Management: 
Attitudes of community pharmacists towards involvement in chronic 
disease management is portrayed in table 3.10, as mean scores(for 5-
reponse scale) and percentage positive response (agree/strongly agree).6 
items were used in Likert scale to have a general idea about pharmacists 
attitudes towards chronic disease management. The coding of negatively 
worded items, in the five response Lickert scale, were reversed for 
analysis, and this denoted by(c) in the table. 
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The highest ratings (95.3%) were given for  the two items: Community 
pharmacist should play important role in chronic disease prevention and 
management and community pharmacists acceptance of team work with 
doctors and other health care professionals in long term conditions 
management(87.5%). 70.3 % of community pharmacists consider chronic 
disease prevention and management is their concern. 54.7% of 
respondents think that patients will accept any community pharmacist 
role in chronic disease management and 51.6% of respondents agreed that 
they have the proper knowledge about chronic diseases. The general 
mean score for all items is above 3.0 (midpoint), showing a positive 
disposition of community pharmacists towards a role in chronic disease 
prevention and management. 
The results revealed that community pharmacists are interested in 
involvement in chronic disease prevention and management but they lack 
the knowledge and they are not completely confident in acceptance by 
patients. Knowledge is built through education and training courses and 
acceptance is built through orientation of patients or other health 
professionals and starting research in different models to reach an 
acceptable model for each party involved in patient care. Community 
pharmacy is a place where pharmacists are in daily contact with chronic 
disease patients e.g. diabetic or hypertensive patients) and a large number 
of healthy people visit pharmacy for different reasons which will give a 
chance for interventions for disease prevention. 
3.1.2.5 Health promotion: 
 3.1.2.5.1-The current involvement of community pharmacists in 
health promotion activities: 
The results were illustrated in table 3.11, as mean scores (for 5-responses: 
very involved=5, nvolved=4, not certain=3, uninvolved=2, very 
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uninvolved=1. Scores above 3 considered positive) and percentage 
positive response (involved/very involved). 11 items were used in a 5 
response’ Likert scale. 
The results showed highest involvement of community pharmacists in 5 
items: healthy diet information e.g. diabetic and hypertensive patients 
(89.1%), obesity and weight reduction education (78.1%), exercise 
especially for certain patients (76.6%), smoking cessation (76.1%) and 
information about contraception methods and medicines (73.4%). 
Activities which were reported by approximately half of respondents 
were: maintenance of normal blood cholesterol (57.8%), dental or oral 
health information(57.8%) and AIDS awareness and prevention (57.6%). 
The least scores were given for skin cancer information (31.3%). 
In general most of the community pharmacists seem to be positively 
involved in many health promotion activities, which prove that 
community pharmacists have a good role in this field but they should be 
involved in proper Ministry of health programs to attain certain nation -
wide targets. Community pharmacists’ relation with ministry of health 
should be strengthened through participation in joined programs, and they 
should not remain as an isolated sector. This will be improved by 
pharmacists themselves giving a professional image in their community 
pharmacies and making a balance between business and professional 
practice. More efforts should be directed towards gaining more 
knowledge in health promotion activities whether in undergraduate or 
postgraduate stage. 
3.1.2.5.2 Attitudes of pharmacists towards health promotion: 
 The results are illustrated in table 3.12, as mean scores and percentage 
positive response (agree/strongly agree). 10 items were used in a 5 
responses Likert scale, for testing the willingness for participation in 
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health promotion activities and factors affecting that. Negatively worded 
items were reversed for analysis, and this denoted by (c) in the table. 
In general most items scores were above the midpoint 3.0, showing a 
positive disposition towards promotion of health. Six items showed high 
scores: Pharmacists should be part of the health promotion activities 
(90.6%), the willingness to be trained in health promotion concepts 
(82.8%), willingness to participate in any health campaigns (activities)  
for disease prevention (81.3%), It is important for community  pharmacist 
to practice health promotion (79.7%), Public will accept contribution of 
the pharmacist in health  promotion services(78.7%), and interest in 
health promotion services(73.5%). Items which receive less scores were 
three items: 37.4% of respondents think that other health professionals 
will  accept pharmacist role in health promotion , 46.9% reported that 
they have time for health promotion activities and 59.4% of respondents 
reported that even if there is no payment for health promotion activities 
they will still include it in their practice. 
About 60.7% of respondents reported that they have sufficient knowledge 
for advising patients in health promotion and disease prevention. 
The results showed that pharmacists attitudes were positive towards 
health promotion, with some barriers such as time and acceptance by 
other health professionals. These factors should be solved together with 
other factors for pharmacist to play role in healthcare system. 
Improvement of pharmacist knowledge, through certified courses whether   
in undergraduate or postgraduate levels will give others the reason for 
acceptance of new pharmacists’ role. There is a lack of health promotion 
policy for pharmacy. Community pharmacy should be involved in 
country health programs and with health promotion units in ministry of 
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health, as a large amount of population who will benefit from this service 
were meeting community pharmacists daily. 
The results of this study is compared with the study among Nigerian 
community pharmacists (Oparah and Okojie, 2004), which used 24 items 
and 23 items to measure the importance of pharmacists attach to healthy 
behavior and perceived involvement in health promotion, respectively. 
About 84% of the respondents indicated a favorable attitude towards 
health promotion. Nearly all respondents (98%) were interested in health 
promotion services, and 94% indicated willingness to devote extra time to 
talk to patients. 
3 .The feasibility of providing some health screening tests and 
vaccination in community pharmacies: 
The results are shown in figure 3.1. Screening tests which showed high 
feasibility to be applied in community pharmacy were: blood pressure 
measurement (89.1%), blood glucose testing (85.8%). About above the 
half of respondents (57.8%) think that pregnancy can be done in 
community pharmacy and 45.2% think that vaccination can also be done. 
Tests which received low profiles were: bone density testing (7.8%), 
urine testing (15.6%) and blood cholesterol testing (28.1%). 
The general trend of the results showed that community pharmacists 
prefer screening tests which they consider easy to provide and which are 
highly demanded by patients e.g. chronic diseases such as: diabetes and 
hypertension. Application of such tests should be step-wise and should 
start with such feasible tests. No official reports showing that such 
practice is done in community pharmacy in developing countries, 
although it is a common practice in many developed countries. 
Developing countries should change rules and regulations to incorporate 
these activities in community pharmacy practice. These tests can be used 
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in chronic disease prevention and can save expenses utilized for treatment 
of these diseases later-on. Training is considered an important factor in 
providing these services. The introduction of these services will help in 
changing the picture of the community pharmacies from business area to 
a professional one. 
3.1.2.6 Responding to symptoms: 
a- Responses were illustrated in table 3.13 in mean scores (for 5-
responses: at all the time=5, frequently=4, not sure=3, sometimes=2, not 
at all=1. Scores above 3 considered positive) and percentage positive 
response (at all the time/frequently) to measure community pharmacists 
involvement in responding to symptoms and treatment of minor diseases. 
Four items were used to measure pharmacists’ general involvement. The 
results showed that more than 90% of respondents were involved in 
responding to symptoms activities: 93.8% of the respondents were 
referring patients to the doctor for further checkup if they suspect other 
problems with patient health, 93.7% of respondents were asking the 
patient about his/her symptoms before giving medicines, 90.7% reported 
that they are involved in dispensing medicines without prescription for 
minor diseases e.g. cough and diarrhea. 
Only 15.6% of the respondents cited that they are recording some cases 
of clinical importance in special patient record. 
b-Response (yes/no) of community pharmacists to questions regarding 
responding to symptoms were shown in table 3.14. The results shows that 
84.4% of reported the non availability of counseling procedure for minor 
diseases, 91.9% were aware about the level at which symptoms will 
indicate serious disease, 75% cited that there is no specific list of minor 
conditions and drugs to be used for them in the pharmacy, 85.9% reported 
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that there is no written form for referring patients to the doctor when 
required. 
c- Pharmacists knowledge about minor disease symptoms:  
The question is in the form of scale describing the level of pharmacists’ 
knowledge which includes: excellent, very good, good, fair and poor. The 
results are shown in figure 3.2., 48.4% of respondents describe that their 
knowledge as very good, 35.9% as good and 10.9% describe it as 
excellent. 
The results generally showed the current positive involvement of 
community pharmacists in responding to symptoms activities, a practice 
which is considered as one of the most important features in community 
pharmacy practice in developing countries. This practice is neglected by 
health authorities in developing countries and is under estimated or run 
intangible. In fact it is considered as one of the professional strategies, 
together with pharmaceutical care and others, suggested for the expected 
potential professional project for pharmacy (Harding and Taylor, 2002). 
For making these activities tangible pharmacy profession in developing 
countries should organize this practice, and as starting point an official 
booklet for over the counter medicines, used in Sudan and other 
developing countries, should be devised. This national reference should 
contain proper description of symptoms to be treated. Efforts and chances 
for continuous education in this area should always be available. 
Knowledge of pharmacists about minor disease symptoms should be 
strengthened through more stress on educational courses in universities or 
specialized centers for training. 
Another important point is introduction of referral forms or mechanisms 
which link community pharmacy with doctors or other health 
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professionals, as lack of such systems will contribute in more isolation of 
the community pharmacist. 
3.1.2.7 Continuous education: 
a. Time spent in updating community pharmacist knowledge; 
Community pharmacists were asked the following question:”How much 
time do you spend each month updating your knowledge?” From the 
results in figure 3.3 it appear that most of the respondents were updating 
their professional knowledge, however the number of hours spent is 
variable. The majority reported 2-6 hours (36.5%), while others spent 1-2 
hours (23.8%) and 6-10 hours (17.2%). Only 4.8% were updating their 
knowledge over 10 hours monthly. Interestingly, 17.4% of respondents 
were not updating their knowledge, and this may be due to complete 
involvement in community pharmacy work (morning and evening). 
 The results showed that the average perceived time spent by community 
pharmacists is less than one hour per week, a value which seem to be 
rather inadequate( if we take the average of 1-6 hours  monthly , the 
range in which the majority fall, we will arrive to 0.875 hours per week). 
Updating knowledge is important is knowing more about 
pharmacotherapy of new medicines ,new trends in pharmacy practice, 
alerts about medicines.etc , and it is one of important factors in building a 
patient-oriented practice in pharmacy because this type of practice needs 
daily referring back to different sources of pharmacotherapy information. 
b. Source of information: Community pharmacists were asked to 
nominate the most important sources of information used for updating 
their knowledge? The results were illustrated in Figure 3.4. Most of 
pharmacists seem to use Drug leaflet (87.5%) and Internet (76.6%) as 
main sources of information. 64.1% of respondents take their information 
from medical representatives and 62.5% take their information from other 
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pharmacists. Only 15.6% obtain their knowledge from Ministry of health 
circulars. 
The result emphasizes the importance of Drug leaflet, Internet, medical 
representatives and pharmacist colleagues as sources of information and 
shows a lack of contact with Ministry of health. Ministry circulars about 
policy or medicines alerts are very important mean for creating a 
professional relationship with community pharmacists. A monthly 
Journal should reach community pharmacist at least quarterly in a year. 
Workshops or seminars sponsored by the ministry, supported by 
manufacturers or companies, will have a good effect in altering the 
relation between ministry or directorate of pharmacy and the pharmacists 
in private pharmacies. Education to pharmacists about how get the proper 
information from internet and the proper sites is essential. Pharmacists 
should balance their information from sources which can show some bias 
of information like manufacturer leaflets, medical representatives with 
other non-biased scientific sources. Although there is high  of use of 
certain sources of information by  the pharmacists but the time of 
updating knowledge per week , which was found to be less than one hour 
per week, is unsatisfactory. 
3.1.2.8 Final pharmacist comments: This open –ended question in the 
end of the questionnaire for any suggestions for development of 
pharmacy practice in community pharmacy. Only 29 community 
pharmacists wrote their comments. The comments shows focus in the 
following themes: 
1-  Courses and training and continuous education in the new patient 
oriented, concepts, and this should be linked with registration of 
pharmacists’ (system of re-registration should be devised) 
2-   Availability of sources for Therapeutic information. 
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3- Changes in pharmacy curriculum to include the new concepts. 
4.  Financial support for pharmacists e.g. good salaries and situation. 
5-  Awareness and understanding of patients and doctors or other 
health professionals about the new patient oriented role of the 
community pharmacists. 
6.  Availability of trained assistant pharmacists to save pharmacist’ 
time for patient oriented practices, 
Other suggestions were: role for pharmacists in repeat prescriptions, 
registering of psychotropic medicines, booklet for over the counter cases, 
and writing prescriptions in Arabic. 
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3.1.3 Doctors Questionnaire: 
The questionnaire received response rate of 65.6% (80/122). The 
distribution of medical officers and consultants in the main governmental 
teaching hospitals in Khartoum State (Khartoum, Omdurman and Bahari 
hospital) is shown in table 3.15. 
The demographic characteristics of the respondents were shown in table 
3.16. 58.7% of the respondents were medical officers and 41.3% were 
consultants.79.8% of the respondents were in the young generation age 
ranges of 21-30 and 31-40 years. Most of respondent were working in 
governmental hospitals (93.8%). Gender is not surveyed in the 
questionnaire as the main focus is the general response of the profession 
of medicine towards the new roles for community pharmacists. 
3.1.3.1 Contact of Doctors with Community pharmacists. 
 a. The response of doctors to the question: How often doctors contact 
community pharmacists? Comparison of responses of medical officers 
and consultants to this question is illustrated in (Figure 3.5). The highest 
contacts are in: more than once per week (medical officers 18.2%, 
consultants 9.1%), and once above three months (medical officers 16.9%, 
consultants 7.8%). The results showed that, in general, contact of medical 
officers is better than consultants. This may be due to consultants being 
more conservative in their relation with pharmacists. The overall profile 
showed that some of doctors showed acceptable contact (more than once 
per week), while another sector showed less or weak contact with 
community pharmacists (once above three months). The total percentage 
of doctors (consultants and medical officers) who contact pharmacists 
more than once per week is 27.3%, which is considered as inadequate 
contact. For community pharmacists to build a patient oriented practice a 
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good contact with doctors is very important. Doctors should be oriented 
about the type of knowledge obtained by pharmacists and especially 
when clinical pharmacists were available in community pharmacy, they 
should introduce themselves to nearby doctors whether in governmental 
or private clinics. 
b. Method of contact of doctors with community pharmacists is illustrated 
in Figure 3.6. 
Most of doctors cited direct visit (83.5%) as their method of contact with 
community pharmacists. The second method of contact is the 
“Telephone” which was cited by 26.6% of the respondents. Other modern 
methods (Fax and Internet) received very low percentages (1.3 % and 
3.8%), respectively. 
There is statistical significant association between occupation and the“ 
direct visit”( sig 0.020)  and use of telephone(sig 0.025) as reported in( 
table 3.17).More medical officers contact pharmacists directly than 
consultants, while  more consultants use the telephone as a method of 
contact. 
Statistical  significant association between Age and Telephone (sig.0.002) 
as a method of contact (table3.18). Younger generations (21-30,31-40 
years) were not using telephone frequently  compared to older one ( 41 
years and above). 
c. Reason of contact of doctors with community pharmacists were shown 
in table 3.19. More than half of respondents  cited their reasons of contact 
with community pharmacists as : checking availability of medicines 
(52.5%) and obtaining scientific information about medicines (56.3%). 
Pharmacists should always be a good source of information in 
pharmacotherapy and this should be strengthened always by changing the 
way this subject taught , as a more clinical depth should be given to 
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subjects like pharmacology, and in general more clinical type of 
education for pharmacy. Continuous education for pharmacists should 
facilitated in area of drug therapy. 
3.1.3.2: Views of Doctors about extended role of community 
pharmacists. 
Nineteen items were used to measure doctors’ perceptions about extended 
activities to be done in the community pharmacy by community 
pharmacists, in a 5 –response Likert scale (strongly agree=5; agree=4; 
neutral=3; disagree=2; strongly disagree=1. 
The results were shown in table 3.20, as mean scores (value above 3 
score in likert scale considered as positive response) and percentage 
positive response (summation of agree/strongly agree). 
Activities which received the highest acceptance of doctors were: 
participation in a team work with doctors and other   health care 
professionals in management of chronic diseases(87.5%), reporting 
adverse drug reactions(85.1%), Ensure compliance and adherence to drug 
regimen in long term conditions(85.1%),health promotion activities 
(85%), advice on drug abuse/misuse(82.5%), referring patients to the 
doctor for further checkup when suspecting problems(77.5%), advice 
patients about healthy lifestyle e.g. exercise(73.8%) and advice and 
education for long term conditions(70%). About more than two thirds of 
respondents accepted a role of the community pharmacist in undergoing 
Drug review (68.8%), repeat prescriptions in chronic diseases (68.8%) 
and informing public about healthy diet (67.6%). Half of respondents 
accept pharmacists prescribing under protocol and their advice on chronic 
disease prevention (51.3 and 51.2%, respectively). 
Most of screening tests ,vaccination and management of minor diseases, 
to be done in community pharmacy, received low profile of acceptance: 
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vaccination(45.2%), screening for blood pressure(41.31%), urine testing 
for pregnancy (36.3%), screening for blood lipids (32.5%), increased role 
in minor illness (30.1%) and screening for blood glucose, glycosuria 
(23.8%). 
Statistically significant association between (occupation) and items of this 
section were shown in table 3.21. There is significant difference between 
occupation and the extended role activity: advice on drug abuse/misuse 
(sig. 0.041). Consultants give more positive acceptance for this activity 
than medical officers. Significant difference between age and other 
different items (Table 3.22) were as follows: advice in long term 
conditions(sig 0.022), health promotion (sig 0.000), team work for 
management of chronic diseases (sig 0.001),compliance and adherence to 
drug regimen in long term conditions (sig 0.008), and undergo medication 
review for chronic disease patients (0.033). In all these extended roles 
doctors of age ranges (31-40 years) had more acceptance for these 
activities than younger generation of (21-30 years). Age ranges above 40, 
were small in number and showed very low acceptance. This may be 
explained by the fact that older generation (most of them consultants) 
understand the depth of these new roles better than young generation. 
The results generally indicate that doctors accept roles of community 
pharmacists in areas regarding their sole specialization (i.e. drugs) as 
reporting of adverse drug reactions and problems of drug compliance, and 
roles regarding general health as health promotion. Interestingly enough 
they have high acceptance for a role of community pharmacists in chronic 
diseases whether this in form of advice and education, drug review or 
participation in team work programs. This role is important role 
especially in developing countries for such chronic diseases which 
require continuous follow up throughout life-span. The area of chronic 
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diseases can be a good prerequisite for introducing clinical pharmacy and 
pharmaceutical care in community pharmacy. Pilot studies should be 
done to investigate the feasibility of introducing this practice in 
community pharmacy in Sudan. Good areas which can use this practice 
are pharmacies attached to hospitals and open to public where chronic 
patients under health insurance collect their medicines and private 
pharmacies that provide medicines for insured patients. As one 
pharmacist (or assistant pharmacist) can undergo normal dispensing and 
another pharmacist (in the start clinical pharmacist) can undergo follow 
up and counseling of chronic disease patients. 
One simple study from Nigeria (Oparah et al, 2006) was done to describe 
pharmaceutical care interventions provided to hypertensive patients in 
community pharmacy setting .The study was a non-randomised, single-
site study using community-dwelling patients and patients were followed 
for a period of six months. The study resulted in improvement of blood 
pressure control and overall patient satisfaction with pharmaceutical 
services. This study represented a bold attempt to implement 
pharmaceutical care in a community pharmacy in developing countries. 
 Doctors showed preservation for most of the screening tests to be done in 
community pharmacy. They are also not confident about pharmacists’ 
role in minor diseases, and considered pharmacy not a suitable place for 
vaccination. Community pharmacists if trained can provide these 
services, as this is the current situation in the developed countries (Bertin, 
2005; Pharmaceutical Service Negotiating Comitte, 2004) 
The same worry about screening roles of pharmacists was shown in a 
survey in U.K. The result of the survey showed that the majority of 
doctors were not in favor of pharmacists screening except for urine 
testing for glucose. The controversy about mass screening for, non-risk 
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cases emphasizes that screening policy involving pharmacists, proper 
guidelines and strategies must be drawn up to deliver optimal benefit 
(Edwards and Spenscer, 1992). 
The problem of what will be the value of the result of the community 
pharmacist screening test to the doctors should be negotiated with both 
professions and a compromise should be reached whether that will be in 
form of a concise protocol for type or number of cases which can be done 
in community pharmacy or any type of agreement for training, referral. 
Etc. 
3.1.3 .3 Perceptions of doctors on pharmaceutical care practice:  
The results were shown in table 3.23, as mean scores (above 3 score in 
likert scale considered positive response)  and percentage positive 
response (agree/strongly agree). Negative items (4 items) were reworded 
and shown in the table as “c”. Nine items were used to investigate doctors 
attitudes towards pharmaceutical care. A 5-resonse scale was used. 
Internal consistency of the items was checked using Cronbach alpha and 
was found to be 0.6275.  
The results in general show positive disposition towards pharmaceutical 
care, as all the scores were found to be above the midpoint: 3.0. The 
highest rating was for: activities for preventing and resolving drug-related 
problems will improve quality of patient care (93.8%). 87.5% of doctors 
show interest to know more about the concept of pharmaceutical 
care.83.8% of respondents admitted that many patients have problems 
related to drug use and 81.3% considered pharmaceutical care practice 
will augment and support doctors role in patient care. Only 33.8% of 
respondents reported that the commercial side of the community 
pharmacy practice will make it suitable for pharmaceutical care practice, 
and 30% said pharmacist role shall be confined only to dispense 
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prescriptions. This reflects the general idea of doctors about the 
community pharmacy, which they mostly consider as a commercial place 
not suitable for deep health investigations , and also the perception of few 
doctors  who limit the pharmacist’ role to distribution only (which show 
less orientation to the current progress in pharmacists education and/or 
less contact with pharmacists). This necessitate continuous orientation of 
doctors about pharmacists clinical role, and for pharmacist to show 
always professional behavior in their practice.    
Statistically significant association between (occupation) and items of this 
section were shown in table 3.24. There is significant difference (sig 
0.033) between occupation and the response towards the item: many 
patients have problems related to drug use. Medical officers showed more 
positive response to this item than consultants. Consultants showed more 
positive response to the item: pharmaceutical care will not add benefit to 
my practice, than medical officers (sig 0.009). 
Statistically significant association between (Age) and items of this 
section were shown in table 3.25. Age ranges of (31-40 years) showed 
higher positive responses to the following items when compared with 
younger generation (21-30 years): the willingness to participate in a team 
work including pharmaceutical care (sig 0.001) and doctors interest to 
know more about pharmaceutical care concept (sig 0.013). 
The result generally indicate acceptance of doctors for pharmaceutical 
care practice, although some were still worried about the commercial or 
business side of the community pharmacy. For application of 
pharmaceutical care in community pharmacy a separation should be done 
between dispensing and pharmaceutical care practice. This can be solved 
by presence of trained assistants or another pharmacist covering other 
activities. More lectures or seminars should be done to orient a large 
Please purchase PDFcamp Printer on http://www.verypdf.com/ to remove this watermark.
  
ϭϲϴ 
sector of doctors about the concept. Research projects should start by 
academics which will help in convincing doctors and policy makers about 
the concept. 
3.1.3.4 Negative experiences of doctors with community pharmacists. 
The results were shown in table 3.26. Respondents were asked to 
nominate the most common negative experiences in order to know some 
points which leads to decrease affinity of co-operation of doctors with 
community pharmacists .Nine items were used and the tenth one is to 
specify as additional problem by the respondent. The results were shown 
as frequency and percentage (%).Most negative experiences were 
reported by less than 45% of respondents. The negative experiences 
mainly were :45% reported that pharmacists gives wrong alternatives for 
drugs they prescribe, 43.8 % reported that pharmacists changed the 
instruction or directions they gave to patient, 35% cited that pharmacists 
were dispensing drugs for serious medical condition without prescription 
,35% reported  pharmacists give wrong drug or dosage. All the following 
experiences received 31.3% responses: pharmacist gives drug not 
indicated in the prescription, pharmacist not acting professionally and 
pharmacist is making skin preparations as cosmetics which make serious 
effects to the patient.  
All such type of problems necessitate a team work approach in which 
there is easy contact between the two professions to solve different 
problems in drug therapy, and needs more steps towards 
professionalization of community pharmacy in developing countries, 
through  professional  project with definite targets . This mainly is 
function of national pharmacists associations together with pioneers from 
academics. Only 5 respondents cited other additional negatives 
experiences which include: wrong information about drugs, deficiency in 
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clinical adjustment, pharmacists not believe in team work and pharmacist 
give suboptimal dose in rural area. 
3.1.3.5 Final comments of doctors about community pharmacists’ new 
roles .Only 23 respondents gave their comments in the last open –ended 
question in the survey. Themes of their comments can be summarized in 
the following topics: pharmacists should participate in seminars and 
rounds, more cooperation of pharmacists with other health professionals 
in workshops and other activities, pharmacists give lectures to the 
community, and prescriptions should be in unified format, contact doctors 
if prescriptions not clear, and pharmacists not to concentrate on 
cosmetics. 
The overall results   of doctors’ survey can be compared with survey in 
U.K about views of general practitioners to an   extended role for 
community pharmacist (Spencer and Edwards, 1992). The responses 
showed a range from very favorable attitudes towards pharmacists 
reporting adverse drug reactions, increasing their role in managing minor 
illness, and advising general practitioners about cost effective prescribing 
to generally unfavorable reactions to pharmacists screening for raised 
blood pressure, hyperlipidemia, and height and weight for preschool 
children. Opinion was equally divided regarding supervising repeat 
prescriptions and for screening for glycosuria. This study did not 
investigate views of doctors on pharmaceutical care as the present study. 
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3.1.4 Community pharmacy customers’ questionnaire. 
The distribution of the customers in Khartoum state main three cities is 
similar to the distribution of the community pharmacists in table 3.1, as 
two customers were chosen from each pharmacy. It follows that most 
respondents were from Omdurman followed by Khartoum and Bahari. 
The response rate for this questionnaire is 50% (128/256). The 
demographic characteristics of the respondents were shown in table 
3.27.More than half of the respondents were males (58.6%),female 
respondents comprise 41.4%.Most of respondent were in the age 
ranges(21-50 years),from this younger generation (21-30) constitute 
45.7%.Older generations shows very less percentage of respondents 
:6.3% for ranges of 51-60 and 3.9 for ranges above 6o years. 50.4 % of 
the respondents were officers, and other respondents were divided 
between : no work( 15.2% ), students(15.2%) and free business (19.2%). 
More than three quarter of the respondents were working in private sector 
(77.5%). 
 
3.1.4.1 General information: 
3.1.4.1.1 Frequency of use of the community pharmacy by customers:  
a. The response of male/female response to the question: How often you 
used the community pharmacy in the past 12 months? Is shown in figure 
3.7. The results show high frequency of use of community pharmacy with 
54.5% (males & females) of respondents reporting that they had visited a 
pharmacy more than once in a month. A further 22.3% (males & females) 
reported visiting pharmacy once each month. Males showed twice 
frequency of use of females once each month (14.9%/7.4%), and 
approximately equal frequency of use “more than once in a month” 
(26.4%/28.1%). In general males showed more use of pharmacy than 
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females, this may be due to males moving all through the day going and 
coming from work, while females in country like Sudan has limited 
movement since most of them are householders and their movement is 
always to nearby pharmacies. 
b. Use of same pharmacy by customers: 
Figure 3.8., depicts the response to the question: Do you always use the 
same pharmacy?    
About 37.5% of respondents reported using the same pharmacy always 
while 45.3% of respondents use the same pharmacy sometimes. More of 
males use the same pharmacy always (31/17) or sometimes (31/27) when 
compared to females. 
c. Reasons for selection of community pharmacy: 
The response to the question: what is the importance of the following in 
selecting the pharmacy you visit? Is shown in table 3.28.The response is 
in form of 4- response scale (very important=4, important=3, less 
important=2, unimportant=1), and was shown in the table as frequency 
and percentage positive response (important/very important).Customers 
cited high importance for: pharmacist provide good advice on request 
(86.8%), availability of medicines (85.6%) and pharmacist happy to talk 
to customers (71.1%). About 69.6% cited good price as the reason for 
selecting the community pharmacy, and this may be due the low 
economic conditions of most of the customers who seek less prices to suit 
their conditions, and may be due to increasing cost of medicines. 
d. Reasons for visiting the community pharmacy:  
The results were shown in table 3.29. Most of respondents (84.3%) cited 
their main reason for visiting pharmacy is for collecting prescription 
medicines.70.9% of respondent’s mention their reason is for collecting 
medicines without prescription for minor disease treatment.41.7% of 
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respondents visited pharmacy for advice concerning medical condition, 
and only 29.1% visited pharmacy for advice regarding drugs they are 
frequently using. Although this percentage is small but it indicate the 
possibility of acknowledging pharmaceutical care practice role of the 
,community pharmacists ,by the public a fact which augment further the 
need for introducing such practice in community pharmacy. 
3.1.4.2 Customers and pharmacist role: 
a. First preference person for advice on health problems: 
The response to the question: whom you prefer for advice regarding your 
health problem? Is shown in figure 3.9. Customers showed high 
preference for the Doctor for advice in their health problems (87.4%). 
The community pharmacists showed the second preference (27.6%), 
before the family member and the nurse. 
b. Community pharmacists as members of health professionals. 
The response to the question: Do you think community pharmacists are 
health professionals as doctors, nurses? is shown in figure 3.10. 
95.2% of the respondents considered community pharmacists as health 
professionals. 
c. Customers’ response: Have you asked your pharmacist for advice in a 
medical condition in the past 12 months?  
The response is shown in figure 3.11. Most of the respondents (80.2%), 
reported that they contact the pharmacist for advice in medical condition 
during the past 12 months. 
d. Customers’ response: If you require advice on any of these conditions, 
would you think of approaching you pharmacist? 
The response for this question is shown in table 3.30. 49.2% of 
respondents reported that they will approach community pharmacist for 
advice in drug misuse, 34.4% for advice in weight and healthy diet and 
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28.9% for advice on disease prevention.18% reported they will not 
approach the pharmacist for any of the suggested conditions. 
e. The easiness of knowing the pharmacist among other staff in 
community pharmacy: 
Responses were illustrated in figure 3.12.  58.9% of respondents reported 
that they don’t have difficulty in knowing the pharmacist when entering 
the pharmacy. About 36.3% of respondents find difficulty in knowing the 
pharmacist, and this may be explained by the fact that most of 
pharmacists are not wearing special professional uniform (white coats 
with title and name), the pharmacy working without pharmacist and may 
be also  due to customers are satisfied by the advice given by any one of 
the available staff. . 
 
3.1.4.3 Pharmacist counseling and advice: 
a. Response to the question: Did you find the pharmacist easy to approach 
and talk to about your medicines? 
The results were shown in figure 3.13.Most of the respondents reported 
that it is easy to meet pharmacist and talk to about their medicines (85%). 
Only 15% of respondents reported that it is not easy to approach the 
pharmacist, and these were 19 in number :nine of them reported the 
reason for that : the pharmacist is very busy, seven of them  cited that the 
counter assistant replied for their queries, and three of them that it is not 
easy to see the pharmacist. None of the respondents cited that they didn’t 
want to talk to the pharmacist. 
b. Responses of customers who find it easy to approach the pharmacist 
for advice and counseling: The responses were shown in table 3.31. More 
than three quarter of the respondents reported that the pharmacist handed 
them their medicines personally (78.9%), 77.3% cited that the pharmacist 
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give them enough time to have all their questions answered. 75% of 
respondents reported that the pharmacist talked to them about their 
medicines, and only 40.6% reported that the pharmacist handed them 
written material regarding their prescription. This show that the current 
role of pharmacists is highly appreciated by the public, with lack of 
printable materials about medicines due to lack of time, demand or both. 
 Figure 3.14 shows customers’ response to the question: Do you think 
pharmacist advice helped you in the use of your medication? 
Three quarter of the respondents (75%) cited that they have a lot of 
benefit from the pharmacist advice which helped them in use of their 
medications. Nobody cited that there is no benefit, indicating positive 
effect of the current practice of the community pharmacists. 
 The customers showed slightly higher response for referral to other 
health professionals (49.1%), than non-referral (43.5%) when responded 
to the question: Did the pharmacist refer you to other health professional 
or institution for further advice or treatment? (Figure3.15). 
3.1 .4 .4 Pharmaceutical care practice: 
The question was in form of 5 response scale to measure level of 
agreement to application of the practice in community pharmacy. The 
results were illustrated in figure 3.16.One of objectives of asking this 
question to public, is to orient them about this new type of practice. The 
results generally showed high disposition towards pharmaceutical care. 
The percentage (agree/strongly agree) is 82.1%. About 60.6% of 
respondents were strongly agreeing to the application of pharmaceutical 
care. Gender comparison (figure 3.17) showed that males agree (47 
strongly agree) more than females (30 strongly agree) for introducing 
pharmaceutical care in community pharmacy, and this may be due to their 
frequently visiting community pharmacies more than females (a point 
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discussed before). 
3.1.4.5 Other services which can be provided in the community 
pharmacy. 
The results of this section were illustrated in table 3.32. The highest 
accepted service reported is the medication review (83.2%). More than 
half of the respondents agreed to the following: Blood pressure 
measurement (57.6%), consultation room (51.2%) and blood glucose 
testing (44.8%). Services which received low acceptance were: smoking 
cessation (38.4%), pregnancy test (29.6%) and vaccination for children 
(28.8%). 
3.1.4.6 Drug related problems: 
The results were shown in table 3.33. The results showed approximately 
equal percentages for the following problems: expensive medicines 
(34.4%), forgetting to take medicines (32%) and not completing 
medicines course (31.2%). Only 19.2% of the respondents reported that 
the drug is not effective for their case. About quarter (24%) of the 
respondents reported that they don’t have any of the mentioned problems 
.few of the respondents (19 in numbers) specified additional problems not 
mentioned in the questionnaire, and this can be summarized as: non 
availability of essential medicines, bitter taste of some medicines. 
 
3.1.4.7 Final customer comments and suggestions:  
Only 59 of the respondents replied to the last section in the questionnaire, 
and themes of their comments can be summarized in the following: 
 1. Advice and consultation of the pharmacists regarding disease 
prevention and medications and consultation should be at specified time 
with written information, leaflets, lectures.etc. 
2. Providing new services for the patient like providing medicines by 
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telephone, sending medicine to patient homes.etc. 
3. Providing doctors addresses to patients in the pharmacy. 
4. Giving injections in pharmacies. 
5. Availability of first aid services in pharmacies. 
Interestingly enough one respondent cited the importance of availability 
of a psychiatric doctor in the community pharmacy, a point which reflects 
a need for pharmacist to have more focus to patients and their 
psychological problems either by advice or referral. 
The general results of this questionnaire showed that there is high use of 
the community pharmacy among customers. Males were slightly frequent 
users. Nevertheless, the difference is not considerably large in this study. 
Most of the customers were not using the same pharmacy a case which 
will pose a problem in application of patient oriented practice in Sudan 
and other developing countries. Means and procedures should be used to 
encourage patients to collect their medicines in the same pharmacy. One 
of these procedures is contract of community pharmacies with health 
insurance institutes (whether private or governmental) which give 
pharmacists the chance for proper consultation of patients whenever they 
come to collect their medicines. The available insurance program in 
Sudan should build such a relation with community pharmacy. Reasons 
for selecting specific pharmacy are related mainly to the pharmacist good 
relation with customers. Customers would choose pharmacies where 
pharmacists appear ready and happy to give advice to patients. The 
situation of the busy pharmacist should be solved before the   profession 
enters in patient oriented practice. It is apparent from results of this study 
that the main reasons for visiting community pharmacies is not for advice 
in medical conditions or other in- depth consultation and only for the 
traditional role of collecting prescription medicines, which although 
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important is less than pharmacists capabilities. Promising enough is that 
customers emphasize non-prescription medicines for minor diseases as a 
good reason for visiting community pharmacy. This is an old field of 
pharmacy and should be reconsidered always for new handling 
procedures or policies. 
Customers considered pharmacist as second preference for advice in their 
health condition. This considered a step forward when compared with 
other study (Hagie et al, 1992).) , which reported the pharmacist as the 
third preference after the doctor and family members .Many customers 
considered this is the sole function of the doctor. Most of Sudanese 
customer had a good understanding of the pharmacist as a member of 
health professionals, a point which should be utilized for building a good 
understanding for the new patient oriented practices, which customers not 
used to in community pharmacies. Customers cited their consulting 
community pharmacist for medical conditions in the last 12 months. This 
may just show an infrequent practice since customers mostly visited 
community pharmacy for collection of prescription items or over the 
counter products. The customers generally showed unsatisfactory results 
regarding some suggested areas for advice in community pharmacy, as 
smoking cessation, weight and healthy diet and cases of drug misuse and 
this may be due to the fact that these roles not seen before to be done in 
such sites, unexpected to be done or may be due to the fact that not all 
customers need this services. A study of needs of customers is important 
to know what type of services required. Customers may find it difficult in 
general to know who is the pharmacist when visiting community 
pharmacy. This important point in patient oriented practice. Pharmacists 
should wear proper suits which differentiate them from other staff and 
make it easier for approaching for advice. A professional image should be 
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built through professional uniform. 
Respondents reported satisfaction with community pharmacist counseling 
and advice, with pharmacist easily approached and in most of the time 
will hand medicines personally, giving them enough time for their 
queries. Most of respondents get benefit from pharmacist advice. There is 
a lack of written information, and this may be due to customers always in 
a hurry, nevertheless a certain sector of customers would benefit from this 
if presented in an attractive manner in proper situations. The habit of 
referral to other health professionals (e.g. doctors) is not satisfactory, and 
this may indicate lack of cooperation between the two professions or 
pharmacist attitudes to work alone and not in a team work. A system or 
policy of referral is vital in patient oriented practice in community 
pharmacy. 
The response of customers to the new concept of pharmaceutical care was 
positive and this reflects the need of the customers to talk about their 
medications to somebody from health professionals. Pharmacists always 
define themselves as drug experts, but their current mode of education is 
not in favor of patient centered practice, since their education is in the 
fields of chemistry of drugs, activities and formulation but they are not 
well equipped in pharmacotherapy, drug related problems and skills of 
communication, which will benefit patients more, a problem which 
should be addressed seriously.  
 Regarding suggested services or extended roles to be done in the 
community pharmacy. Most respondents accepted medication review, 
consultation rooms, and measurement of blood pressure and to some 
degree blood glucose testing. Medication review and accepted screening 
services is the starting point for pharmaceutical care or patient oriented 
practice in community pharmacy. Reluctance of customers from areas as: 
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vaccination, pregnancy testing and smoking cessation can be explained. 
For the first two services may be customers feel that such tests require 
strict procedures which is not available in pharmacy or may be pharmacy 
is not the place of safety and privacy for tests as pregnancy test. For 
smoking cessation may be most of respondents were not smokers or 
maybe they don’t know about such programs and that pharmacists can do 
that. 
Drug related problems cited by the respondents were mainly of patients’ 
compliance with their medications. This necessitates formulation of a 
standard medication review program, nationally accepted, and supported 
by universities, pharmacy directorates, manufacturers and company 
agents. Regulations should permit community pharmacists to undergo 
some screening test as (screening for raised blood pressure and blood 
glucose). Finally customers reported their need for first aid services in 
community pharmacy a point which seems logical in a profession 
practicing within the community and should not lack this knowledge. 
 The results of this study are compared to study on consumer perceptions 
of and attitudes to community pharmacy done on U.K. (Hagie et al, 
1992). The results of the study showed that loyalty to a particular 
pharmacy increased with increased patient age. First preference for health 
issues is the doctor, followed by the family members and the pharmacist 
as a third preference, which is in contrast to our present study (pharmacist 
cited as second preference).53% felt the pharmacists allowed them ample 
opportunity to discuss their problems fully. The study also indicated that 
in contrast to the well documented fact that females were the most 
frequent users of pharmacy; their study showed that males were the more 
frequent users; this is in line with our present results. Another pilot study 
from U.K (Iversen et al, 2001) investigating attitudes of general public to 
Please purchase PDFcamp Printer on http://www.verypdf.com/ to remove this watermark.
  
ϭϴϬ 
the expanding role of the community pharmacist reported that 
respondents were particularly in favor of community pharmacists 
providing support for other health professionals, for healthy living session 
and for health screening to be done by pharmacists. Subjects were less 
supportive of pharmacist involvement in monitoring   long-term illness as 
asthma, providing antibiotics for minor respiratory infections or 
providing contraceptive pills without prescription. These results were 
similar to the present study in acceptance of some screening tests, but 
points surveyed were different from our present study. Pharmaceutical 
care acceptance not investigated in U.K study. 
3.2 Comparison of practice between Sudan and other countries: 
Comparison of community pharmacy practice in Sudan and developed 
countries shows that although the patient-oriented practice started in 
those countries but still the progress in community pharmacy is slow. The 
type of relation of the community practice with the government in some 
of the developed countries (e.g. U.K& Australia) helped much in 
developing some patient-oriented practices. There is a contract between 
governments and community pharmacy to provide normal dispensing and 
some patient oriented services. The government encourages community 
pharmacy by giving financial funds. This type of relation is lacking in 
Sudan and most developing countries. There are always plans and 
strategies to be applied for community pharmacy. In USA the managed 
care organizations, helped a lot in introducing pharmaceutical care. In 
USA and Australia (U.K in progress),there a system for linking 
continuous education hours with re-registration of pharmacist , which will 
help a lot in creation of pharmacists updated in their professional 
knowledge. Such system is lacking in Sudan. 
In the developed countries there are strict systems for recording 
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psychotropic medicines in especial registers in community pharmacy. In 
Sudan such system is not available. In developed countries still there are 
many barriers to application of patient-oriented practices similar to the 
developing countries. 
In the developed countries the type of education of the pharmacists 
changed towards more patient focused education and departments were 
established for clinical pharmacy and pharmacy practice. There are no 
departments for such disciplines in Sudan. There are many research 
projects in community pharmacy in the developed countries. Few projects 
investigating different aspects of patient-centered practices in community 
pharmacy settings started to emerge in Sudan (Eltayeb and Mohamed S, 
2009; Osman and Mohamed ,2009; Bakri and Mohamed  ,2009). 
Community pharmacy practice in Gulf countries is mostly similar to 
Sudan with slight differences. Traditional roles are still dominating. The 
only difference is that in Gulf countries there are proper systems for 
recording narcotics, psychotrpics and other non- psychotropic medicines 
in community pharmacy. There is no patient oriented practice in  
community pharmacies in Gulf area.    
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CHAPTER FOUR 
CONCLUSION AND RECOMMENDATIONS 
4.1 Conclusion 
The results of this study generally show that: 
1-  Developed countries had proper strategies and plans for 
community pharmacy. 
2- There is support by the government for many patient oriented 
practices in community pharmacy in developed countries. 
3- Education of pharmacy changed in developed countries to include 
a more shift towards clinical pharmacy and other patient oriented 
practices. 
4- Community pharmacists in Sudan is interested in application of 
pharmaceutical care and other extended roles , and they reported 
the following as main barriers:  lack of clinical education, lack of 
understanding of pharmacist new role, Lack of concept of team 
work with other health professionals and Physicians and other 
health care professionals are not aware of the pharmacists' patient 
focused practice. 
5- Community pharmacy in Sudan generally requires more 
development, and more importance should be given to recording of 
psychotropics and other controlled medicines. 
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6- Community pharmacists in Sudan should give importance to 
continuous education. 
7- There is lack of trained assistant pharmacists in community 
pharmacy. 
8- Sudanese doctors were accepting a role of community pharmacist 
in chronic disease prevention and management, health promotion, 
with some preservation regarding screening tests. 
9- Sudanese doctors had positives attitudes toward pharmaceutical 
care, and interested to know more about it. 
10- Community pharmacy customers reported their acceptance for 
pharmaceutical care and some screening tests to be done in 
pharmacy 
11- Community pharmacy customers showed satisfaction for the 
present role of pharmacists in advice giving. 
12 – Community pharmacy customers have some drug related problems 
mainly with compliance and adherence to drug regimen. 
 
4.2 Recommendations: 
-  Changes should be done in pharmacy education in Sudan to 
incorporate new lines of clinical pharmacy and pharmacy practice 
in the undergraduate curriculum, and post graduate studies should 
be established. 
-  A strategy for improvement of community pharmacy practice 
should be devised, and this should include change in regulations, 
systems for training, continuous education,research projects and 
funding for patient-oriented practices 
-  Research projects in the new pharmacy fields should start, and it 
should be supported by pharmaceutical manufacturers and 
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companies, universities and all pharmacy profession.Pharmacy 
practice departments should be included in pharmacy colleges. 
-  Community pharmacies should have a link with health promotion 
units in ministry of health, and should participate in the national 
health promotion activities. 
-  Orientation should be given to other medical professionals and 
public about the new roles of the pharmacist . 
-  Government should enter in some limited contracts for services in 
community pharmacies, and  a role in patient-oriented practice can 
be done in governmental or private pharmacies dealing with 
insured chronic disease  patients e.g health insurance pharmacies 
like “Shwamich” . 
-  Community pharmacists should have special grouping or society to 
discuss their problems and ambitions. 
-  Economic conditions force the public to seek clinical advice from 
the pharmacist in many health conditions,and this well handled by 
community pharmacists ,a role which should be acknowledged and 
further integrated in policies. A system for referral should also be 
devised for community pharmacists. 
-  Community pharmacy should be a center for education in drug use 
and problems and for chronic disease prevention. 
 
4.3 limitations of the study: 
-  the results cannot be generalized  for pharmacists, customers and 
doctors since response rates were 50%,%50% and 65.6% 
respectively, but it gives interesting depths in areas investigated, 
and pave the way for further studies. 
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-  Bias cannot be completely excluded in answers given by 
respondents, although all efforts were done to minimize that. 
-  8% precision is chosen to afford for a suitable practical sample 
size. 
 
4.4 Suggested models for community pharmacy practice in 
developing countries. 
The following three models were the suggested practice models found 
suitable for application in developing countries after survey of the current 
situation internationally. 
Medication review for chronic disease model:  
This will be a prerequisite for introduction of pharmaceutical care in 
developing countries. Similar models were MTM (medication therapy 
management) in USA and Medscheck in Canada (Government of 
Ontario, Ministry of Health and long-term Care 2007). 
   ) and medication use review, in U.K. 
The system will nominate the group of patients to do the review, the 
frequency (suggested be each three months); patients who take more than 
four medicines were the target. Every step should be documented by the 
pharmacist. Referral system should be available. Proper training should 
be available for the pharmacists. 
Health promotion model: 
This will be linked with governmental units and pharmacists will 
participate in specific programs. Pharmacist will participate in education, 
screening .Focus should be given to prevention of diseases like cardiac 
diseases, Diabetes Aids, sexually transmitted disease …etc.Brochures and 
leaflets should be used. 
Responding to symptoms model: 
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Proper type of minor diseases will be chosen. Documentation is essential. 
Referral system should be there. Patients will be announced about the 
service. Proper evaluation should follow. 
A community pharmacy as starting point model should be chosen, results 
should be evaluated by experts. From that model it will be disseminated 
to others. 
Medication review is suggested to be the best model for developing 
countries because it can combine many activities as education, screening, 
discussing drug problems and management at further stages, In the 
developed countries they reached this point in community pharmacy, 
after 30 years from the emergence of  pharmaceutical care. Medication 
review should be combined with tests for raised blood pressure and 
glucose testing for diabetics. 
Pharmacists are expected to undergo these models with proper support 
from universities, government and other professional institutes. 
Payment or remuneration for pharmacist cognitive services should be 
discussed later on, after the acceptance by the public and it should not be 
an obstacle for application. 
Pharmaceutical care in its pure original form (general practice in all 
patients) is difficult to apply in one step; alternatively focus in chronic 
disease medications is the best choice .There is a need for change of the 
mindset ideas of public about community pharmacy gradually. The future 
look for community pharmacy is that of health center location, and not a 
mere drug shop. 
It is promising to find in Sudan the appearance of a practice which will be 
a nucleus for change in community pharmacy. It is reported in the 6th 
annual international pharmacy conference the setting up of advanced 
community pharmacy practice at Khartoum Centre for Pharmaceutical 
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Care. The center is a governmental community pharmacy linked to health 
center. There is clinical pharmacist responsible for counseling only while 
other registered pharmacists are responsible for frontline and dispensing 
of medications (Ahmed H, 2010). 
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4.5 DRAFT PROPOSAL FOR POLICY MAKERS 
 
1- Introduction of clinical pharmacy and pharmacy practice in the 
undergraduate programs. 
2- Change in regulations to permit community pharmacists to: 
- Practice pharmaceutical care and other clinical pharmacy 
practices as: Drug review for chronic disease patients (with 
proper facilities as: consultation room, patient medication 
records  ...Etc.). 
-  Undergo screening tests e.g. blood pressure, blood glucose..etc. 
3- Joint work of community pharmacists with health promotion unit 
in the Pharmacy Administration in the Ministry of Health to fulfill 
certain health targets: e.g. prevention of Malaria, AIDS, kidney 
problems, Diabetes and Cardiovascular diseases, with proper 
incentives where possible.  
4- Government should enter in contracted form of relationship with 
community pharmacies, to do some services starting with 
dispensing and ending with some Drug reviews for certain chronic 
patients and pharmaceutical care. In the start this can be piloted in 
pharmacies related to the Health Insurance System. 
5- Private pharmacies can be piloted for these practices also e.g. to 
choose 5-10 or more pharmacies in Khartoum state which has 
proper facilities i.e. spacious with consultation rooms and area for 
screening tests. 
6- Policy for minor disease management in community pharmacies 
should be adopted: 
- Detailing the type of diseases. 
- Detailing procedure of consultation. 
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- Detailing the limit after which referral is required. 
- Proper documentation. 
- National format for community pharmacists’ referral. 
7- Community pharmacists should have registers for Controlled drugs 
(Narcotics and psychotropics), and other medicines which are 
controlled for another reason of misuse. These registers should be 
available for authorities review. 
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ϮϭϮ 
Professional Development of Community 
     Pharmacy Practice and Strategies for Implementation 
 In Sudan 
Questionnaire 
· This questionnaire is for a dissertation of PhD in 
community pharmacy ( Retail pharmacy) practice, Faculty 
of Pharmacy, University of Khartoum. The research title is 
' Professional development of community pharmacy 
practice and strategies for implementation in developing 
countries'  
 
· Please complete all questions following the instructions 
against each question. 
 
· Your views and perceptions are extremely valuable   to us 
in establishing improved models of pharmacy practice, 
and in understanding obstacles and barriers. 
 
· It is not our intention that you give ideal or perfect answers 
to the questions, but we are interested in your views, 
knowledge and skills, and how you actually practice. 
 
· The information obtained by this questionnaire will only be 
used for the purpose of the study; we assure you that 
names and addresses will remain anonymous. 
 
· Your cooperation and help are highly appreciated. 
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ϥΎϴΒΘγ·Δ˰ϴϟΪϴμϟ΍ϰϣΪΨΘδϣ  
 
ϞοΎϔϟ΍Δ˰ϴϟΪϴμϟ΍ϥϮ˰˰ Α˰ί  
 
· ΔϟΪϴѧμϟ΍ϰѧϓΓ΍έϮΘϛΪѧϟ΍ΔѧΟέΪϟΔѧγ΍έΩιϮѧμΨΑϥΎϴΒΘѧγϻ΍΍άϫ±ΔϟΪϴѧμϟ΍ΔѧϴϠϛ±
ϡϮѧσήΨϟ΍ΔѧόϣΎΟΕΎϴϟΪϴѧλϰѧϓΔϟΪϴѧμϟ΍ΔѧϨϬϣΔѧγέΎϤϣήϳϮѧτΗΔѧγ΍έΪϟ΍κΨ˰ѧΗ
ϊϤΘΠϤϟ΍
 
· ϤϟΎΑΔϳΎϨόϟ΍ϰϓ˱΍ΪϳΪΟ˱΍έϭΩϯΩΆϳ˱ΎϴϤϟΎϋέΎλϰϟΪϴμϟ΍ϥ·ϊѧϣϪϠϛΎѧθϣϞΣϭξϳή
ΏϰϤѧδϳΎϣϚϟΫϭˬΓήϤΘδϤϟ΍ΔόΑΎΘϤϟ΍ϭ΢μϨϟ΍ϢϳΪϘΗϭ˯΍ϭΪϟ΍ΔϴϧϻΪϴѧμϟ΍ΔѧϳΎϋήϟ΍
ϰοήϤϟΎΑϢϳΪѧϘΗϰѧϟ΍ϩ΍ΪѧόΘϳϞѧΑςѧϘϓ˯΍ϭΪѧϟ΍ϑήѧλϰϓϩέϭΩήμΤϨϳϻϚϟάΑϭˬ
ξϳήϤϟΎΑΔλΎΨϟ΍ΕΎϣΪΨϟ΍ 
 
· ϥ΄θϟ΍΍άϫϰϓϢϜ΋΍έ΁ωϼτΘγϻϑΪϬϳϥΎϴΒΘγϻ΍΍άϫ 
 
 
ϣϢϜϟϭϢϜϧϭΎόΗϦδΣϰϠϋήϜθϟ΍ϞϳΰΟΎϨ  
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Ϯϭϲ 
SURVEY FOR PHARMACISTS
DEMOGRAPHIC INFORMATION :  
Please tick the appropriate answer:  
A-Pharmacist and staff information: 
Gender  :       male                female  
Age in years:  21-30            31-40            41-50              51-60          61 and above. 
Year of graduation :…………………………………………………………………. 
University of graduation:…………………………………………………………. 
        Education: 
B Pharm                                   M pharm/Sc 
Postgraduate diploma              PhD    
Number of pharmacists working in the pharmacy: 
Male pharmacists number        0          1          2              3             4           >  4       
Female  pharmacists number    0         1           2             3             4            >  4       
Number of counter assistants   0          1           2            3              4            >  4       
B-Pharmacy information: 
Location: Market area                         Near a hospital/ health center         
                 Near a  private clinic           Residential area 
Ownership: pharmacist                       non-pharmacist  
General information: 
 A- Please indicate by available ( ü  ) in the pharmacy or not available( ×):  
Telephone                                                                                          
Computer                                                                                                    
Internet                                                                                                      
Refrigerator                                                                                             
Consultation room                                                                                     
Special laboratory area                                                                                     
secured cabinet/box for psychotropic and narcotic drugs                         
Register for controlled prescriptions                                                        
Register for patient medication records                                               
Ministry of health registered products list                                                 
File for ministry of health circulars and regulations                                      
File for controlled prescriptions (narcotic and psychotropic)                       
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System for reporting adverse drug reactions                                              
DISPENSING , COMPOUNDING AND DRUG INFORMATION: 
Is there a written procedure for dispensing to be followed by the staff: Yes         ,No  
 
Indicate  the frequency of your performing the following activities when dispensing 
prescriptions by  ticking the appropriate box:  
      (A) At all the time,   (B)frequently,   (C)  Not sure, (D) Some times,  (E)Not at all  
EDCBAActivity
      checking name,sex,age,medicines,dose and duration in each 
prescription. 
1) 
     explaining instructions for use verbally. 2) 
     explaining instructions verbally + hand writing. 3) 
     explaining instructions verbally+ printed information 4) 
     providing oral counseling on the dispensed medicines 5) 
     asking the patient about any drug allergies or 
hypersensitivities before handing medicines. 
6) 
     dispensing prescription medicines without prescription 7) 
     tracing any prescribing errors, drug or food interaction in the 
prescription. 
8) 
     asking each patient about previous drugs he is using 9) 
     asking each patient about current  medical condition 10) 
     Counter assistant is preparing prescriptions and instructing  
patients on use of medicines 
11) 
     explaining side effect of medicines to the patients 12) 
     doing medication review/checking proper use of  medicines 
for patients who bring their home medicines to the pharmacy . 
13) 
     correcting any prescription errors by contacting the prescriber 14) 
     correcting errors in  prescription without referring to the 
prescriber . 
15) 
     giving proper generic alternatives without referring to the 
doctor 
16) 
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PHARMACEUTICAL CARE AND PATIENT CENTERED PRACTICE 
Pharmaceutical care is a new patient care practice. It involves a systematic process by 
which the pharmacist takes the responsibility of preventing or resolving patients’ 
medication related problems and follow up patients to achieve  the desired therapeutic 
outcomes  
 
Q1 Please indicate the level of your agreement or disagreement with the following 
statements by ticking the appropriate box: 
(A) strongly agree, (B) agree, (C) neutral, (D)  disagree, (E)  strongly disagree  
General attitudes: 























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Q2- Please indicate the degree of  importance of the following barriers to 
application of Pharmaceutical care in community pharmacy in Sudan : 
(A) very important, (B) important, (C) not sure, (D) less important, (E) not important  
 


E D C B A Statement: 
     Lack of payment  1) 
     Lack of time 2) 
     Lack of space in the pharmacy 3) 
     lack of software for medication assessement 4) 
     lack of financial capital to implement changes 5) 
     No clinical patient data available 6) 
     Lack of understanding of pharmacist new role 7) 
     Lack of trained assistant staff. 8) 
     Lack of access to drug information 9) 
     Lack of protocols or consensus –reports for treatment 10) 
     Pharmacists not aware of the new patient focused 
practice 
11) 
     Physicians and other health care professionals are not 
aware of the pharmacists’ patient focused practice 
12) 
     Attitudes and opinions of pharmacy owners 13) 
     Lack of clinical education 14) 
     Lack of therapeutic knowledge 15) 
     Lack of communication skills 16) 
     Lack of concept of team work with other health 
professionals 
17) 
     Lack of documentation skills 18) 
     Fear of patient’s rejection 19) 
     Legislation barriers 20) 
     Structure of the health system 21) 
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CHRONIC DISEASES MANAGEMENT 
Chronic diseases management : considers the role of the pharmacist in managing  
long term conditions  e.g. diabetic, hypertensive patients. 
Q1 Please state the level of your agreement or disagreement with the following by 
ticking the appropriate box:
(A) strongly agree, (B) agree, (C) neutral, (D)  disagree, (E)  strongly disagree  
 
HEALTH PROMOTION: 
Health promotion comprises efforts to enhance positive health and prevent ill-health , 
e.g smoking, cessation, weight reduction.  
Q1 Please indicate the degree of your involvement in the following activities by 
providing advice and/or education: 
(A)  very involved, (B) involved, (C) not certain, (D)  uninvolved, (E) very 
uninvolved  
E D C B A Statement 
     You don’t have the proper knowledge about chronic 
diseases 
1) 
     Community pharmacist should play important role in 
chronic disease prevention and management 
2) 
     You accept team work with doctors and other health care 
professionals in long term conditions management 
3) 
     You  think patients will not accept any community 
pharmacist role in chronic disease management 
4) 
     Many patients visiting the pharmacy require chronic  
disease management  
5) 
     Chronic disease prevention and management is not the 
concern of the community pharmacist. 
6) 
E D C B A activity 
     Smoking cessation (stopping) 1) 
     Healthy diet e.g. diabetic and hypertensive patients 2) 
     Exercise especially for certain patients 3) 
     Maintenance  normal blood cholesterol  4) 
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Q2 Please indicate the degree of your agreement or disagreement of the 
following:  
(A) strongly agree, (B) agree, (C) neutral, (D) disagree, (E) strongly disagree  
 
     Obesity and weight reduction 5) 
     Dental or oral health information 6) 
     Skin cancer 7) 
     Contraception methods and medicines  8) 
     AIDS awareness and prevention 9) 
     Unused or waste medicines  10) 
     Medical health devices: for measuring blood 
pressure, Blood glucose etc. 
11) 
E D C B A Statement 
     You don’t have the sufficient base of knowledge  for  
advising patients on health promotion and disease  
prevention 
1) 
     Pharmacists should be part of the health promotion 
activities 
2) 
     You are not interested in health promotion services 3) 
     You don’t have the time to educate patients on health 
issues 
4) 
     You think other health professionals will not accept 
pharmacist  role in health promotion 
5) 
     Public will accept contribution of the pharmacist in 
health  promotion services  
6) 
     It is not important for community  pharmacist to practice 
health promotion 
7) 
     You are willing to be trained in health promotion 
concepts 
8) 
     If there is no payment for health promotion activities I 
will not include it in my practice 
9) 
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Q3 PLEASE INDICATE WETHER THE FOLLOWING ACTIVITY CAN BE 
DONE IN THE COMMUNITY PHARMACY : 
  feasible and can be done (ü ),  not feasible and can not- be done ( x )                          
                                                                                                            
- Blood glucose testing 
- blood cholesterol testing 
-blood pressure measurement 
- pregnancy test 
- vaccination . 
- urine testing 
- bone density testing for osteoperosis 
 
RESPONDING TO SYMPTOMS: 
Q1 Please state the frequency with which you are doing the following activities :  
  (A) At all the time, (B) frequently, (C) not sure, (D) sometimes, (E) not at all             
            
 
Q2 Is there a recorded counseling procedure for minor diseases followed by all the 
staff: Yes            No 
Q3 How you can describe your knowledge about minor disease symptoms : 
Excellent            v. good                good            fair                 poor 
     You are willing to participate in any health campaigns 
(activities)  for disease prevention 
10) 
E D C B A Activity  
     dispensing medicines without prescription for minor 
diseases e.g. cough-diarrohea 
1) 
     asking the patient about his/her symptoms before 
giving medicines 
2) 
     referring patients to the doctor for further checkup if 
I suspect other problems 
3) 
     recording some cases of clinical importance in 
special patient record 
4) 
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Q4 You are aware about the level at which symptoms will indicate serious  disease: 
Yes             No 
Q5 There is specific list of minor conditions and drugs to be used for them in the 
pharmacy : 
Yes           No  
Q6 There is a written form for referring patients to the doctor when required: 
Yes          No 
 
CONTINOUS EDUCATION: 
Q1 How much time do you spend each month updating your professional knowledge: 
 
Nil             1-2 hours         2-6 hours             6-10 hours                 over 10 hours 
 
Q2 Nominate the most important sources of information you are using for 
updating your professional knowledge  
Medical  representatives                             
Continuing education courses                        
Drug leaflets                                                          
Medical journals                                             
Mass media (television, radio etc.)                . 
Other pharmacists                                          
Ministry of health circulars                                 
Internet                                                          
 
FINAL PHARMACIST COMMENTS : 
Please express any suggestions for the development of pharmacy practice in 
community pharmacy (you can answer either in Arabic or English): 
…………………………………………………………………………………………
…………………………………………………………………………………………
…………………………………………………………………………………………
…………………………………………………………………………………………
…………………………………………………………………………………………
…………………………………………………………………………………………
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…………………………………………………………………………………………
…………………………………………………………………………………………
……………….......................................................................... 
..........................................................................................................................................
..........................................................................................................................................
..........................................................................................................................................
.................................... 



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
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

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

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E D C B A Statement 
     You are already aware and knows about the concept of 
pharmaceutical care. 
ϭͿ 
     You support introduction of pharmaceutical care practice, as 
a patient care practice, in community pharmacy 
ϮͿ 
     Traditional role (product oriented) is better than patient 
oriented practice 
ϯͿ 
     The pharmacist can establish and strengthen relationship 
with patients 
ϰͿ 
     Many patients visiting the pharmacy have medication 
related problems  
ϱͿ 
     You prefer solving medication problems in  any prescription 
regardless of type of disease 
ϲͿ 
     You prefer solving medication problems in specific high risk 
patients e.g. chronic disease 
ϳͿ 
     Pharmaceutical care is not important in our developing 
countries  
ϴͿ 
     The present knowledge and skills of the pharmacist are 
inadequate for patient centered practice 
ϵͿ 
     You are willing to be trained  in pharmaceutical care 
concepts 
ϭϬͿ 
     You have no enough time to practice pharmaceutical care  ϭϭͿ 
     You lack knowledge about therapeutic outcome     ϭϮͿ 
     It is difficult to have constant meetings with patients for 
follow up and counselling  
ϭϯͿ 
Please purchase PDFcamp Printer on http://www.verypdf.com/ to remove this watermark.
  
ϮϮϲ 
 
 
 
 
 
 
 
 
 
APPENDIX 4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Please purchase PDFcamp Printer on http://www.verypdf.com/ to remove this watermark.
  
ϮϮϳ 
DOCTOR'S VEIWS AND PERCEPTIONS ON COMMUNITY PHARMACISTS 
EXTENDED ROLE 
Please tick the answer appropriate for you: 
Part I: General information . 
1) Place of practice : Governmental hospital              Private hospital            
                                  Health centre :                          Private clinic 
                                 Other, specify ……………….......................………………  
 
2) Occupation:         Consultant                                  Registrar          
                                  Medical officer                          House officer                     
3) Date of graduation: …………………………………………………………… 
4) University ……….……………………………………………………………. 
5) Age: 21-30            31-40            41-50             51-60          61 and above 
Part II: Contact and communication with community pharmacist. 
Please tick the answer appropriate for you: 
1) How often you contact the community pharmacist? 
 every day                               more than once per week              
once in a week                       once in a month           
 once in three months            once above three months time 
2) What is your method of contact with the community pharmacist?    
direct visit               telephone               fax               internet(e-mail)   
3) Reason/s for your contact with the pharmacist : 
Checking availability of medicines 
Scientific information about medicine 
Checking error in dispensing 
Checking price of medicine 
Other, specify …………………………………………………….……………. 
Part III Views about extended role of community pharmacist:- 
 
The traditional role of the pharmacist concentrates on the drug product oriented 
practice (dispensing), and the extended roles is related to the involvement of the 
pharmacist in a more patient focused pharmaceutical care practice. 
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Please indicate the level of your agreement or disagreement with the following 
activities to be done in the community pharmacy by the community pharmacist by 
ticking the appropriate box: 
(A) strongly agree,  (B) agree, (C) neutral, (D) disagree, (E) strongly disagree  
EDCBAActivity
     Reporting adverse drug reactions 1) 
     Increased role in managing minor illness e.g. cough, 
diarrheoa, cold 
2) 
     Informing public about healthy diet 3) 
     Advice patients about healthy lifestyle e.g. exercise 4) 
     Advice on drug abuse/misuse. 5) 
     Advice on  chronic disease prevention 6) 
     Screening for blood glucose, glycosuria 7) 
     Screening for  blood pressure 8) 
     Screening for blood lipids 9) 
     Urine testing for pregnancy. 10) 
     Vaccination for children 11) 
     Prescribing under protocol 12) 
     Advice and education for long term conditions 13) 
     Health promotion e.g smoking cessation Obesity and weight 
reduction 
14) 
     Participate in a team work with doctors and other    health 
care professionals in management of chronic diseases. 
15) 
     Ensure compliance and adherence to drug regimen   in long 
term conditions.  
16) 
     Undergo medication review for all medicines used   by 
patients with chronic diseases through scheduled meetings  
17) 
     Review and advice on repeat prescriptions 18) 
     Refer patients to the doctor for further checkup when 
suspecting problems  
19) 
 
Part IV – Perceptions on pharmaceutical care practice: 
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Pharmaceutical care is a new patient focused practice in which the pharmacist will be 
responsible for solving drug related problems to improve patient quality of life. 
 
Please describe your level of agreement or disagreement to the following statements 
regarding  the components of Pharmaceutical care. 
 
(A) strongly agree,  (B) agree, (C) neutral, (D) disagree, (E) strongly disagree  
EDCBAstatement
     Activities for preventing and resolving drug-related problems 
will improve quality of patient care 
1) 
     Many patients have problems related to drug use 2) 
     Pharmaceutical care practice will augment and   support 
doctors role in patient care  
3) 
     Pharmacists by practicing pharmaceutical care, will interfere 
with our medical role 
4) 
     The commercial side of the community pharmacy practice will 
not make it suitable for pharmaceutical care practice 
5) 
     Pharmacist role shall be only to dispense prescriptions 6) 
     Pharmaceutical  care will not add benefit to my  practice 7) 
     I will be willing to participate in any team work  including 
pharmaceutical care practice  
8) 
     I will be interested to know more about this concept of 
pharmaceutical care 
9) 
 
Part V – Negative experiences with community pharmacists: 
 
Please choose the most common negative experiences with community 
pharmacists(you can choose more than one answer ): 
Experience                                                                                   
1- Pharmacist is scaring/frightening patients by giving too  
  much information about drugs                                                                       
2- Pharmacists give wrong drug or dosage.                                                     
3- Pharmacist changed the instruction or directions I gave to patient.                 
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4- Pharmacist gives drug not indicated in the prescription.                                
5- Pharmacist not acting professionally,                                                                  
6- Pharmacist gives wrong alternatives for drugs I prescribe                                  
7- Pharmacist dispensing drugs for serious                                                           
    medical condition without prescription.                                                           
8- Pharmacist is making skin preparations as cosmetics                               
which make serious effects to the patient.                                                         
9- Pharmacist give wrong information to patient about his disease                  
10- Other (specify) 
…………………………………………………………………………………………
……………………………………………………………………………… 
Part VI – Please state any additional comments regarding your views about the new 
role of the community pharmacists (Either in Arabic or in English): 
 
…………………………………………………………………………………………
…………………………………………………………………………………………
…………………………………………………………………………………………
…………………………………………………………………………………………
…………………………………………………………………………………………
…………………………………………………………
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